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1.1. Introduction!The( rise( in( antibiotic( resistant( bacteria,( such( as( methicillin( resistant(
Staphylococcus, aureus( (MRSA)( and( multidrug( resistant( Pseudomonas, aeruginosa((MDR(P.,aeruginosa),(has(received(much(attention(in(recent(years,(but(the(rate(of(development(of(new(antibiotics(to(treat(these(emerging(‘’superbugs’’ is(very(slow.((As( an( example,( only( one( new( antibiotic,( Linezolid,( has( been( approved( for( the(treatment(of(acute(skin(infections(since(2000,(although(Tedizolid(is(currently(being(developed.(The(skin(represents(the(primary(defence(mechanism(against(infection;(hence( injuries( or( burns( constitute( significant( pathways( for( bacterial( infection.(Burns(are(especially(susceptible(to(bacterial(colonisation(with(an(estimated(10(%(of( all( burn( injuries( becoming( infected.( Infection( in( acute( burn(wounds( normally(manifest(in(the(form(of(biofilms.(Infection(consequences(include(greatly(increased(patient(morbidity(and(mortality,(and(increased(cost(of(treatment,(especially(due(to(prolonged( lengths( of( stay( in( hospitals.( These( problems( are( accentuated( when(wound(infections(occur(in(children,(due(to(the(added(difficulties(in(early(diagnosis(and(treatment(at(early(ages.((Two(of(the(most(important(burn(wound(colonisers(are(Staphylococcus,aureus((S.,
aureus)(and(Pseudomonas,aeruginosa((P.,aeruginosa).(S.,aureus(is(naturally(present(on( the(skin(of(about(30(%(of(healthy(humans,(but( this(bacterium(is(often(able( to(cause( severe( infection(as(well.(MethicillinPresistant(S.,aureus( (MRSA)( is( the(most(frequently( detected( antibioticPresistant( pathogen( in( hospitals( worldwide.( Its(resistance( extends( to( other( kinds( of( betaPlactam( antibiotics.( P., aeruginosa( is( a(common(cause(of( infection(for(immunePdeficient(patients,(which(is(often(the(case(in(burns(units,( and( it( is( inherently( resistant( to(most( antibiotics.(One(of( the(main(difficulties( presented( by( these( antibioticPresistant( pathogenic( organisms( is( their(ability(to(transfer(their(resistance(to(future(generations.(( The(lack(of(effective(new(antibiotics(has(led(to(interest(in(alternative(therapies,(including(antimicrobial(peptides,(microbial(therapy,(and(the(use(of(viruses(that(kill(bacteria.( Such( bacterial( viruses,( called( bacteriophages( or( phages,( attach( to(bacterial(cell(surfaces,(use(them(as(a(host(for(their(own(replication,(and(eventually(
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produce( bacterial( lysis.( Bacteriophages( therefore( have( potential( for( control( of(microbial(infections.(((Therapeutic( use( of( bacteriophages( dates( from( the( 1930s,( and( they( are( now(being( reconsidered(as(alternatives( to(antibiotics.(This( constitutes(an(opportunity(for( the( development( of( novel( treatment( strategies,( hence( the(motivation( of( this(thesis.( The( advantages( of( bacteriophage( therapy( include( their( capacity( to( infect(bacterial( cells,( their( abundance( and( their( ecological( ‘’friendliness’’.( They( can( be(used( as( a( ‘’phage( cocktail’’,( they( multiply( exponentially,( and( they( do( not( affect(human( microflora( and( hence( do( not( generate( unwanted( side( effects.( However,(their(broad(diversity(presents(a(challenge(to(our(understanding(of(their(potential,(both( regarding( their( specificity,( susceptibility( to( environmental( conditions,( and(mechanisms(of(action.(An(engineering(point(of(view(can(therefore(be(applied(with(respect(to(this,(in(order(to(design(smarter(and(quicker(treatment(strategies(if(they(are(to(be(used(in(bacteriophage(therapy.(((Bacteriophages(have(been(used(against(skin(and(wound(infections,(with(success(rates( up( to( 90( %( against( Staphylococcus, aureus,( Klebsiella, pneumoniae( and(
Pseudomonas, aeruginosa.( For( instance,( ‘’phage( cocktails’’( have( been( shown( to(increase(survival(significantly(in(mice(with(burn(wound(injuries,(and(when(used(in(ear( infections(of(dogs.(Once(a(safe(phage(or( ‘’phage(cocktail’’(has(been( identified,(the(next(step(is(to(deliver(it(to(the(point(of(infection(without(losing(efficacy,(either(during( delivery( or( storage.( Delivery( to( the( infection( site( and( longPterm( storage(methods( for( bacteriophage( formulations( offer( additional( opportunities( to( be(explored(within(this(thesis.((One(of(the(potential(options(that(has(been(considered(for(the(stabilisation(and(
in;situ( delivery( of( bacteriophages( for( phage( therapy( are( simple( oilPinPwater(emulsions.(Particularly,(nanoPemulsions(present(several(advantages(when(used(in(healthcare,(such(as(the(reduction(in(the(required(amount(of(surfactant((which(may(be( prejudicial( for( use( on( skin( at( high( concentrations).( This( is( because( although(more( surfactant( is( required( for( the( same( volume( of( the( discontinuous( phase( for(nanoPemulsions,( a( smaller( concentration(of(nanoPemulsion(droplets( are( required(to( achieve( stabilisation( when( compared( to( emulsions.( ( In( addition( to( this,( their(
Chapter(1( !(
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small(droplet(sizes(allow(a(better(penetration(and(distribution(in(and(through(the(skin(when( compared(with( classical( emulsions( and(microPemulsions.( OilPinPwater(emulsions( especially( enhance( transdermal( penetration.( Moreover,( depending( on(the(formulation(and(the(use(of(thickeners,(numerous(textures(can(be(achieved.(The(large( number( of( possibilities( regarding( emulsion( components( constitutes( an(important( challenge( in( order( to( accomplish( biocompatibility( in( a( healthcare(application,(so(careful(design(of(experiments( is(essential.(At( the(same(time(nanoPemulsions(can(provide(stability(in(longPterm(storage(without(involving(a(significant(decrease(in(their(infectivity.(((The(efficacy(of(encapsulation(for(delivery(and(storage(of(bacteriophage(has(been(demonstrated,(but(other(methods( including(simple(combination(of(bacteriophage(with( emulsions( have( been( shown( to( be( effective.( Nevertheless,( phage( infectivity(and( survival( may( be( influenced( by( the( formulation,( which( can( damage( phage(structural( components.( Phages( may( be( exposed( to( abnormal( environmental(conditions( such( as( the( emulsion( components( themselves.( Furthermore,( the(compounds( present( in( the( nanoPemulsion( may( influence( bacterial( growth( itself,(and(thus(mask(the(specific(effect(of(the(phage.((( To( conclude,( the( increasing( problem( of( antibiotic( resistance( of( pathogenic(bacteria( infecting( burn( and(wound( sites( needs( to( be( faced( from( novel( points( of(view(in(order(to(achieve(a(more(efficient(treatment.(This(constitutes(the(highPlevel(motivation(of( the(project.(Following( this,(bacteriophages(have(been(proved( to(be(efficient( as( antimicrobial( agents,( but( their( diversity( and( complexity( constitute( a(challenge(for(the(inPdepth(knowledge(of(their(mechanisms(of(action.(Attempting(to(face(this(challenge(from(an(engineering(point(of(view,(using(theoretical(approaches(to( understand( bacteriophage( therapy( and( to( design( treatment( strategies( more(efficiently,( is( one( of( the( specific( motivations.( Lastly,( some( bacteriophage(encapsulation(methods(have(already(been(reported(in(the(literature.(However,(the(influence( of( the( delivery( vehicle( on( bacteriophage( behaviour( is( not( regarded.(These( facts( contribute( to( increase( the( difficulty( in( developing( new( ways( for(bacteriophage(delivery,(as(their(interactions(with(bacteria(and(with(other(external(elements(are(not(well(understood.((
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The(ultimate(goal(of(the(work(presented(in(this(thesis(is(the(use(of(oilPinPwater(nanoPemulsions( as( a( model( stabilisation/encapsulation( method( in( order( to(understand(the(behaviour(of(bacteriophages(in(this(kind(of(formulations(for(future(potential(commercial(applications.(
!
1.2. High4Level!Objectives!Taking( into(account(the(motivation(of( the(project(described(above,( there(are(a(series( of( impact( pathways( that( will( be( addressed( in( detail( in( the( Literature!
Review,(in(order(to(ascertain(the(main(gaps(in(knowledge(and(the(objectives(to(be(achieved.(These(points(of(repercussion(can(be(classified(as(social,(economical,(and(technological.( Following( this,( the( highPlevel( objectives( of( this( project( are(summarised(as(follows:(P Improving( the( current( burn( wound( management( strategies( in( children,(specially(regarding(diagnosis(and(acute(infection.(((P Overcoming( the(current(antibiotic( resistance(present( in( infection(sites( such(as( burn( wound( infections,( using( alternative( therapies( that( include( the(application(of(bacterial(viruses,(or(bacteriophages.(( P Engineering(a(topical(cream,(containing(stabilised(bacteriophages,(which(can(be(applied(to(wounds.(( P Achieving( a( detailed( understanding( of( the( mechanisms( of( action( of(bacteriophages(against(pathogenic(bacteria(regarding(the(different(steps(that(constitute( the( infection(process( from(a(qualitative(and(quantitative(point(of(view,(particularly(in(a(wound(environment.((First( of( all,( the( development( of( novel( antibacterial( technologies(would( reduce(morbidity,(mortality(and(healthcare(costs(due( to(bacterial(wound(or(surgical( site(infections,( and( infections(of( burns.( It( is( therefore(key( to( explore( the(background(related( to( the( current( situation( regarding( burns( and( burn( site( infections,( the(antimicrobial( therapies( that( are( clinically( applied( presently,( and( identifying( the(need(for(innovative(treatment(strategies.(This(addresses(the(social(and(economical(impact(of(the(project.(As(far(as(technology(and(knowledge(are(concerned,(several(
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2.1. Introduction!Based! on! the! high2level! objectives,! and! the! aims! described! in!Chapter! 1,! this!
Literature!Review! consists!of! five!different!parts,! regarding! the!most! important!points! that! are! present! in! this! thesis.! Firstly,! a! review! about! the! incidence,!statistics,! current! treatments! and! prevention! of! burn! injuries! will! be! used! as! a!background!in!order!to!justify!the!aim!of!the!project.!The!main!species!of!infection2causing! bacteria! and! their! susceptibility! to! antibiotics! will! also! be! discussed! in!Section!2.2.!Following!that,!a!review!of!the!nature!of!biofilms!present!in!burns!and!wound! infections! will! be! conducted! in! Section! 2.3.! A! summary! of! the! nature! of!bacteriophages,! their! interactions! with! hosts,! stability,! and! their! potential!application!as!antibacterial!agents!is!then!presented!in!Section!2.4.!An!evaluation!of! the! emulsification! methods! and! the! implementation! of! the! emulsification!technique!as!an!effective!and!selective! “drug”!delivery!vehicle!will! constitute! the!fourth! subdivision! of! this! chapter! (Section! 2.5).! Finally,! some! mathematical!modelling! approaches! regarding! bacterial! growth,! bacteriophage! infectivity! and!therapy!are!also!shown!in!the!last!section!(Section!2.6).!!
!
2.2. Burns! and! Wound! Infections:! Statistics,! Clinical!
Treatment!and!Assessment.!Perspectives!
!






Figure!2.2:!Age!and!sex!incidence!of!burn!cases!in!children.!!(1986!–!2007,!both!included).!Interpretation!of! Figures!2.1! and!2.2! shows! that!minor! and!moderate! injuries!are!the!most!common!amongst!burns!patients.!It!appears!that!the!majority!of!cases!are!young!males!from!one!to!two!years!old,!as!shown!in!Figure!2.2.!Note!that!the!definition! of! ‘’minor’’! and! ‘’moderate’’! injuries! corresponds! to! a! scale! of! severity!that!is!a!function!of!the!total!body!surface!area!(%!TBSA)!burned.!This!parameter!will!be!further!discussed!in!Section!2.2.2.!Figure!2.1!also!reveals!the!appearance!of!
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a!growing!number!of!unknown!cases!over!time.!This!suggests!a!need!for!improved!accuracy!when!registering!new!patients.!!!Additionally,! Figures! 2.3! and! 2.4! include! information! about! the! places! where!burn!injuries!are!more!likely!to!occur,!and!the!sources!of!said!injuries,!respectively.!
!!
Figure!2.3:!Locations!where!burn!injuries!are!more!likely!to!occur!to!children.!!













to!scalds.!As!hot!beverage!and!hot!water!scalds!have!been!proved!to!be!especially!notable,!the!remaining!text!will!focus!on!them!and!on!their!consequences.!!Minor! hot! drink! scalds! involve! costs! of! approximately! £1,850! per! case,!comprising!consumables,!medication,! anaesthesia,!dressings,!personnel,! facilities,!and! length! of! hospital! stay,! which! constitutes! the! main! contribution! to! the!expenditure.! !Shorter!stays!in!hospital! involve!lower!costs,!apart!from!the!cost!of!the! treatment! itself.! In! addition,! burns! often! require! follow2up! for! a! number! of!years! in! children,! further! increasing! the! costs.! A! complicating! factor! is! the!possibility!of!Toxic!Shock!Syndrome!(TSS)!or!infection!(Griffiths!et!al.!2006)!which!can! lead! to!a!much!more! serious!and!hence!expensive! situation.!There!are! some!other!considerations!(apart!from!infection)!that!can!influence!the!cost!parameters,!mainly!in!serious!burn!cases.!For!example,!lengths!of!stay!depend!on!the!amount!of!calories! required!by! the! resting!body,!which! rises! significantly! for! burns! victims!and! leads! to! hypermetabolism.! This! condition! persists! throughout! the! healing!time,!and!even!when!the!burn!wound!is!closed,!until!6!–!12!months!post%burn.!Data!from! some! studies! show! that! female! children! show! a! decreased! hypermetabolic!response! compared! to!males! (Mlcak! et! al.! 2006).! Another! complicating! factor! is!fluid! loss! through! the!skin,!which!may!produce!edema!or!electrolyte! imbalances.!Calculations!conducted!by!Namdar!et!al.!suggest!that!appropriate!fluid!removal!is!essential!to!avoid!further!complications!(Namdar!et!al.!2010).!
2.2.2. Current!Clinical!Assessment!and!Treatment!There!is!a!sensitive!issue!when!diagnosing!scalds!and!burn!injuries!in!children:!managing! to! discern!whether! it! was! an! accidental! injury! or! not.! Some! facts! are!checked,! such! as! the! compatibility! of! the! current! injury! according! to! the! child’s!medical!history,! their!behaviour,!or! the!presence!of!other! injuries.!Luckily! in! the!UK! there! is! a! small! percentage! of! non2accidental! cases! (only! 2! %! of! registered!cases! in! the!emergency!department)! (Benger!&!McCabe!2001;!Titus!et! al.!2003).!Non2accidental! burn! cases! clearly! present! greater! challenges! and! potential! costs!during!treatment.!!When!assessing!burn!wounds,!the!measurement!of!burn!size!via!surface!area!is!the!first!and!key!part.!Quantification!of!the!injured!skin!extension!is!calculated!in!
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terms! of! a! percentage! of! the! total! body! surface! area,! TBSA! (Anon! n.d.;!Miminas!2007).!Some!of! the!most!popular!methods!used!are! the!Lund!and!Browder!chart!(LB,!which!can!be!observed!in!Figure!2.5)!(Lund!&!Browder!1944),!the!DuBois!and!DuBois! formula!(Perry!et!al.!1996)!and!some!upgraded!formulae!such!as!the!one!developed!by!Yu,!Lin!and!Yang,!including!three2dimensional!scans!(Yu!et!al.!2010).!!!
!
Figure!2.5:!Lund!and!Browder!Chart.!Reprinted!with!permission!from!the!copyright!holder!(See!(Miminas!2007)).!Using! the! LB! chart! and! the! depth! of! damaged! skin! (sometimes! using! Laser!Doppler! Imaging!for!burn2depth!estimation!on!the! first!day!of! therapy!and!every!other! day! subsequently)! provides! an! idea! about! the! severity! of! the! injury.!Differences!in!burn!injury!locations,!even!if!they!represent!the!same!percentage!of!TBSA,!have!different!consequences! in! terms!of! the! required!degree!of! care,!need!for! surgery,! or! likelihood! of! infection.! More! in2depth! considerations! have! to! be!taken! into! account! if! life2threatening! factors! are! present,! or! if! the! patient! has!unusual!issues,!such!as!psychiatric!problems.!!The! common! protocol! in! wound! management! includes! wound! cleaning! with!normal!saline!solutions,!covering!with!topical!creams,!which!can!be!antimicrobial!
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or!antibiotic2containing!depending!upon!the!infection!status,!followed!by!dressings,!gauzes! and! bandages.! Once! the! survival! of! the! patient! is! not! a! concern,! every!treatment! focuses! on! the! recovery! and! repair! of! the! burnt! area! regarding! its!aspect,! function!and!movement.!This! can!either!be!achieved!by!wound!dressings!alone!or! some! form!of! skin! replacement.!Wound!dressings! are!used! routinely! to!prevent!infection!and!to!keep!the!wound!moist.!!A! desirable! burn! wound! dressing! has! the! following! characteristics! (Mandal!2007;!Wasiak!et!al.!2013):!2 Adherence,!which!is!reduced!when!infections!are!present.!2 Good!water!vapour!transport.!2 Elasticity!and!durability.!2 Minimal!storage!requirements.!2 Low!cost.!!They!must!also!contribute!to:!2 Minimisation!or!elimination!of!pain,!consequently!decreasing!the!amount!of!narcotics!needed!(Gee!Kee!et!al.!2013).!!2 Inhibition! of! infection,! fluid! and! blood! accumulation,! thereby! preventing! a!reduction!in!the!metabolic!demand.!2 Inhibition!of!scarring.!2 Minimisation!of!disability.!2 Minimisation! of! the! number! of! dressing! changes,! which! involve! large!amounts!of!materials!or!anaesthesia!and!many!hours!of!nursing.!!!2 Minimisation!of!the!length!of!stay!in!hospital!(which!lasts!at!least!one!month!or!up!to!three!months!for!children,!according!to!Herndon!et!al.!(Herndon!et!al.!1993)).!!Some! of! the! current! burn! wound! treatment! methods! are! described! and!compared!in!the!literature!(Mandal!2007;!Hassan!&!Shah!2006;!Khan!et!al.!1998;!Knight!et!al.!2005;!Kumar!et!al.!2004;!Lal!et!al.!2000;!Lang!et!al.!2005;!Malic!et!al.!2005;!Ou!et!al.!1998;!Rajayogeswaran!et!al.!2008;!Smith!et!al.!2009;!Whitaker!et!al.!2007;!Hansbrough!et!al.!1984;!Amani!et!al.!2006;!Demling!n.d.;!Bhatti!et!al.!2009;!Wasiak!et!al.!2013),!but!a!brief!summary!is!provided!here:!
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SILVAZINE; 11.2!days! 49!%!!2 DuoDERM®,;GranuFlex®!and!other!hydrocolloid!dressings! (ConvaTec,! (Anon!n.d.)):!are!opaque!dressing!with!an!active!surface!containing!gelatine,!pectin!and! cellulose.! It! has! been! used! to! provide! a! moist! wound2healing!environment,! while! protecting! against! contamination,! even! with! open!wounds.! The! results! are! not! very! different! from! BIOBRANE! in! terms! of!healing!time!or!pain!scores!but!these!dressings!are!not!as!expensive!(Cassidy!et!al.!2005).!!!2! XEROFORM™;Petrolatum;Gauze!(COVIDIEN,!Kendall,!(Anon!n.d.)):!is!used!for!deep! wounds! due! to! its! bacteriostatic! action! when! exudation! occurs.!According! to!Gravante! and!Montone,! these! kinds! of! gauze! are! also! suitable!for!superficial!burns!where!risks!of!infection!are!lower!(Gravante!&!Montone!2010).!!As!a!summary,!and!according!to!the!review!by!Wasiak!et!al.!(Wasiak!et!al.!2013),!dressings! containing! silver! sulfadiazine! (e.g.! SILVAZINE)! produce! poorer! healing!outcomes! than! biosynthetic! (skin! substitute)! dressings! (e.g.! BIOBRANE,;
TransCyte®),! silver2containing! dressings! and! silicon2coated! dressings.! Superficial!and!partial!thickness!burns!treated!with!hydrogel!dressings!(e.g.!DuoDERM®)!heal!more!quickly!than!those!treated!with!usual!care.!!!Additionally,! if! the! skin! is! sufficiently! damaged,! grafting! (sometimes! auto2grafting)!processes!are!required.!The!main!considerations!are!the! increase! in!the!probability!of!infection,!as!grafting!requires!removal!and!replacement!of!skin,!and!the!additional!costs!and!potentially!longer!recovery!times.!
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2.2.3. Toxic!Shock!Syndrome!Toxic! Shock! Syndrome! (TSS)! is! in! general! the! most! probable! cause! of! burn2related!deaths! in!modern!burn!units! (approximately!54!%!of! the!cases!of!death)!(Church! et! al.! 2006).! It! normally! occurs! when! Staphylococcus; aureus; and/or!
Pseudomonas; aeruginosa; colonise! and! infect! the! burn! site! (Fekih! Hassen! et! al.!2014).! Other! pathogenic! organisms! can! infect! burn! sites! but! these! are! less!common! and! require! further! study! (Frame! et! al.! 1992).! These! pathogens! are!normally!present!in!the!air!and!on!furniture!in!hospitals,!especially!in!rooms!with!high!rates!of!occupancy!(Khojasteh!et!al.!2007).!TSS! is!primarily!seen!in!children!younger!than!four!years!old!with!small!burns!(Trop!et!al.!2004)!in!the!3!–!4!days!post2burn! (McAllister! et! al.! 1993).!Although! it! is!not! very! frequent,! it! represents!the! most! common! cause! of! unexpected! mortality! in! children! with! this! kind! of!injury! (Young!&! Thornton! 2007).! One! example! of! its! frequency! of! occurrence! is!reported! by! Edward2Jones! et! al.! in! their! survey! (Edwards2Jones! et! al.! 2000):!approximately!2.5!%!of!the!children!admitted!to!UK!burns!units!showed!symptoms!of!TSS.!!!Some! antimicrobial! treatments! such! as! silver! sulfadiazine! or! antibiotics! can!increase! the! amount! of! toxin! produced! by! these! organisms! in! specific!environmental!conditions.! !The!toxin,!only!produced!by!20!%!of!the!strains,!over!stimulates!the!immune!system!causing!temperature!rise,!rash,!diarrhoea,!vomiting!and! lack! of! appetite,! hypotension,! tachycardia! and! even! death,! which! are! the!typical! symptoms! or! macroscopic! signs! of! TSS.! However,! in! some! cases! these!symptoms!are!not!observed,!or!are!actually!signs!of!simpler!infections!or!the!need!for!surgical!intervention!in!deep!burns!(Jenkins!&!Young!2010).!!!Monitoring! is! highly! recommended! for! children! suffering! pyrexia! (Young! &!Thornton! 2007)! since! nowadays! the! only!way! to! diagnose! infection! is! by! direct!observation!and!wound!assessment.!Recognising!if!the!burn!site!is!indeed!infected!becomes!more! complicated!when! the!wound! is! already! completely! covered!with!some!kind!of!dressing.!The!patient’s!condition!worsens!very!quickly!if!there!is!no!rapid!therapy!or!if!it!is!delayed!or!inadequate.!Sometimes!no!macroscopic!signs!are!observed!and!infection!can!continue!undetected.!It!could!be!possible!that!the!way!
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burn!wounds!are!managed!(hence!the!type!of!dressings)!may!directly!influence!the!appearance!and!development!of!TSS.!Unfortunately,!dressings!that!encourage!cell!growth! may! also! stimulate! pathogen! proliferation! (Jenkins! &! Young! 2010;!Weinzweig!et!al.!1994).!!A!serious!further!complication!of!TSS!appears!when!the!causal!microorganisms!are! antibiotic2resistant;! these! are! named! multidrug2resistant! (MDR)! bacteria.!These! are! especially! aggressive! amongst! young! children,! elderly! people,! and!patients!with! compromised! immune! functions,!which! is! often! typical! of! patients!suffering! from! burns.! One! of! the!most! common! antibiotic2resistant! organisms! is!methicillin2resistant! S.; aureus! (MRSA)! (Rashid! et! al.! 2006)! but! some! others! are!reported! by! the! European! Centre! for!Disease! Prevention! and!Control! (European!Centre!for!Disease!Prevention!and!Control!2014):!2 Staphylococcus;aureus:! It! is! a! Gram2positive! bacterium.! This!means! that! its!outer!cell!wall!presents!a!thick!layer!of!peptidoglycan.!It!normally!colonises!the! skin!of! about!30!%!of!healthy!humans,! but! is! also! able! to! cause! severe!infection.!As!stated!before,!MRSA!is!the!most!important!cause!of!infection!and!the!most! identified!antibiotic2resistant!pathogen! in!hospitals!worldwide.! Its!resistance!extends!to!other!kinds!of!beta2lactam!antibiotics,!making!S.;aureus;a! multi2drug! resistant! bacterium.! MRSA! proliferation! has! been! specially!perturbing!over!the!past!two!decades,!as!evidenced!by!Murray!et!al.!in!their!evaluation!of!the!USAISR!Burn!Centre!(Houston,!USA)!(Murray!et!al.!2009).!!As!an!example,! it!has!been!reported!that!in!2013,!30,528!isolates!presented!resistance! to! the! antibiotic! Linezolid! in! Europe,! 1.2! %! amongst! the! MRSA!isolates!and!0.1!%!among!the!methicillin!sensitive!S.;aureus!(MSSA)!isolates!(European!Centre! for!Disease!Prevention!and!Control!2014).!The!antibiotic!resistance! of! S.; aureus! against! this! particular! antibiotic! is! significant! since!




Figure!2.6:!Percentage!of!S.#aureus!isolates!resistant!to!methicillin!in!Europe!in!2013.!!Extracted!from!(European!Centre!for!Disease!Prevention!and!Control!2014).!! According! to! Figure! 2.6,! the! incidence! of! MRSA! is! more! pronounced! in!Mediterranean! countries.! However,! a! decline! of! MRSA! has! been! reported,!especially! in! the! first! decade! of! the! century,! in! nine! out! of! 30! countries.!Despite!this!positive!development,!MRSA!remains!a!public!health!priority!in!Europe.!!2 Streptococcus;pneumoniae:!Its!importance!in!burn!wounds!lies!in!the!fact!that!it! presents! some! virulence! factors! that! permit! its! adherence! to! epithelial!cells.!S.;pneumoniae!has!been!reported!to!be!resistant!to!penicillin,!but!also!to!macrolides,! lincosamides! and! streptogramins! (MLS),! although! they! are!chemically! distinct.! It! is! not! very! common! in! burn! patients! and! can! be!considered!as!a!community%acquired!pathogen!in!the!burns!unit!(Glasser!et!al.!2010).!!2 Klebsiella;pneumoniae:! It! is! a! normal! coloniser! of! the! gastrointestinal! tract!but! can! also! be! found! on! skin,! opportunistically! infecting! patients! with!compromised! immune! systems.! It! can! spread! rapidly,! even! reaching!outbreak!levels!in!hospitals.!It!is!resistant!to!multiple!antibiotics,!for!instance,!beta2lactam!antibiotics,!due!to!various!mechanisms!(Bennett!et!al.!2010).!
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; Regarding! resistance! to! aminoglycosides! (Figure! 2.8),! there! are! various!trends! depending! on! the! country:! increasing! trends! were! observed! for!Denmark,! Ireland,! Italy! and! Sweden.! On! the! other! hand,! significantly!decreasing! trends! were! observed! for! countries! such! as! Austria,! the! Czech!Republic,! Malta! and! Spain.! Despite! the! diminishing! resistance! in! Europe,!
Pseudomonas;aeruginosa; is! still! considered! as! a!major! cause! of! healthcare2associated!infections.!!The! variety! of! available! antimicrobial! drugs! is! enormous! but! they! need! to! be!rationally!prescribed.!Self2medication!must!be!avoided,!as! it!appears!to!be!one!of!the!major!causes!of!antibiotic! resistance,! together!with!home!wastage!and!water!contamination! with! unused! antibiotics.! Depending! on! the! type! of! pathogen,!resistance! follows! different! patterns! even! decreasing! in! some! cases,! or! being!stabilised! as! demonstrated! in! Figures! 2.6! –! 2.8.! The! final! and! unfortunate!consequence! of! the! increasing! resistance! is! the! partial! loss! of! antimicrobial!
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treatment! options! and! the! necessity! of! screening! for! alternatives.! As! a!consequence! there! is! an! urgent! need! of! prevention! and! consciousness2raising!regarding! the! inappropriate! use! of! antibiotics.! A! very! recent! example! is! the! 7th!European!Antibiotic!Awareness!Day!(November!17th!2014).!The!European!Centre!for! Disease! Prevention! and! Control! (ECDC)! released! its! latest! data! on! antibiotic!resistance! (Anon! 2014)! regarding! an! increase! of! carbapenem! resistance! in!






The!aim!of!these!kinds!of!campaigns,!such!as!the!one!shown!in!Figure!2.9,!is!to!raise! attention! and! consciousness! from! the! general! population,! and! also! from!healthcare!professionals!and!research!scientists,!in!order!to!overcome!the!problem!and!propose!alternatives.!The!issue!of!antibiotic!resistance,!together!with!the!slow!development! and! approval! of! new! antibiotics,! has! been! addressed! by! the!World!Health!Organisation! (WHO)! and! the!UK!Government,! in! order! to! create! a! 5! year!strategy! to! optimise! the! use! of! the! current! antibiotics,! to! improve! prevention! of!bacterial! infections,! to! control! the! distribution! of! prescriptions! with! pondered!decisions!regarding!if!an!antibiotic!is!really!needed!or!not,!and!most!importantly,!to!alert!patients,!healthcare!professionals,! farmers!and!animal!keepers!about! the!importance!of!antibiotic!treatment!regimens!(WHO!2014;!Anon!2013).!!
2.3. Bacterial!Biofilms!The! seriousness! of! the! presence! and! development! of! bacterial! infections,!particularly! in!burn!wounds,!has!been!demonstrated! in!Section!2.2! from!a! social!and! clinical! point! of! view.! It! is! also! key! to! understand! how! bacterial! infections!manifest.!The!concept!of!bacteria!being!in!nature!as!associated!communities!dates!from! the! early! stages! of! the! history! of! microbiology,! when! Antonie! van!Leuwenhoek! described! aggregates! of! ‘’animalcules’’! after! observation! of! swabs!from!human! tooth!surfaces! (Costerton!1999).!Many!more!demonstrations!of! this!fact! have! been! reported! over! the! years,! in! many! different! environments! and!natural!ecosystems!(Watnick!&!Kolter!2000).!Bacteria!in!nature!live!preferentially!on! surfaces,! as! opposed! to! laboratory! cultures,! where! they! normally! appear! in!suspension,!as!planktonic!cultures.!In!fact,!bacterial!biofilms!represent!the!most!common! form! of! bacterial! life! in! nature! (Hall2Stoodley! et! al.! 2004).! Bacterial!biofilms! are! defined! as! ‘‘highly! structured! matrix2enclosed! communities,! whose!cells! express! genes! in! a! pattern! that! differs! profoundly! from! that! of! their!planktonic!counterparts’’!(Stoodley!et!al.!2002).!The!formation!of!biofilms!depends!on! the! environmental! conditions! that! promote! adherence! of! cells! to! certain!surfaces,!but!also!on!the!specific!lineage!of!bacteria!(Croes!et!al.!2009;!Götz!2002;!Tang!et!al.!2012).!!!
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In!particular,!Staphylococcus;aureus!and!Pseudomonas;aeruginosa;form!biofilms!that! have! been! widely! studied! in! the! literature.! S.; aureus! can! produce! a! multi2layered!biofilm!embedded!within!a!glycocalyx!layer,!composed!basically!of!teichoic!acids! and! a! polysaccharide! antigen,! with! heterogeneous! host! protein! as! well!(Archer!et!al.!2011;!O’Gara!2007).!Formation!of!S.;aureus!biofilms!can!be!enhanced!by! the! secretion! of! inflammatory! toxins! that! disrupt!mucosal! tissues! and! favour!infection! (Anderson! et! al.! 2012).! On! the! other! hand,! P.; aeruginosa! also! forms!biofilms!that!are!very!well!studied!since!they!are!the!main!cause!of!cystic!fibrosis.!!The! large! genome! of! P.; aeruginosa! is! important! regarding! its! ability! to! form!biofilms.!Due! to! its!pili,! and! the!polysaccharide!matrix,!P.;aeruginosa! irreversibly!binds! to! surfaces.! Similarly! to!S.;aureus,!P.;aeruginosa! biofilms! are!multi2layered!(Høiby!et!al.!2001).!!!Biofilms! are! responsible! for! different! kinds! of! infections,! including! dental!plaque,! cystic! fibrosis! and! other! chronic! infections,! urinary! track! infections,! and!wound! infections! amongst! others! (Bjarnsholt! 2013).! As! far! as! wounds! are!concerned,! bacteria! can! cause! infection! and! inflammation! by! damaging! and/or!penetrating!the!skin.!There!are!two!possible!scenarios!when!infection!occurs:!the!absence! or! appearance! of! clinical! symptoms.! If! an! infection! causes! clinical!symptoms! (fever,! inflammation,! etc.),! it! is! known! as! acute! infection! and!may! be!lethal.! In! addition! to! this,! if! the! infection! persists,! despite! the! immune! response!and! antimicrobial! therapy,! it! is! a! chronic/persistent! infection.! Biofilms! are!extremely!abundant!in!chronic!wounds!in!comparison!to!acute!wounds!(James!et!al.!2007),!and!it!has!been!demonstrated!that!they!produce!delayed!healing!of!such!wounds! (Roy! et! al.! 2014),! and! enhance! the! appearance! of! antibiotic! resistance!(Percival!et!al.!2012).!!Acute!and!chronic! infections!constitute!an!extensive!and!serious!public!health!problem,! and! therefore! their! management! and! treatment! require! a! deeper!understanding! of! the!mechanisms! and! conditions! by!which! biofilms! are! formed.!This!is!explored!in!Section!2.3.1.!!
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‘‘persister’’!cells.!This!type!of!cells!are!intrinsically!not!resistant!to!antimicrobials,!but! they! show! multidrug! tolerance! (MDT),! in! the! case! when! they! are! deeply!dormant! (Lewis! 2007).! Antibiotics! are! generally! effective! against! active! growing!bacteria.!They!reach!their!target!in!the!cell!and!prevent!normal!function,!leading!to!a! failure!of! the! cell! system,!and! thus! cell! killing.!However,!persister! cells! are!not!growing,! so! that!even! if! the!drug!molecule! reaches! its! target,!no! function!will!be!blocked! (because! no! function! is! taking! place)! and! bacteria! will! survive! (Lewis!2007).!Persister!cells!are!therefore!not!eliminated!from!the!biofilm!infection!site,!and! represent! a! possible! source! of! repopulation! of! the! biofilm,! making! the!antibiotic!therapy!less!effective.!!!
2.3.2. Biofilms!and!Wound!Dressings!Treatment!of!biofilms!in!chronic!wounds!has!been!extensively!modelled!in;vitro!in! the! literature.! Particularly! in! the! case! of! cutaneous! chronic! wounds! there! is!currently!no!single!antimicrobial!agent!that!is!completely!effective!against!both!the!planktonic! cells! and! the! biofilm2forming! cells! (Percival! et! al.! 2014).! Some! of! the!antimicrobials! that! have! been! normally! used! in! wound! infection! treatments!include!antiseptics!(mainly! for!prevention),!silver!products,!such!as!silver!nitrate!and! silver! sulfadiazine! (silver! is! ionised! via! moisture! in! the! wound,! and! has!antimicrobial! properties),! various! wound! dressings! containing! silver! and! iodine!(Said,!Dodoo,!et!al.!2014),!a!novel!honey2based!treatment!(Dryden!et!al.!2014),!and!traditional! antibiotics.! The! efficacy! of! these! antimicrobial! agents! has! been!compared! in! the! literature! as! well! (Said,! Walker,! et! al.! 2014).! For! instance,!depending!on!the!‘’age’’!and!phenotype!of!the!biofilm,!antibiotics!can!be!completely!inefficient! against! S.; aureus! and! P.; aeruginosa! biofilms,! while! iodine2containing!dressings!effectively!disrupt!said!biofilms!(Hill!et!al.!2010).!The!treatment!time!has!also!a!dramatic!effect!on! the!eradication!of!biofilms! in!wounds,!as!demonstrated!for! superficial! murine! wounds! (Roche! et! al.! 2012):! the! quicker! the! antibiotic!treatment! is! applied! after! infection,! the! better! the! performance.! Some!environmental! conditions,! such! as! pH! and! the! presence! of! amino! acids! can! also!alter!the!performance!of!antimicrobials!(Sanchez!et!al.!2014;!Percival!et!al.!2014),!with! traditional! antibiotics! being! generally! the! least! effective! because! of! the!reasons!explained!in!Section!2.3.1.!!
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All!the!studies!regarding!the!efficacy!of!anti2biofilm!treatments!conclude!that!it!is! best! to! take! a!multifactorial! approach! towards! controlling!biofilms! in! infected!wounds,!using!the!so!called!“anti2biofilm!tool2box”!of!therapies,!to!kill!and!prevent!reattachment.! It! is!also!key!to!be!clinically!responsible!with!respect! to! the!use!of!antimicrobial! agents! to! prevent! development! of! resistance! and! multidrug!tolerance!(Percival!et!al.!2012;!Percival!et!al.!2014).!However,!it!is!also!important!to! explore! new! treatment! options! against! biofilms! in! order! to! expand! the!possibilities! of! the! “anti2biofilm! tool2box”.! In! this! sense,! bacteriophages! will! be!considered!in!the!next!section.!!
2.4. Bacteriophages!
2.4.1. Bacteriophage!as!an!Alternative!Antimicrobial!Treatment!!As! a! consequence! of! the! development! of! widespread! antibiotic! resistance,!several! alternative! therapies! are! starting! to! emerge.! Some! of! the! potentially!interesting!antimicrobial!therapies!are!improved!antibiotics,!techniques!to!modify!bacterial! phenotypes! to! make! them! more! susceptible! to! antibiotics,! activated!antibacterial! agents,! and! bacteriophages! (Taylor! et! al.! 2002).! One! of! the! main!difficulties! presented! by! these! antibiotic2resistant! pathogenic! organisms! is! their!ability!to!transfer!their!resistance!to!future!generations.!!!The!therapeutic!use!of!bacteriophages!dates!from!the!early!30s,!but!was!almost!forgotten!completely!except!in!the!Soviet!Union!and!some!countries!from!Eastern!Europe.! Nevertheless,! several! relevant! non2English! language! publications!appeared,!reporting!success!rates!against! infection!of!80295!%!for!phage!therapy!(Alisky! et! al.! 1998).! Nowadays,! phages! are! being! reconsidered! in! order! to!overcome! the! limitations! of! antibiotics.! Some! of! their! advantages! include! their!capability! to! infect! bacterial! cells,! even! if! their! particular! hosts!mutate,! they! are!abundant! and! ecologically! friendly,! they! can! be! used! as! a! “phage2cocktail”,! they!multiply!exponentially,!they!do!not!affect!normal!human!microflora!and!therefore!do!not!generate!side2effects!(Kutateladze!&!Adamia!2010;!Hanlon!2007).!However,!their!overwhelming!diversity!presents!a! challenge! to!our!detailed!understanding!of!their!possibilities.!!
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In! the! 1940s,! several! companies! (L’Oréal,! for! instance)! commercialised! and!publicised! therapeutic! phage! preparations! which! were! ready2to2use! remedies!(Fortuna!&!Miedzybrodzki!2008).!In!this!sense,!the!most!disappointing!issue!is!the!current! lack! of! interest! of! big! pharmaceutical! companies,! which! is! absolutely!essential! for! their! clinical! application.! On! the! other! hand! the! pharmaceutical!industry! has! a! strong! economical! interest! in! maintaining! the! current! use! of!antibiotics.!!Regarding! infections! that! affect! skin! burns,! bacteriophages! have! already!been!used!in!Georgia!and!Poland,!with!success!rates!up!to!90!%!against!Staphylococcus;








2.4.2. Nature!of!Bacteriophages!and!General!Information!The! first! identification! of! bacteriophages! or! bacterial! viruses!was! surrounded!by! great! controversy.! Some! opinions! award! this! discovery! to! the! English!microbiologist!F.!W.!Twort!in!1915.!The!French2Canadian!F.!d’Herelle!followed!the!former’s! theories! two! years! later.! Some! acknowledge! d’Herelle’s! contribution!whereas!others!accuse!him!of!plagiarism!(Duckworth!1976).!!Bacteriophages! are! obligatory! parasites! that! infect! bacteria.! There! is! a! huge!diversity! of! these! viruses,! mainly! in! aquatic! environments,! and! recent! evidence!demonstrates! that! viral! activity! maintains! genetic! diversity! amongst! bacteria!
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Bacteriophages! are!normally! specific!when! they! infect! bacteria;! that! is! to! say,!they!are!unique!for!a!particular!strain!of!host!cell.!On!the!other!hand,!bacteria!can!develop! defence! mechanisms! to! ensure! their! survival! in! the! presence! of!bacteriophage.!One!of!the!critical!stages!of!phage!infectivity!is!their!attachment!to!the!host!cell!surface.!Some!resistant!bacteria!secret!a!barrier!that!prevents!phage!attachment,! or! they! develop! mutations! of! their! phage! receptors,! preventing!injection!of! viral! genetic!material,! and!hence!blocking! infection.!Others! can! even!avoid! being! killed! after! transference! of! the! nucleic! acid.! On! the! other! hand,!bacteriophages!continually!mutate!to!adapt!themselves!to!new!situations!(Krüger!&!Bickle!1983)!and!overcome!bacterial!resistance!mechanisms.!!The!general!morphology!of!phage!includes!an!icosahedral!head,!containing!the!genome,!and!tails,!which!can!be!rigid!or!flexible,!contractile!or!non2contractile.!One!of! the! best! studied! is! T4! (Escherichia; coli;bacteriophage),! which! is! shown! as! an!example!in!Figure!2.12:!!
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5500 Phages examined in the electron microscope 229
Table 1. Overview of phage families
Shape Nucleic acid Virus group Particulars Example
Tailed DNA, 2, L Myoviridae tail contractile T4
Siphoviridae tail long, noncontractile λ
Podoviridae tail short T7
Polyhedral DNA, 1, C Microviridae conspicuous capsomers φX174
2, C, S Corticoviridae complex capsid, lipids PM2
2, L Tectiviridae inner lipid vesicle, pseudotail PRD1
2, L SHI, group∗ inner lipid vesicle SH1
2, C STV1 group∗ turret-shaped protrusions STIV
RNA, 1, L Leviviridae poliovirus-like MS2
2, L, seg Cystoviridae envelope, lipids φ6
Filamentous DNA, 1, C Inoviridae a. long filaments fd
b. short rods MVL1
2, L Lipothrixviridae envelope, lipids TTV1
2, L Rudiviridae TMV-like SIRV-1
Pleomorphic DNA, 2, C, S Plasmaviridae envelope, lipids, no capsid L2
2, C, S Fuselloviridae same, lemon-shaped SSV1
2, L, S Salterprovirus same, lemon-shaped His1
2, C, S Guttaviridae droplet-shaped SNDV
2, L Ampullaviridae∗ bottle-shaped ABV
2, C Bicaudaviridae∗ two-tailed, growth cycle ATV
2, L Globuloviridae∗ paramyxovirus-like PSV
C Circular; L linear; S superhelical; seg segmented; 1 single-stranded; 2 double-stranded
∗Awaiting classification
stranded DNA or RNA. The three families of tailed phages constitute the order
Caudovirales. Polyhedral phages have “cubic” symmetry and are icosahedra
or similar polyhedra (leviviruses). The various families of PFP phages are not
grouped into orders. A few of them have lipid envelopes or contain lipids as parts
of internal vesicles (Tectiviridae) or the capsid (Corticoviridae). In addition to
phages of established families, a number or archaeal phages have recently been
described. They still await classification by the ICTV, but differ profoundly from
other known phages and clearly represent novel virus families. The total number
of high-ranking phage taxa of family or equivalent rank is thus 20 (Table 1 and
Fig. 2).
Phages are listed by host genera because they are essentially host genus-
specific in replication. However, enterobacteria are so closely related that poly-
valent phages are common there, especially in the coli-Shigella-Klebsiella group.
Enterobacteria are thus considered here as a single host “genus”. Other polyvalent
phages exist in tectiviruses [1, 2, 4] and in archaebacteria (infra, see Salterprovirus
and Globuloviridae).
Recent changes in bacterial classification are accounted for. The largely phe-





Figure!2.13:!Morphotypes!of!bacteriophage.!!!(Note:!ss!Single2stranded;!ds!Double2stranded).!(Reprinted!with!permission!from!the!copyright!holder!(See!(Ackermann!2007))).!As! far! as! the! pathogenic! bacteria! are! concerned! (which! were! described! in!Section! 2.2.3),! Table! 2.4! summarises! the! morphologies! of! phages! that! typically!infect!them,!and!the!numbers!of!different!phages!that!were!observed.!!
Table!2.4:!Phages!of!the!four!main!bacteria!that!cause!burn!wound!infections.!(Note:!Tailed!phages!=!Myoviridae!+!Siphoviridae!+!Podoviridae;!PFP!Pleomorphic!phages,!variable!sizes!and!shapes),!extracted!from!(Ackermann!2007).!
Host!genus! Myoviridae# Siphoviridae# Podoviridae# Tailed!phages! PFP!
Streptococcus! 2! 276! 12! 290! 2!
Staphylococcus! 28! 183! 4! 215! 2!
Klebsiella! Polyvalent!phages!for!enterobacteria!
Pseudomonas! 139! 241! 119! 499! 12!! As! a! conclusion,! most! of! the! specific! bacteriophages! for! Streptococcus,!




2.4.3. External!Factors!Affecting!Phage!Activity!Potential!phage! infection!activity!and!survival!over! time!may!be! influenced!by!external!factors,!which!can!damage!several!structural!components!including!phage!nucleic!acids.!As!encapsulation!or!stabilisation!of!bacteriophages!may!provide!an!opportunity! to! develop! a! new! burn! wound! therapy,! these! factors! may! become!more! significant.! In! this! context! phages! may! be! in! abnormal! environmental!conditions! (temperature,! pressure,! shear! forces,! etc.),! or! in! contact!with! foreign!materials.! Generally,! bigger2headed! tailed! phages! are! more! stable! in! adverse!conditions! (Jończyk! et! al.! 2011)! but! the! dependence! between! their! stability! and!their!morphological!family!needs!to!be!confirmed.!!!Some! of! the! predictable! factors! that! may! affect! phage! viability! in! the!encapsulation/stabilisation!process!are!described!in!this!section.!2 Temperature! (Jończyk! et! al.! 2011;! Iriarte! et! al.! 2007;! Hurst! et! al.! 1980;!Olson! et! al.! 2004):! It! constitutes! one! of! the!most! relevant! parameters! as! it!influences!the!main!stages!of!the!phage!infectious!cycle.!There!is!normally!an!optimal! temperature! for! phage! penetration,! and! multiplication! of! DNA.!Higher!temperatures!during!longer!times!of!exposure!can!denature!DNA,!and!some!chemical!compounds!assist!this!undesirable!process.!Moreover,!several!examples! of! exceptional! bacteriophages! that! live! and! survive! in! extreme!environments! are! found! in! the! literature,! but! in! general,! the! natural! phage!medium!governs!the!influence!of!temperature.!As! far! as! bacteriophage! storage! is! concerned,! room! temperature! is! not!habitually!used.!The! recommended! storage! temperature! in! the! literature! is!around!4! °C! for!short!periods!and!−80! °C! (and!adding!5210!%!glycerol)! for!longer!times.!Recently,!Golec!et!al.!(Golec!et!al.!2011)!stated!that!preserving!tailed!phages!in!freshly!infected!hosts!is!more!effective!than!merely!freezing!phage!lysates.!Lyophilisation!has!also!being!explored!by!Puapermpoonsiri!et!al.!(Puapermpoonsiri!et!al.!2009).!!2 Pressure! (Capra! et! al.! 2009;!Avsaroglu! et! al.! 2006):!Bacteriophage! activity!can!also!be!affected!by!pressure!due!to!alterations!in!their!protein!structures.!The!referenced!cases!investigate!this!effect!without!considering!temperature!
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variations.!One!representative!example!is!the!use!of!high!pressure!processing!in!the!food!industry!(high!pressure!homogenisation!HPH,!using!pressures!of!the! order! of! 102102! MPa),! specifically! the! treatment! of! diary! products!containing! bacteriophages.! There! is! evidence! regarding! the! influence! of!pressure,!number!of!passes!and!initial!phage!concentration.!As!a!conclusion,!very!high!pressure!values!are!required!to!produce!a!significant!loss!of!phage!survival,!so!phages!can!be!considered!to!be!resistant!to!pressure!effects.!!!2 Shear! forces! (Dancis! 1978;! Branston! et! al.! 2011):! The! basic! structural!components! of! bacteriophages! (DNA,! proteins)! have! been! proved! to! be!affected! separately!while! exposed! to! turbulent! fluid! flows! in!bioprocessing.!Duration!of! shearing,! speed!of! rotation!of! equipment,! etcetera,! are! some!of!the!factors!affecting!breakage,!denaturation!and!damage!of!these!compounds.!Consequently,!the!response!of!bacteriophages!as!a!whole!entity!to!turbulent!situations! has! a! key! role! in! their! implementation! for! nanotechnology!applications!at!large!scale.!According!to!the!literature!reviewed,!filamentous!bacteriophages!apparently!tolerate! reasonably!extreme!processing! stresses! (2.9×106!W!kg21,! expressed!as! energy! dissipation! rate! per! kilogram!of! fluid! in! a! high2energy! fluid! flow!device)!without!losing!their!infectious!activity.!However,!dependence!of!this!tolerance!on!phage!morphology!would!require!further!study.!!
!2 pH! (Jończyk! et! al.! 2011):! Depending! on! their!morphology! and! host! genus,!bacteriophages!can!survive!for!long!periods!of!time!in!various!pH!conditions!from!acids!at!less!than!pH!3!to!alkalis!at!pH!9210.!When!a!significant!loss!of!infectivity! occurs,! the! phages! precipitate,! sometimes! reversibly.! Authors!suggest! that! coagulation! and! precipitation! might! be! induced! by! protein!denaturation! or! severe! changes! in! protein! conformation,! as! a! result! of! the!environmental!pH!conditions.!!2 Salinity!and!osmotic!pressure!(Jończyk!et!al.!2011;!Mylon!et!al.!2010):!The!presence!of!some!salts!or!ionic!!compounds!such!as!NaCl,!sucrose,!or!citrate!have!been!shown!to!diminish!phage!viability,!mostly! if!an!abrupt!change! in!osmotic!pressure!occurs,! i.e.! ,!when!there! is!a!steep!concentration!gradient.!
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This!may!cause!phage!DNA!to!extrude!from!the!tail,!or!their!heads!to!break!off.! Nevertheless,! some! bacteriophages! live! in! oceans! and! some! others!develop!mechanisms! to! stabilise! themselves! against! the!presence! of! strong!electrolytes.!!!2 Chemical! compounds:! The! effect! of! chemical! compounds! varies! from! the!prevention! of! phage! replication! to! the! reversible/irreversible! decrease! of!bacteriophage! infectivity.! Fatty! acids! (Reinhardt! et! al.! 1978;! Sands! et! al.!1979),!cholesterol!and!bacterial/non2bacterial!phospholipids!(Williams!et!al.!1940),!pyridines,!pyrimidines,!indole,!quinones!and!quinolones!(Wooley!et!al.!1952),!and!organic!solvents!(Matsubara!et!al.!2007)!have!all!been!reported!to!influence!phage!stability!and!infectivity.!!2 Others:! Other! factors! affecting! phages! are! UV! irradiation,! fluorescent! light!irradiation,! humidity! (Iriarte! et! al.! 2007),! presence! and! concentration! of!metallic!elements!(Hurst!et!al.!1980;!Iriarte!et!al.!2007),!etcetera.!!! Therefore,!there!is!an!obvious!need!for!understanding!and!quantification!of!the!influence!of! formulation,!preparation!conditions,! components,! etcetera,!on!phage!stability! in! relation! to! the! development! of! a! novel!wound! dressing! therapy! that!includes!bacteriophages.!!
2.4.4. Interaction!of!Bacteriophages!and!Biofilms!In! addition! to! the! environmental! conditions! that! may! affect! bacteriophage!performance!against!bacteria! (Section!2.4.3),! it! is! important! to! take! into!account!that!most!wound!infections!consist!of!biofilms,!as!opposed!to!bacterial!planktonic!cultures!as!observed!in;vitro!in!the!laboratory.!As!an!example,!biofilm2associated!S.;








2.5.1. Introduction!Nano2emulsions!present!several!advantages!over!conventional!emulsions!when!used!in!healthcare,!such!as!reduction!in!the!required!amount!of!surfactant!(which!may!be!prejudicial!for!use!on!skin!at!high!concentrations)!(Bouchemal!et!al.!2004),!and!the!small!droplet!size!that!allows!a!better!penetration!and!distribution!in!and!through! the! skin! compared! with! classical! and! micro2emulsions! (Prakash! &!Thiagarajan!2011;!Azeem!et!al.!2009).!Particularly,!oil2in2water!emulsions!enhance!transdermal!penetration.!Moreover,!depending!on!the!formulation!and!the!use!of!thickeners,!numerous!textures!and!aesthetic!characters!can!be!achieved.!The!large!number!of!possibilities!regarding!emulsion!components!constitutes!an! important!challenge!in!order!to!accomplish!biocompatibility!in!a!healthcare!application.!!Encapsulation!or!microencapsulation!is!a!very!effective!way!of!controlled!drug!delivery,! targeting! the! specific! site! of! release,! maintaining! the! appropriate! drug!concentration! and! ensuring! the! desired! compatibility.! This! control! is! possible!thanks!to!the!particular!physical!and!chemical!properties!of! the!carrier.!As! far!as!oil2in2water!emulsions!are!concerned,!there!is!already!evidence!about!their!use!as!carrier! for! nutrients,! lipophilic! drugs! and! vitamins! (Okochi! &! Nakano! 2000;!Kukizaki!2009).!The!main!drawback! is! the!relative! instability!of!emulsions!when!stored!or!diluted,!such!that!formulations!of!this!type!have!a!short!shelf2life.!!One!of! the!possible! applications!of!nano2emulsions!as! carriers!of! viruses! is! to!prevent!aggregation!phenomena!(Bondoc!Jr!&!Fitzpatrick!1998) as,!if!irreversible,!it!results!in!precipitation!and!loss!of!biological!activity.!At!the!same!time!emulsions!can!provide!stability!in!long2term!storage!without!involving!a!significant!decrease!in!their!infectivity!(Schramm!2005a).!!
2.5.2. General!Information!about!Emulsions!Emulsions!are!colloidal!dispersions,!that!is!to!say,!(at!least)!two2phase!systems!in! which! small! droplets! of! an! immiscible! liquid! are! dispersed! in! a! different!continuous! liquid! phase! (e.g.!water! and! oil)! (Schramm!2005a).!When! emulsions!are!highly!diluted,!droplets!move!following!the!patterns!of!Brownian!motion!and!
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behave! as! viscous! Newtonian! fluids.! The! range! of! droplet! sizes! and! features! is!summarised!in!Table!2.5:!!
Table!2.5:!Classification!and!characteristics!of!emulsions!according!to!droplet!sizes.!
Emulsion!Type! Droplet!Size!(nm)! Features!






• Energy!input!is!required!Macro2emulsion! 20!–!10,000! • Kinetically!stable!• They!require!energy!to!be!formed!! Three!main!types!of!emulsion!can!be!generated,!depending!upon!which!kind!of!liquid!forms!the!continuous!phase!(Charcosset!et!al.!2004):!2 Oil2in2water! (o/w)! emulsions,! where! oil! constitutes! the! dispersed! phase!(minority!phase),!and!water!forms!the!continuous!phase.!2 Water2in!oil! (w/o)!emulsions,!where!water! forms! the!dispersed!phase,! and!oil!forms!the!continuous!phase.!2 Multiple! emulsions,! such! as! water2in2oil2in2water! (w/o/w)! emulsions,!namely!systems! in!which!oil!droplets!containing!an! internal!aqueous!phase!are!dispersed! in!an!external!aqueous!phase,!and!oil2in2water2in2oil! (o/w/o)!emulsions! (Vladisavljević! &! Williams! 2005).! These! are! useful! in! drug!delivery,! for! instance,! for! intravenous! administration! of! antibiotics! against!methicillin2resistant! Staphylococcus; aureus! infections! (Okochi! &! Nakano!2000).!! As!far!as!the!stability!of!droplets!is!concerned,!their!surface!tends!to!contract!to!form! spheres,! minimising! the! surface! area! to! compensate! the! imbalance! of!intermolecular!forces!that!occurs!in!the!interface.!Therefore,!the!total!surface!free!energy!is!reduced.!Thermodynamically!emulsions!consisting!of!small!droplets!are!unstable,!with!high!values!of!Gibbs!energy!as!a!consequence!of!their!large!surface!
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area,!according!to!Equation!2.1,!which!is!valid!when!pressure!and!temperature!are!constant!(Drioli!et!al.!2005;!Schramm!2005b):!! Equation!2.1!In! this! equation,! γ! (J!m22)! represents! the! interfacial! tension,! that! is! to! say,! the!work! done! (ΔG)! (J)! per! unit! area! (ΔA)! (m2)! to! produce! new! surface! area.! As! a!consequence,!the!higher!the!interfacial!tension,!the!more!unstable!the!emulsion.!! Emulsion! formation! requires! more! energy! than! the! minimum! necessary! to!decrease!the!droplet!size!or! increase!the!surface!area,!since!there!are!often! large!losses! of! energy! in! the! form! of! heat.! Deformation! of! droplets! before! rupture!implies! the! presence! of! viscous! forces! that! depend! on! turbulence,! as! can! be!deduced! from!Equation!2.2.!This!equation!represents! the!Weber!number! (We),!a!dimensionless! number! that!measures! the! fluid’s! inertia! compared! to! its! surface!tension!(Schramm!2005b;!Tadros!et!al.!2004):!!! Equation!2.2!
Where!ηC! represents! the! viscosity! of! the! continuous!phase! (N! s!m22),! γ’! is! the!shear!rate!(s21),!R!is!the!droplet!radius!(m),!and!γCD!is!the!interfacial!tension!(J!m22).!A!critical!value!of!We!can!be!found!depending!on!the!viscosity!ratio!(continuous!to!dispersed! phases).! The! viscosity! and! shear! rates! turn! out! to! be! essential! when!mechanical! processes! are! involved,! giving! different! values! of!We! that! generate!different!droplet!sizes.!!The! existence!of! interfacial! tension! implies! a!pressure!difference!between! the!inner!and!outer!parts!of!the!droplet,!which!is!given!by!the!Young2Laplace!equation!for!perfectly!spherical!droplets!(Schramm!2005b):!
ΔP = PD −PC =
2 γCD
R ! Equation!2.3!Where!ΔP! is! the!pressure!difference!between! the! inner!and!outer!parts!of! the!droplet! (Pa),! PD; correspond! to! the! dispersed! phase! pressure! (Pa),! PC! is! the!continuous!phase!pressure!(Pa),!γCD;is! the! interfacial! tension!(J!m22),!and!R! is! the!droplet! radius! (m).! According! to! this,! the! pressure! inside! the! droplet! is! always!higher! than! in! the! outer! region.! Taking! Equation! 2.3! into! account,! the! Weber!
ΔG = γΔA










number! (Equation! 2.2)! could! also! measure! the! ratio! of! the! shear! rate! over! the!Laplace!pressure:!







' ! Equation!2.4!! The! measurement! of! interfacial! tension! in! emulsions! can! be! carried! out! by!means! of! different! methods.! This! parameter! together! with! contact! angle! and!wettability,!are!major!in!emulsion!characterisation.!In!this!context,!contact!angle!is!defined!as!the!angle!at!which!an!emulsion!droplet!interface!meets!a!solid!surface!(Schramm! 2005b).! It! depends! on! the! interfacial! tension! and! the! forces! acting!within! and! around! the! droplet,! and! therefore,! the! contact! angle! constitutes! a!measurement!of! the!affinity!of! the!emulsion! towards! the!solid,! that! is! to!say,! the!wettability!of!the!solid.!!Emulsion! stability,! once! the! droplets! are! formed,! is! determined! by! a! wide!variety!of! forces,! such! as! van!der!Waals! attractions!because!of! the! charge!of! the!droplets!when!immersed!in!water,!electrostatic!and!steric!repulsions!produced!by!the! presence! of! surfactants! or! other! surface2active! agents,! and! hydrophobic!interactions! or! surface! forces! due! to! the! interfacial! mobility! (Petsev! 2004).!Stability!can!be!enhanced!by!means!of!emulsifiers!or!surfactants,!normally!surface2active! compounds! of! various! types,! which! lower! the! interfacial! tension! and/or!increase! viscosity! and! retard! droplet! movement.! Surfactants! can! be! ionic,! non2ionic! or! proteins.! One! of! the! most! common! rules! to! predict! the! suitability! of!surfactants! for! a! given! kind! of! emulsion! uses! an! empirical/semi2empirical!dimensionless! parameter! known! as! HLB! (Hydrophilic2Lipophilic! Balance).! This!represents! the!ratio!of! the!size/mass!of! the!hydrophilic!portion!of! the!surfactant!molecule!in!relation!to!the!lipophilic!portion,!and!can!determine!the!orientation!of!the! surfactant! molecule! at! the! interface! between! the! two! phases.! The! more!hydrophilic!the!surfactant,!the!higher!the!value!of!HLB.!In!general,!the!appropriate!values! for!w/o! emulsions! are! in! the! range! 3–6!while! o/w! emulsifiers! have!HLB!values! of! about! 8–18! (Vladisavljević!&!Williams!2005).! Another! practical! rule! in!terms! of! formulation! is! Bancroft’s! rule:! the! continuous! phase!will! be! the! one! in!which!the!surfactant!is!more!soluble!(Bibette!et!al.!1999).!A!general!classification!
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of! surfactants! depending! on! their! chemical! nature! is! presented! in! Table! 2.6!(Schramm!2005a;!Anon!n.d.;!Nielloud!2000):!!
Table!2.6:!Classification!of!surfactants.!
Class! Examples! Structures! HLB!value!
Anionic! Sodium!stearate! CH3(CH2)16COO–Na+! 18*!Sodium!dodecyl!sulfate! CH3(CH2)11SO4–Na+! 41.8*!Sodium!dodecyl!benzenesulfonate! CH3(CH2)11C6H4SO3–Na+! 9.4*!
Cationic!
Laurylamine!hydrochloride! CH3(CH2)11NH3+Cl–! 21.3!**!Trimethyl!dodecylammonium!chloride! C12H25N+(CH3)3Cl–! 23.3!**!Cetyl!trimethylammonium!bromide!! CH3(CH2)15N+(CH3)3Br–! 21.4!**!
Non2ionic!
Polyoxyethylene!alcohol! CnH2n+1(OCH2CH2)mOH! 10!Nonylphenyl!Ether!!(n≈5)! C9H192C6H42(OCH2CH2)nOH! 10!Polysorbate!80!w+x+y+z=!20,!R=(C17H33)COO!! !
15!
Zwitter2ionic!
Dodecyl!betaine! C12H25N+(CH3)2CH2COO–! 39.3!**!Lauramidopropyl!betaine! C11H23CONH(CH2)3N+(CH3)2CH2COO–! 47.9!**!Cocoamido222hydroxypropyl!sulfobetaine!! CnH2n+1CONH(CH2)3N+(CH3)2CH2CH(OH)CH2SO3–! 2!!*!Calculated!by!empirical!equations,!which!imply!that!there!is!a!linear!variation!of!the!HLB!value!with!the!lipophilic!tail!length!(Nielloud!2000).!**!Obtained! from! (Nielloud!2000),! via! the!Davies! formula! (Equation! 2.5),! and!the!values!for!each!hydrophilic!and!lipophilic!group!in!the!molecule.!
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HLB = 7+ Hydrophilic group contributions( )∑ −
− Lipophilic group contributions( )∑
! Equation!2.5!
! The! main! causes! of! instability! of! emulsions! are! the! following! (Petsev! 2004;!Schramm!2005b):!2 Ostwald! ripening:! Caused! by! the! relative! solubility! of! the! dispersed!phase! in! the! continuous!phase,! especially! for! the! smaller!droplets.! Small!droplets!tend!to!be!accumulated!into!larger!ones!(which!are!susceptible!to!coalescence!themselves)!by!molecular!diffusion!mechanisms,!favoured!by!larger! Laplace! pressures.! The! addition! of! surfactants! reduces! this!coalescence! phenomenon,! as! they! stabilise! the! interfaces.! A! different!strategy! for! o/w!emulsions! involves! the! addition!of! highly! insoluble! oils!that! limit! diffusion.!The! reduction!of! solubility! between!phases!becomes!especially! important! in! the! formation! of! nano2emulsions,! where! the!droplet!size!is!particularly!small.!!!2 Creaming/Sedimentation:!It!is!the!result!of!a!density!difference!between!the! dispersed! and! continuous! phases,!where! the! heavier! phase! tends! to!move! downwards! to! form! two! separate! layers.! In! the! particular! case! of!o/w! emulsions,! the! oil! droplets! will! be! accumulated! at! the! top.! This!phenomenon!can!be!avoided!by!reducing! the!density!difference!between!the!two!phases.!! 2 Coalescence:! Two! or! more! droplets! irreversibly! merge! into! a! single!droplet,! such! that! the! total! interfacial! area! is! reduced.! The! liquid! film!between! the! two! entities! disappears! as! a! result! of! the! presence! of!attractive! forces.! Coalescence! differs! from! aggregation! as! in! the! latter!case! the! attached! droplets! do! not! lose! their! identities! and! there! is! no!change!in!the!interfacial!area.!!! 2 Flocculation:! It!occurs!as!a!consequence!of!a!minimum!in!the!interaction!energy,!yielding!droplet!aggregates!which!are!separated!by!a!thin!layer!of!liquid.! It! is! normally! the! first! step!before! coalescence! and!also! enhances!creaming,!due!to!an!increase!in!the!apparent!size!of!“droplets”.!
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! In! summary,! the! formation! of! stable! emulsions! depends! on! many! factors:!selection! and! concentration! of! surfactant,! order! of! addition! of! the! components,!temperature,!shear!forces!and!energy!input!to!produce!rupture,!etcetera.!!!Some!of!the!methods!for!the!production!of!nano2emulsions!are!described!below!(Mason!et!al.!2006):!2 Ultrasonic! agitation:! A! vibrating! surface! (at! normally! 20! kHz! or! more)!agitates! the! premixed! emulsion! at! high! power,! creating! extreme! shears.!They! concentrate! in! a! particular! region,! so! recirculation! is! necessary! to!obtain!narrower!droplet!size!distributions.!2 High2pressure! microfluidic! devices:! The! premixed! emulsion! is! forced!through!micro2channels! by!means! of! a! piston! (at! even!more! than! 2,000!atm).! Recirculation! is! also! required! to! overcome! heterogeneities! due! to!the!pulsing!flow.!!!These! two! processes! for! the! production! of! nano2emulsions! are! highly! energy!consuming.! ! Optimisation! in! terms! of! materials! and! energy! is! desirable! in! this!work,!including!a!limited!time!for!screening!as!well.!Thus,!for!the!purposes!of!the!present! work,! two! methods! will! be! discussed! and! compared! in! detail! in! the!following! sections,! one! involving! high! energy! consumption! but! an! easy!experimental! procedure! (homogenisation),! and! one! with! lower! energy!requirements! (phase! inversion),! taking! into! account! the! available! data! in! the!department!regarding!experimental!methods!and!formulations.!
2.5.3. Phase!Inversion!Method!The!Phase!Inversion!Temperature!(PIT)!method!was!introduced!by!Shinoda!et!al.! in! the! late! sixties! (Shinoda! &! Saito! 1969);! when! they! witnessed! variation! of!droplet! size! and! stability! depending! on! temperature,! and! the! HLB! of! non2ionic!emulsifiers! with! ethoxylated! chains.! Here! chain! solubility! is! related! to! the!hydrogen! bonds! between! the! ether! group! and! the! water! molecules.! These!surfactants! are! highly! dependent! on! temperature,! becoming! lipophilic! when!temperature! increases,! as! a! consequence! of! the! dehydration! of! the!
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polyethyleneoxide! chain! and! the! rupture! of! these! hydrogen! bonds.! Thus!temperature!can!cause!phase!separation!(Tadros!et!al.!2004;!Souza!et!al.!2009).!!Transitional!phase!inversion!(Tadros!et!al.!2004)!in!emulsions!can!be!defined!as!the!induction!of!a!change!in!the!surfactant!affinity!towards!the!aqueous!or!organic!phase!by!modifying!factors!that!affect!the!HLB,!in!this!case!the!temperature.!This!change!of!affinity!can!be!expressed!as!an!unequivocal!effect!of!the!thermodynamic!environment!on!the!HLB!value.!!Macroscopically,! the!phenomenon!occurring!during!PIT! emulsification! implies!the!change! from!an!o/w!emulsion! to!a!w/o!emulsion! (or!vice!versa)!at!a! critical!value!of!temperature,! that! is!to!say,! the!continuous!phase!becomes!the!dispersed!phase.! At! this! point,! the! droplet! size! reaches! a!minimum,! as! does! the! interfacial!tension,! due! to! a! change! in! curvature.! However,! the! small! size! of! the! droplets!would!normally!induce!a!strong!coalescence!effect,!so!rapid!cooling!is!necessary!to!switch! the! affinity! of! the! surfactant! in! the! opposite! direction,! in! order! to! obtain!small! stable! droplets.! From! a! thermodynamic! point! of! view,! there! exists! a!relationship!between!the!mixture!properties!and!the!phase!volume!at!which!phase!inversion! occurs,! demonstrated! by! the! existence! of! a! discrete! phase! inversion!event.!Experimental!evidence!suggests!that!inversion!is!influenced!by!the!structure!of!the!initial!coarse!emulsion!and!its!rupture!during!agitation!(Dickinson!1982).!!!Several!methods!have!been!developed! to!measure!PIT! temperatures.! Some!of!them!are!rheology,!microcalorimetry!(Souza!et!al.!2009),!conductimetry!(Allouche!et!al.!2004)!and!visual!observation!of!phase!separation.!The!PIT!changes!with!the!experimental!conditions!and!depends!on!factors!such!as!the!types!of!oil,!the!phase!volume!ratio,!the!type!and!concentration!of!emulsifiers,!etcetera!(Shinoda!1969).!!!On!the!other!hand,!the!premix!processes!to!completely!solubilise!surfactant,!the!surfactant! to!oil! ratio! and! the! rate!of! cooling!and/or!heating!determine! the! final!droplet! size! (Fernandez! et! al.! 2004).! As! a! conclusion,! three!main! factors! can! be!considered!(Salager!et!al.!2000):!formulation!variables!regarding!the!nature!of!the!components,! composition! variables,! and! process! variables! (protocol! and!operational! conditions,! such! as! temperature,! stirring! or! even! pressure).!
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Considering! the! first! and! third! groups! of! variables,! the! variation! of! operational!parameters! may! have! a! significant! effect! on! the! nature! of! the! phases! and! their!physicochemical!properties,!such!as!their!density!and!viscosity.!!!The!main!disadvantage!of!the!PIT!method!is!that!the!technique!does!not!allow!the! surfactant! to!position! itself! at! the! interface!and! fully! coat! the!nano2emulsion!droplets!(Solans!et!al.!2005).!!!
2.5.4. Homogenisation!!Nano2emulsions! can! also! be! produced! using! high2pressure! (high! energy!consuming)!devices!such!as!a!micro2fluidisers!or!high2pressure!homogenisers.!The!fundamental! principle! of! these! techniques! is! based! on! the! breakdown! of! larger!droplets! into! smaller! (nano2)! droplets.! Emulsification! via! homogenisation! is!commonly!used!in!the!food,!personal!care!and!pharmaceutical!industry,!since!they!are!easily!scalable!for!large!production!rates.!!When! considering! emulsification! in! high! pressure! devices! it! is! important! to!consider!the!formation!of!new!droplets!as!a!dynamic!process!where!a!combination!of!droplet!break2up!and!coalescence!occurs!(Niknafs!et!al.!2011).!The!controlling!variables!in!this!process!are!the!emulsifier!type,!its!concentration,!and!the!rate!at!which! it! can! coat! the! newly! formed! interface.! The! rate! of! formation! of! the! new!interface! is! a! function! of! the! hydrodynamic! conditions! within! the! high! energy!dissipation! zone! (flow! characteristics),! the! rate! of! energy! dissipation! (which!determines! the! energy! that! is! actually! used! in! breaking! the! larger! droplets! into!smaller! droplets),! the! viscosity! of! both! the! continuous! and! dispersed! phases!(which! makes! oil2in2water! and! water2in2oil! emulsions! completely! different!regarding!the!outcome!of!the!homogenisation!process),!and!the!residence!time!in!the!break2up!zone.!!!Droplet!size!distribution!is!an!important!property!for!product!quality!(stability,!shelf2life,! appearance,! controlled! release! in! the! case! of! encapsulated! substances,!etc.)!and! is!aimed!to!be!controlled! in! the!process.!Some!parameters! that!have!an!effect! on! droplet! size! are! the! homogenisation! pressure,! the! number! of! passages!through!the!high2pressure!homogeniser,!and!the!homogenisation!temperature!(El!
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Kinawy!et!al.!2012).!Also,!conventional!high2pressure!homogenisers!generate!back!pressure!which!opposes!emulsification! (resistance).!However,! this!back!pressure!can!enhance!emulsification!in!some!cases,!by!suppression!of!collapse!cavitation!in!the! high2pressure! device! (Saheki! et! al.! 2012).! Droplet! size! distribution! can! be!experimentally! measured! and! also! predicted! via! population! balances! combined!with!computational!fluid!dynamics!(Dubbelboer!et!al.!2014).!!
2.6. Mathematical!Modelling!Strategies!The!seriousness!of!antibiotic!resistance!as!a!public!health!threat!nowadays!has!been!revised!and!demonstrated!in!this!chapter,! together!with!the!main!strains!of!bacteria! that! present!multidrug! resistance! and/or! tolerance! and! are! common! in!infected! burn! wounds! (i.e.! S.; aureus! and! P.; aeruginosa).! Some! alternatives! to!antibiotics! have! also! been! explained,! focusing! on! bacteriophages! since! they!present!several!advantages!with!respect!to!conventional!antimicrobial!drugs!(see!Section! 2.4).! Bacteriophage! therapy! is! being! reconsidered! in! these! times! of!antibiotic! resistance!outburst! (Reardon!2014),!but! it! is!key! to!better!understand!the! mechanisms! of! action! of! bacteriophages! against! planktonic! and! biofilm!infections,! if! the! in;vitro! to! in;vivo! treatment!transition!is!to!take!place.!There!are!added! difficulties! that! do! not! exist! for! usual! antibiotics:! bacteriophages! are! self2replicating! pharmaceuticals,! but! do! not! always! behave! in! that! manner! in; vivo,!involving! the! need! of! large! or! repeated! doses! in! live! hosts,! even! when! positive!results! have! been! achieved! in! cell! culture! (Payne! et! al.! 2000).! The! outcome! of!phage! therapy! in; vivo! is! poor! in! some! cases,! due! to! many! different! reasons.!Moreover,! it! is! not! possible! to! use! the! same! pharmacokinetic! and!pharmacodynamic!principles!of!conventional!drugs!since!both!bacterial!replication!and! bacteriophage! infection! are! density2dependent! processes! (Payne! &! Jansen!2001).! In! this! sense,! a! mathematical! modelling! approach! based! on! population!dynamics! is! a! sensible! strategy.! The!main! outcomes! of! this! theoretical! approach!are! the! understanding! of! the! infection! process,! and! the! establishment! and!prediction!of!optimal! inoculum!size,!and! timing.!Modelling!strategies!allow!rapid!and! easy! screening! of! many! different! experimental! variables,! including! various!physicochemical!properties!of!viruses!regarding!transport!and!spread!in!different!media,!and!also!the!inclusion!of!new!components!in!the!system!(such!is!the!case!of!
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emulsion! droplets! in! the! formulations! that! concern! the! present! work).!Mathematical!modelling!has!been!extensively!applied!in!the!literature!in!different!fields,!such!as!food!disinfection!using!phages,!transport!of!viruses!in!porous!media!in!aquifers!or!similar,!and!bacteriophage!therapeutic!use.!!!Since! replication! of! bacteria! occurs! as! well! as! infection! of! bacterial! cells! by!bacteriophages,!the!existing!mathematical!models!for!cell!replication!are!reviewed!in! the! first! place,! followed! by! loss! of! infectivity! of! bacteriophages.! Finally,! a!complete! model! is! considered! for! different! scenarios.! This! model! includes! the!system! formed! by! bacteria! growing! and! bacteria! being! infected,! bacteriophages!infecting!and!lysing!bacteria,!bacteriophages!proliferating!and!being!(sometimes)!inactivated.!!!





Model! Formulation! Parameters! Ref.!
Logistic! ! dN(t)dt = a N(t) 1− N(t)C"#$ %&' !!
a;=!Growth!rate!(h21)!
C!=!Carrying!capacity!!(CFU!ml21)! (Verhulst!1838)!
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θ!=!Parameter!(2)!! The!models!shown!in!Table!2.7!describe!only!the!number!of!organisms!and!do!not!include!the!consumption!of!substrate,!as!a!model!based!on!the!Monod!equation!would! do.! It! is! assumed! that! there! is! sufficient! substrate! to! reach! intolerable!numbers! of! organisms.! All! the!models! in! Table! 2.7! are! essentially! based! on! the!Verhulst!(logistic)!model!of!population!growth.!For!all!the!models!in!Table!2.7!the!growth! rate,!a,! represents! the! ‘’per2capita! birth! rate’’! (or! bacterial! growth! rate),!while!C!is!the!carrying!capacity!or!maximum!population!size.!The!carrying!capacity!is!the!bacterial!growth!rate!divided!by!a!‘’friction’’!coefficient,!which!influences!the!rate!of!density!dependent!regulation.!This!mathematically!shows!how!the!growth!rate! decreases! when! the! population! size! increases! due! to! competition! for!resources!(Ross!2009).!The!biological!meaning!of! these!two!parameters,!a!and!C,!remains! constant! for! all! the! models,! despite! the! introduction! of! additional!parameters.!
Chapter!2! !!
!!! 49!
The! difference! between! the! logistic! and! the! Gompertz! model! is! that! in! the!former!the!growth!rate!linearly!decays!when!the!population!size!increases,!while!in!the! later!the!decay! in!the!birth!rate! is!exponential.!The!shape!of! the!Gompertz!curve! in! its! integrated! form!(concentration!of!bacteria!versus! time)! is! sigmoidal,!although! asymmetric! in! contrast! to! the! Verhulst! logistic! curve! (Buchanan! et! al.!1997).! The! model! by! Richards! (Richards! 1959)! is! more! flexible,! allowing! the!sigmoidal!curve! to!adopt!different!shapes!via! its!parameter!η;(Ross!2009).! If! the!parameter!η!is!equal!to!unity,!the!Richards!model!is!exactly!the!same!as!the!logistic!model.!!!As! far!as!hyperbolastic!models!are!concerned!(Tabatabai!et!al.!2005),! three!or!four! parameters! are! used,! thus! giving! more! mathematical! flexibility.! They! are!asymmetric!curves,!and!are!normally!used!for!tumour!growth,!but!can!be!applied!to!any!population!dynamics!situation,!such!as!the!spread!of!diseases,!or!infection.!The!so!called! ‘’Hyperbolastic!H1’’!model!allows! the!growth!rate,!a,! to!be!positive!for!growth,!or!negative!for!inhibition!or!decay.!If!the!parameter!θ!is!equal!to!zero,!then! the!H1!model! is!equivalent! to! the! logistic!model,!but! the!growth!rate! in!H1!times! the! carrying! capacity,! C! is! equal! to! the! logistic! growth! rate,! a.! The!‘’Hyperbolastic! H2’’! and! ‘’Hyperbolastic! H3’’! models! include! one! additional!parameter,! and! have! flexible! inflection! points! allowing! to! fit! data!with! different!shapes.!! As! a! summary,! the! logistic! (Verhulst)! model! is! a! two2parameter! symmetric!(around! the!point!of! inflection)!model,!while! the!Richards!model! generalises! the!logistic!model!by!introducing!an!additional!parameter!to!the!equation,!in!order!to!deal! with! asymmetrical! growth.! The! Gompertz! equation,! which! is! also! a! two2parameter! asymmetric! equation,! attains! its! maximum! growth! rate! at! an! earlier!time!than!the!logistic!due!to!the!exponential!relationship.!!!!!!
! Chapter!2!!
!! 50!
These! mathematical! models,! and! many! others,! have! been! proposed! to! fit!sigmoid!growth!curves,!and!compared!in!the!literature!(Savageau!1980;!Tsoularis!&!Wallace!2002;!Yuancai!et!al.!1997;!Zwietering!et!al.!1990).!However,!no!model!is!perfect!for!fitting!experimental!data!and!the!goodness!of!the!fit!may!dramatically!depend!on!the!particular!experimental!data!set.!It!is!therefore!sensible!to!test!the!appropriateness!of!different!models,!and!study!the!compromise!between!a!good!fit!and! the! computational! resources! that! are! utilised! in! the! fitting! of!more! complex!models.!!!
2.6.2. Modelling!Bacteriophage!Loss!of!Infectivity!In!order!to!quantify!phage!inactivation!due!to!the!influence!of!potential!external!factors,! three! main! kinetic! models! have! been! found! in! the! literature.! All!concentrations! of! bacteriophage! are! expressed! as! “plaque! forming! units! per!millilitre”! (PFU!ml21),!which!corresponds! to! the!number!of!viable!bacteriophages!(able!to!infect!bacteria)!per!unit!of!sample!volume.!a) Two2transition!model:!Equilibrium!between!the!infectious,!P!(active)!form!of!the!bacteriophage!and!the!non2infectious,!PI!(inactive)!form!(Matsubara!et!al.!2007):!
P↔ PI ! Equation!2.6!
dP(t)
dt = k1PI (t)− k−1P(t) !
Equation!2.7!











' 1− e− k1+k−1( ) t( ) ! Equation!2.8!!




P→ PI ! Equation!2.9!The!rate!of!change!of!the!infectious!form!(P)!to!the!non2infectious!form!(PI)!is!expressed!in!Equation!2.10:!!
dP(t)
dt = −k '  P(t) ! Equation!2.10!! Where! k’! is! the! observed! rate! constant! (h21),! depending! on! temperature.!Integration!of!Equation!2.10!yields!Equation!2.11:!!
P(t)
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 t = −k t = − tD10
! Equation!2.12!! Where! k; is! the! inactivation! rate! constant! (h21),! and! D10! is! the! decimal!reduction! time! (h)! (time! required! for!one!base!10! logarithmic! reduction! in!the!number!of!active!phages).!!The! two2transition! model! and! the! first! order! kinetics! are! conventional!approaches!that!have!some!limitations!when!fitting!experimental!data!to!a! linear!semi2logarithmic!distribution:!!2 They!assume!that!all!the!phages!in!the!population!have!the!same!probability!of!being!inactivated!(not!surviving).!2 However,! large! changes! in! temperature,! pressure,! or! concentration! are!considered!to!be!probabilistic!events,!so!not!all!the!individuals!are!expected!to!behave!in!the!same!way.!!2 They!do!not!consider!the!heterogeneity!of!a!population,!even!if!it!is!pure.!! !
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&= −b T,P( )  tn T ,P( ) ! Equation!2.13!! Where!b(T,;P)!(h2n!)!is!the!scale!coefficient,!and!n(T,;P)!(dimensionless)!is!the!shape! coefficient! of! the! distribution! (both! temperature! and! pressure!dependent! in! this! particular! case).! Depending! on! the! value! of! n(T,; P),!different!shapes!in!the!distribution!can!be!observed:!2!n(T,;P)!<1!for!monotonic!upward!concave!curves.!2!n(T,;P)!=1!for!linear!curves.!2; n(T,; P)! >1! for! monotonic! downward! concave! curves,! as! is! the! case! for!typical!bacteriophage!inactivation!curves.!
!
2.6.3. Modelling!Bacteriophage!Infectivity!As!explained!in!the!introduction!to!this!modelling!section,!the!therapeutic!use!of!bacteriophages!against!bacterial! infection!has!significant!differences!with!respect!to! any! conventional! antimicrobial! drug:! bacteriophages! replicate! using! the!bacterial!machinery,! and! lysis! of! the! bacterial! cells! produces! the! release! of! new!phage! particles! that! can! continue! the! infection! process.! On! the! other! hand,!antimicrobial!drugs,!such!as!antibiotics,!are!chemical!compounds!that!are!utilised!once,!and!when!they!are!consumed!they!can!not!be!used!any!longer.!Therefore,!it!is!clear!that!the!study!of!the!bacteriophage2host!interactions!from!a!kinetics!point!of!view!is!desirable.!Many!mathematical!models!have!been!proposed!in!the!literature!with!different!degrees!of!complexity,!and!some!of!them!are!shown!and!compared!in!this!section.!!!
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Different!factors!related!to!bacteriophage!infectivity!have!been!modelled!from!a!mathematical!point!of!view,!for!instance,!inactivation!of!viruses!(see!Section!2.6.2)!(Anders! &! Chrysikopoulos! 2006;! Bertrand! et! al.! 2012;! Schaldach! et! al.! 2006),!transport!of!bacteriophages!through!different!media!(Barth!&!Hill!2005;!Knappett!et!al.!2008;!Mallén!et!al.!2005;!Schijven!et!al.!2002),!or!formation!of!plaques,!their!characteristics!and!importance!on!bacterial!lysis!(Abedon!&!Culler!2007;!Gallet!et!al.!2011).!However,!in!this!section!the!general!infection!process!is!reviewed,!taking!into!account!the!lytic!cycle!of!bacteriophages!(Figure!2.11).!There!are!four!steps!in!the! infection! of! bacterial! cells! by! bacteriophage! particles,! from! a! microscopic!perspective:!1. Diffusion! or! transport! of! bacteriophages! from! the! bulk! of! the! solution! (or!from! the! environment)! to! the! surface! of! bacterial! cells.! Unless! otherwise!stated,! it! is! considered! that! many! bacteriophages! can! attack! one! bacterial!cell,! but! only! one! phage! can! effectively! establish! contact! and! initiate!infection! (Beretta! &! Kuang! 1998;! Carletti! et! al.! 2004).! When! in; vitro!situations! are! considered,! the! actual! distance! between! bacteriophages! and!bacteria! is! so! small! that! it! can! be! neglected,! and! therefore! this! step! is! not!considered.! That! is! not! the! case!when! infection! in!marine! environments! is!studied.!!2. Specific! recognition! of! receptors! on! the! bacterial! outer! membrane,! and!adsorption!to!its!surface.!Different!approaches!can!be!used!from!a!modelling!point!of!view,!but!all!of!them!are!based!on!the! ‘’mass2action!law’’,!assuming!that! the! kinetics! of! phage! adsorption! resemble! enzyme! kinetics,! where! a!phage2host!intermediate!compound!is!formed.!!! 3. Injection! of! bacteriophage! genetic! material.! There! are! several! examples! in!the! literature! that! are! dedicated! to! this! particular! step! in! the! infection!process! from! a! molecular! biology! and! a! structure! biology! point! of! view!(Haseltine! et! al.! 2005;! Angelescu! &! Linse! 2008;! Hui! &! Liao2Fu! 2009).!However,! a! less! detailed! approach! is! used! in! order! to! model! the! infective!cycle!of!bacteriophages!in!this!thesis.!!
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4. Bacteriophage! self2replication! using! the! bacterial! machinery! and! releasing!new! virus! particles! after! bacterial! lysis.! This! step! can! be!modelled! as! if! it!consisted! of! a! simple! ‘’chemical! reaction’’! depending! on! the! number! of!bacteria! and! bacteriophages,!which! occurs! at! a! certain! lysis! rate! –! second2order!reaction!kinetics.!! Taking! all! these! steps! into! account,! a! general! system!of! differential! equations!can! be! formulated,! in! order! to! define! the! variation! of! the! concentration! of! the!different!species!in!the!system!with!time:!
dS(t)
dt = Bacterial growth rate}{ − Bacterial infection rate}{
dI(t)
dt = Bacterial growth rate}{ + Bacterial infection rate}{ −
        − Bacterial inactivation rate}{ − Bacterial lysis rate}{
dP(t)
dt = Phage inflow rate}{ − Phage inactivation rate}{ −
         − Phage adsorption rate}{ + Phage release of progenie rate}{
! Equation!2.14!!
Where!S(t)! is! the!concentration!of!susceptible!(to!phages)!bacteria!(CFU!ml21),!
I(t);is!the!concentration!of!infected!bacteria!by!bacteriophage!(CFU!ml21),!and!P(t)!is!the!concentration!of!free!bacteriophages!(PFU!ml21);!all!of!these!at!time!t.!!!Depending!on!the!model,!the!terms!in!Equation!2.14!can!vary.!As!far!as!bacterial!growth! rate! is! concerned,! all! the!models! in! Section!2.6.1! can!be! implemented! in!Equation!2.14,!as!will!be!observed!later!on!in!this!section.!Bacterial!infection!rate!is!identified! with! the! rate! of! adsorption! of! phages! to! the! bacterial! surface,! and!modelled!as!a!second2order!reaction.!It!is!equivalent!to!the!phage!adsorption!rate,!which!is!negative!in!Equation!2.14!since!the!derivative!of!P(t)!with!respect!to!time!refers! to! free! bacteriophages! (and! free! bacteriophages! ‘’disappear’’! when! they!become! adsorbed! phages).! The! inactivation! of! bacteria! and! bacteriophages! are!generally!considered!as!first2order!decay!processes,!that!is!to!say,!the!inactivation!rate! is! proportional! to! the! concentration! of! bacteria! and! bacteriophage!respectively,!with!inactivation!rates!being!the!proportionality!constants.!Note!that!the!different! inactivation!models! in!Section!2.6.2! could!also!be!applied.!Bacterial!lysis! is! regarded! as! a! first2order! reaction,! and! its! rate! is! proportional! to! the!concentration! of! infected! bacteria.! In! the! cases! where! the! distance! between!
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bacteria!and!bacteriophages! can!not!be!neglected,! a! term!of!phage! inflow!rate! is!included!too.!Finally,!the!rate!of!release!of!new!phage!particles!is!modelled!as!the!bacterial!lysis!rate!times!the!number!of!phages!produced!per!bacteria,!also!known!as!the!burst!size.!!!In! order! to! summarise! the! main! general! models! of! phage! infectivity,! the!following!variables!can!be!defined!in!the!first!place:!!
• N(t)!=!Concentration!of!total!bacteria!(susceptible!+!infected)!(CFU!ml21).!
• S(t)!=!Concentration!of!susceptible!bacteria.!It!can!also!be!expressed!as!S(x,;t)!when! variation! of! concentration! with! respect! to! space! and! time! are!considered!(CFU!ml21).!
• I(t)!=!Concentration!of!infected!bacteria!(CFU!ml21).!
• P(t)! =! Concentration! of! free! bacteriophages.! It! can! also! be! P(x,; t); when!variation! of! concentration! with! respect! to! space! and! time! are! considered!(PFU!ml21).!
• R’(t)! =! Concentration! of! reversible! phage2host! complex! (PFU2CFU! ml21)! in!adsorption!models.!
• I’(t)! =! Concentration! of! irreversible! phage2host! complex! (PFU2CFU!ml21)! in!adsorption!models.!




















'− b S(t) P(t) !
dI(t)
dt = b S(t) P(t)− k I(t) !
dP(t)
dt = −b S(t) P(t)−µp  P(t)+ L k I(t) !
dN(t)









N(t) = S(t)+ I(t) !(Beretta!&!Kuang!2001;!Carletti!2006)! dS(t)dt = a S(t) 1− N(t)C"#$ %&'− b S(t) P(t) !dI(t)
dt = −µi  I(t)+ b S(t) P(t)− e
−µi  T b S t −T( )  P t −T( ) !
dP(t)
dt = β −µp  P(t)− b S(t) P(t)+ L e
−µi  T b S t −T( )  P t −T( ) !
dN(t)









N(t) = S(t)+ I(t) !(Storms!et!al.!2012)! dN(t)dt = 0 !
dR '(t)
dt = k1  N(t) P(t)− k2 + k3( )  R'(t) !
dI '(t)
dt = k3  R'(t) !
dP(t)
dt = k1  N(t) P(t)+ k2  R'(t) !(Storms!et!al.!2010;!Storms!et!al.!2012)! dP(t)dt = −b N0  P(t)− P0  1−ε( )"# $% !(Storms!et!al.!2010)! dP(t)dt = −b N0  P(t) !(Shao!&!Wang!2008)!! dN(t)dt = a N(t)− b N(t) P(t) !dP(t)
dt = −b N(t) P(t) !(Payne!et!al.!2000)! dS(t)dt = a S(t)− b S(t) P(t) !
dI(t)
dt = a I(t)+ b S(t) P(t)− k I(t) !
dP(t)
dt = k L I(t)− b S(t) P(t)−m P(t) !
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Table!2.9!(Continued)!(Payne!&!Jansen!2001)! dS(t)dt = a S(t)− b S(t) P(t)−H (t) S(t) !dI(t)
dt = a I(t)+ b S(t) P(t)− k I(t)−H (t) S(t) !
dP(t)
dt = k L I(t)− b S(t) P(t)−m P(t)− h(t) P(t) !(Payne!&!Jansen!2003)! dS(t)dt = a S(t)− b S(t) P(t)−H (t) S(t)− c A(t) S(t) !dI(t)
dt = a I(t)+ b S(t) P(t)− k I(t)−H (t) I(t)− c A(t) I(t) !
dP(t)
dt = k L I(t)− b S(t) P(t)−m P(t)− h(t) P(t) !
dA(t)
dt = −d A(t) S(t)− d A(t) I(t)− n A(t) !(Gourley!&!Kuang!2004;!Liu!et!al.!2007)!
∂S x, t( )
∂t = DS
∂2S x, t( )
∂x2 + a S x, t( )  1−







(− b S x, t( )  P x, t( ) !
∂P x, t( )
∂t = DP
∂2P x, t( )
∂x2 −µp  P x, t( )−m P
2 x, t( )− b S x, t( )  P x, t( )+
+k L e−µi  T e
− x−y( )2 4  Di  T
2 π  Di  T−∞
∞
∫  S y,  t −T( )  P y,  t −T( )  dy !(Bull!2006)! dS(t)dt = 0 !
dP(t)
dt = −P(t) m+ k S(t)( )+ L e
−µi  T  b S(t) P t −T( ) !! The!majority!of!the!models!in!Table!2.9!have!a!similar!structure!and!are!based!on! the! existence! of! certain! thresholds! due! to! the! particular! nature! of!bacteriophages!as!self2replicating! ‘’drugs’’.!The!determination!of! these!thresholds!and! key! parameters! for! each! particular! case! are! described! in! the! following!paragraphs.!!In! the! first! model! by! Beretta! &! Kuang! for! a! marine! bacteriophage! infection,!(Beretta!&!Kuang!1998;!Carletti!et!al.!2004),! it! is!considered!that!susceptible!and!infected!bacteria!compete!for!resources!(the!total!concentration!of!bacteria!N(t)!is!considered!in!the!first!differential!equation,!as!can!be!seen!in!Table!2.9),!although!infected! bacteria! do! not! reproduce! (the! differential! equation! for! I(t)! does! not!include!any!growth!terms).!In!their!analysis,!they!consider!that!the!burst!size!(L)!is!the!most!relevant!parameter!from!the!biology!point!of!view,!and!they!calculate!the!
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virus! replication! threshold,!L*,! below!which! infection! can! not! occur.! If! the! burst!size!is! larger!than!the!replication!threshold,!the!system!is!capable!to!support!and!continue!infection.!The!virus!replication!threshold!is!shown!in!Equation!2.15:!
L*=1+ µPb C ! Equation!2.15!!Where!µp!is!the!bacteriophage!death!rate!(h21)!and!b;C!represents!the!number!of!new!infections!per!phage!per!unit!of!time.!!!The!existence!of! the!critical!value!of!L! shown!in!Equation!2.15!means!that! the!phage! population! can! only! survive! (since! they! need! bacteria! to! replicate! and!‘’live’’)!if!a!bacteriophage!produces,!on!average,!at!least!one!new!phage!during!its!life,!if!the!concentration!of!bacteria!is!equal!to!the!carrying!capacity.!!
L*! is! related! to! the! basic! reproductive! number! R0,! which! is! defined! as! the!number!of!secondary!infections!per!infected!cell.!
R0 = L 
b C
µP + b C
=
L
L* ! Equation!2.16!!Where! µp! is! the! bacteriophage! death! rate! (h21),! b; is! the! bacteriophage!adsorption!rate!(ml!CFU21!min21),!C!is!the!bacterial!carrying!capacity!(CFU!ml21),!L!is!the!burst!size!(PFU!CFU21),!and!L*!is!the!critical!value!of!burst!size!(PFU!CFU21).!
! The! second!model! by!Beretta!&!Kuang! (Beretta!&!Kuang!2001;!Carletti! 2006;!Carletti! 2007)! assumes! the! same! fact! as! the! first! model! by! the! same! authors!regarding! competition! for! resources.! However,! this!model! is! formed! by! delayed!differential! equations:! susceptible! bacteria! can! reproduce! normally! according! to!the! logistic!model!of!growth,!but! infected!bacteria,!since!they!are! ‘’controlled’’!by!bacteriophages,!replicate!viruses!inside!them!and!die!by!lysis!after!a!latency!time,!
T.!At!any!time!t,!the!concentration!of!infected!bacteria!I(t)!is!the!summation!of!all!the! rates! of! infection! at! previous! times! b; S(t−T); P(t−T),! multiplied! by! the!probability!that!infected!bacteria!have!to!survive!from!time!t−T!up!to!time!t!with!the!given!mortality!µi,! that! is! e−µi  T .!Another! important!difference!with!respect! to!the! previous!model! is! that! an! inflow! of! bacteriophages! from! the! environment! is!included.! The! authors!mathematically! analyse! the!model! and! conclude! that! it! is!
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weak!with!respect!to!random!fluctuations!in!the!concentration!of!bacteria,!but!it!is!robust! regarding! the! variation! in! the! concentration! of! phages,! entering! and/or!leaving! the! system! from! surrounding! regions.! They! also! calculate! the! virus!replication! threshold,!L*,!which!has! the! same!meaning!as! in! the!previous!model,!and!it!is!also!related!to!the!basic!reproductive!number.!In!this!case!R0!is:!









L* ! Equation!2.17!!The!basic!reproductive!number! in!this!case!needs!to!be!modified,!as!shown!in!Equation!2.17,!since!during!the! latency!period!not!all! the!bacteria! infected!at!t−T!arrive! to! the! lysis!at! time! t,! and!only! the! fraction!e−µi  T !of! the! infected!bacteria! is!capable!of!arriving!to!lysis.!! The!papers!by!Storms!et!al.!(Storms!et!al.!2010;!Storms!et!al.!2012)!focus!on!the!adsorption!step!in!the!lytic!cycle.!They!initially!define!adsorption!as!a!second!order!kinetic!process,!based!on!experimental!data!and!considering!that!the!probability!of!desorption!of!phages!from!the!bacterial!surface!is!very!low.!The!model!is!shown!in!Equation!2.18.!!
P + N b!→! I ' ! Equation!2.18!!Bacteriophages!(P)!adsorb!to!bacteria!(N)!at!a!rate!b!(ml!CFU21!min21),!forming!an! irreversible! complex! (I’),! similar! to!what! is!observed! in! the! complex!enzyme2substrate.!!!Nevertheless,! they! define! what! they! consider! a! more! suitable! model! that!consists!of!two!sequential!steps.!The!benefit!of!this!reaction!mechanism!is!that! it!makes!use! of! three! reaction! rate! constants,!making! the!model!more! robust.! It! is!given!by!the!following!equation:!!
P + N k1, k2← →## R '
k3# →# I ' ! Equation!2.19!! In! the!sequential!model,!bacteriophages!(P)!adsorb!to!bacteria!(N)!at!a!rate!k1!(ml!CFU21!min21),! forming!reversible!complex!(R’).!However,! the!next! irreversible!step! is! necessary! for! a! successful! infection.! It! is! considered! that! the! host!concentration! is! constant! (dN(t)/dt! =! 0),! and! that! free! bacteriophages! exist! in!
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equilibrium! with! the! reversible! complex.! The! equilibrium! can! be! shifted! to! the!right,!eventually!leading!to!the!adsorption!of!all!phages!in!the!system.!!!Further! to! the! two2step! model,! they! introduce! the! concept! of! adsorption!efficiency! (Storms! et! al.! 2012),! which! explains! why! in! some! experiments! only!about! 50!%! of! the! bacteriophage! population! succeeds! in! adsorbing! to! bacterial!cells.!Adsorption!efficiency!(ε)!is!defined!as!‘’the!fraction!of!a!phage!population!that!irreversibly!binds! to!a!host!cell’’.!This!model!has! the!advantages!of!being!simple,!accurate,! and! robust.! It! has! two! modelling! parameters:! the! adsorption! rate!constant!and!the!adsorption!efficiency.!The!former!is!an!indication!of!how!quickly!adsorption! takes! place,! whilst! the! latter! reveals! what! fraction! of! the! phage!population!undergoes!adsorption.!! There! are! many! publications! that! attempt! to! find! optimal! values! for! the!different! infectivity! parameters! (Cairns! et! al.! 2009;!Bull! 2006;!Dennehy!&!Wang!2011;!Fuhrman!et!al.!2011;!Gallet!et!al.!2009;!Heineman!&!Bull!2007).!An!example!is!the!papers!by!Shao!&!Wang!(Wang!2006;!Shao!&!Wang!2008),!where!the!optimal!lysis!time!(which!is!the!same!as!the!latent!period!or!intracellular!time!of!the!lytic!cycle)!is!found,!assuming!that!the!experimental!time!is!much!shorter!than!the!lysis!time,! and! therefore! there! is! no! production! of! phage! progeny.! This! assumption!leads! to! the! simplified! model! shown! in! Table! 2.9,! including! an! additional!simplification:! it! is! assumed! that! bacterial! growth! is! merely! exponential.! Their!paper! contemplates! the! different! steps! of! infection! according! to! the!mass2action!kinetics,! starting!with! the! specific! recognition! of! the! host,!which! takes! a! certain!period! of! time,! known! as! the! search! time! (ts).! It! is! directly! proportional! to! the!concentration!of!bacteria!(it! is!common!sense!that!the!more!bacterial!cells! in!the!system,! the! quicker! a! phage! particle! would! find! a! host! to! adsorb! to),! and! it!influences!the!length!of!the!generation!time!(which!is!the!search!time!plus!the!lysis!time).! There! is! another! important! time! parameter,! which! is! the! time! between!infection!and!assembly!of!the!progeny,!called!the!eclipse!period,!e.!!!!!
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They!presume!that!there!is!an!optimal!lysis!time!(that!makes!the!phage!growth!rate!optimal!as!well)!since!a!balance!between!the!generation!time!and!the!phage!burst! size! exists:! in! order! to!maximise! the! phage! growth! rate,! it! is! necessary! to!shorten!the!generation!time!and/or!to!increase!the!burst!size.!These!two!traits!are!positively!linked!–!the!longer!the!generation!time!(due!to!a!longer!lysis!time),!the!larger! the! burst! size.! However,! a! long! lysis! time! is! not! always! desirable,! since!phages!with!too!long!a!lysis!time!can!lose!the!opportunity!of!initiating!many!new!infections,!though!its!burst!size!would!be!larger.!On!the!other!hand,!a!phage!with!too!short!a! lysis! time!would!be!able!to! infect!other!host!cells! in! the!environment!earlier,!but!with!a!much!reduced!gain!because!of!reduced!burst!size.!Intermediate!lysis! times! are! thus! optimal! to! obtain! phage! maximal! growth! rate.! The! phage!growth!rate,!p! (h21),! is!defined!in!terms!of!the!burst!size,! the!search!time!and!the!the!lysis!time:!
p = ln L( )ts +T
=
ln M  T − e( )( )
ts +T
! Equation!2.20!! Where!L!is!the!burst!size!(PFU!CFU21),!ts!is!the!search!time!(h),!T!is!the!lysis!time!(h),!M!is!the!maturation!rate!(h21),!and!e!is!the!eclipse!time!(h).!An!optimal!value!of!the!lysis!time! Tˆ !(latent!period)!can!be!obtained!finding!the!maximum!of!the!phage!growth!rate! pˆ ,!that!is!to!say,!when!the!derivative!of!the!growth!rate!with!respect!to!the!lysis!time!is!equal!to!zero:!
dp
dT = 0 ⇒  Tˆ=e+
1
pˆ ! Equation!2.21!! A!similar!optimality!model! is!developed!by!Bull!(Bull!2006)! for!two!phage! life!history!traits,!lysis!time!and!host!range.!!!Models!by!Payne!and!Jansen!(Payne!et!al.!2000;!Payne!&!Jansen!2001;!Payne!&!Jansen!2003)!are!key! in!understanding! the!complicated!nature!of!phage! therapy,!since! they! define! different! thresholds! both! for! concentration! of! bacteria! and!concentration!of!bacteriophage! in!order! to!maintain! infection.! In! this! sense,! they!are!similar!to!the!models!developed!by!Beretta!&!Kuang,!but!in!this!case!they!also!include! critical! times! for! inoculation,! for! instance.! As! an! example,! the!determination!of!the!basic!reproductive!number!is!shown!here.!According!to!their!
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papers,! there! is!a! threshold!density!of!bacteria! that!must!be!present! in!order! for!the!virus!numbers!to!increase,!the!proliferation!threshold,!XP,!and!it!is!related!to!the!basic!reproductive!number,!R0.!





k − a( )
!is! the! bacterial! life! cycle,! L kk − a( ) !represents! the! number! of! new! viruses!produced! in! the! bacterial! life! cycle,! and! b S(t)b S(t)+m( ) !is! the! number! of! new!infections! produced! by! each! of! the! new! viruses.! This! means! that! the! basic!reproductive!number!is!the!number!of!new!infections!per!bacterial!life!cycle.!If!the!infection!is!to!be!maintained,!R0!has!to!be! larger!than!unity.!From!that!condition,!the! concentration! of! bacteria,! S(t)! can! be! worked! out,! and! expressed! as! the!proliferation!threshold!in!Equation!2.23.!
XP =
m k − a( )
b k L −1( )+ a( )
b a <<< b k L" →"""" XP ≅
m k − a( )
b k L
If  R0 >1⇒ S(t)> XP
! Equation!2.23!
! Some! other! conditions! for! the! existence! and! permanence! of! infection! are!defined!by!Payne!&!Jansen,!because!of!the!active!/!passive!nature!of!bacteriophage!therapy.!Bacteriophages!can!act!similarly! to!conventional!antimicrobial!drugs!via!passive! therapy,! but! are! also! able! to! actively! continue! bacterial! eradication! via!active! therapy! (replication).! For! example,! the!viral! inundation! threshold! (PFU!ml21)! expresses! whether! phages! can! reduce! the! number! of! bacteria! to! a! certain!degree.! Under! inundation! therapy! (passive! therapy),! the! production! of!bacteriophage! progeny! by! lysis! is! negligible,! and! bacteria! will! be! killed! if! the!inoculum!of!phage!is!greater!than!a!different!threshold,!the!clearance! threshold!(PFU!ml21).!!!The! condition! for! active! replication! (therapy)! of! bacteriophage! is! that! the!concentration!of!bacteriophage! is! larger! than! the! inundation! threshold,!and! that!the!proliferation!threshold!is!exceeded!by!the!bacterial!concentration.!On!the!other!
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hand,!if!only!the!virus!inundation!threshold!is!exceeded,!only!passive!therapy!will!occur,! and! the! concentration! of! bacteriophages! can! decrease! until! it! becomes!smaller! than! the! clearance! threshold,! and! then! bacteria! can! regrow.! Therefore,!there!is!a!critical!time!point!at!which!the!bacterial!density!passes!the!proliferation!threshold!and!active!therapy!can!proceed,!known!as!the!proliferation!on2set.!!!Payne!and!Jansen!include!variations!in!the!basic!model,!as!shown!in!Table!2.9,!introducing! host! responses! to! both! bacteria! and! bacteriophages,! and! also! the!combined!therapy!using!bacteriophages!and!normal!antibiotics.!!!A! different! kind! of! model! is! the! one! that! includes! the! spatial! variable,! or!diffusive!model!(Gourley!&!Kuang!2004;!Liu!et!al.!2007).!These!are!delayed!models!(there! is! a! time! delay,! analogously! to! (Beretta! &! Kuang! 2001;! Carletti! 2006;!Carletti! 2007)),! and! both! bacteria! and! bacteriophages! can! move! in! the! period!between!infection!and!lysis,!so!that!the!release!of!the!progeny!after!lysis!can!occur!in!a!point!that!is!far!away!from!the!location!where!infection!initially!happened.!!! To!conclude,!mathematical!models!can!be!extremely!useful!in!the!development!and!validation!of!bacteriophage!therapy.!Both!bacterial!growth!and!bacteriophage!infectivity!are!density!dependent!processes!(Smith!2008),!and!the!mass2action!law!is! generally! used! to! formulate! the! models! for! simplicity.! The! passive! /! active!nature!of!bacteriophage!therapy!makes!the!determination!of!certain!concentration!thresholds!essential,!and!it! leads!to!the!calculation!of!optimal!times!and!infection!parameters! in! order! to! achieve! optimal! eradication! of! bacterial! infection.! It! has!been!demonstrated!in!the!literature!that!even!simple!models!fit!experimental!data!reasonably!well!(Cairns!et!al.!2009)!and!allow!the!determination!of!thresholds!and!rate! constants,! which! are! important! to! phage! therapy.! Combined! experimental!studies!of!in;vitro!systems!and!modelling!approaches!are!thus!essential!to!build!a!meaningful!picture!of!the!kinetic!aspects!of! in;vivo!phage!therapy.!Understanding!the!behaviour!of!such!populations,!and!the!evolutionary!aspects!of!bacteria–phage!interactions!is!key!to!the!success!and!development!of!the!use!of!bacteriophages!for!therapy!and!prophylaxis!(Levin!&!Bull!2004).!!!
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2.7. Conclusions!This! literature! review! demonstrates! the! seriousness! of! the! accidental! burn!wounds! problem! in! the! UK.! The! fact! that! children! are! the! most! affected! group!amongst! burn! patients! enhances! the! social! impact! and! relevance! of! the! project.!Moreover,! the! outstanding! increase! of! antibiotic! resistant! strains! of! common!bacteria,! responsible! for! community2acquired! infections! (mainly! in! the! form! of!biofilms),!urgently!demands!alternative!treatments.!!!There! is! also! evidence! regarding! the! growing! and! renewed! interest! towards!bacteriophages!and!phage!therapy,!which!may!constitute!a!suitable!option!thanks!to!their!ability!to!evolve!and!adapt!to!the!emerging!resistant!strains,!and!their!lack!of!side!effects,!contrary!to!conventional!treatments!based!on!synthetic!drugs.!The!in2depth!study!of!bacteriophages!also!constitutes!a!challenge!itself.!!There! are! a! variety! of! well2known! technologies! for! encapsulation! or!stabilisation,! which! could! be! applied! to! these! bacterial! viruses,! in! particular!emulsification! techniques.! Emulsification! processes! would! allow! to! produce!suitable!encapsulating/stabilising!particles!with!an!appropriate!size!and!shelf2life,!and! reduce! energy! and!material! consumption! during! the! production.! Moreover,!emulsions! would! present! several! advantages! in! terms! of! biocompatibility! and!easiness! of! use! and! storage! as! well.! Therefore,! an! attempt! to! implement! an!established!technology!to!create!an!improved!bacteriophage!therapy!product!will!be!made.!!Lastly,!mathematical!model!approaches!are!desirable!for!the!study!of!bacterial!growth!and!bacteriophage!infectivity,!since!the!renewed!interest!for!phage!therapy!against! bacterial! infection! comes! from! a! more! detailed! understanding! of! the!genetics! and! biology! of! bacteriophages,! and! their! interactions! with! bacteria.!Bacteriophages! are! very! different! to! conventional! antibiotics! in! their! mode! of!action,!and!present!certain!limitations,!but!also!advantages.!Both!can!be!analysed!from!a!theoretical!point!of!view,!in!order!to!cleverly!design!experiments,!and!also!facilitate! the! transition! from! in; vitro! therapy! to! in; vivo! treatments! of! infection.!Mathematical! models! can! be! used! as! a! predictive! tool! as! well:! existing! models!
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allow! the! calculation! of! inoculation! times,! and! suitable! concentrations! of! both!bacteria! and! bacteriophage,! given! the! special! pharmacokinetics! and!pharmacodynamics! of! phage.! Additional! advantages! of! the! use! of! mathematical!models! is! their! flexibility! to! introduce! changes! for! varying! experimental!conditions,!such!as!the!use!of!a!bacteriophage/nano2emulsion!formulation!against!infection,!for!instance,!and!their!rapid!and!easy!acquisition!of!results,!compared!to!purely!experimental!approaches.!
!
2.8. Objectives!According!to!the!reviewed!literature,!and!the!motivations!explained!in!Chapter!
1,! the! aims! of! the! present! project! are! explained! here.! They! include! the! detailed!understanding!of! the!mechanisms!of!action!of!bacteriophages!against!pathogenic!bacteria! (specifically! S.; aureus! and! P.; aeruginosa),! regarding! the! different! steps!that! constitute! the! infection! process! from!a! qualitative! and!quantitative! point! of!view! (experimental! and!modelling! approaches! respectively).! The! objectives! also!comprise! the! stabilisation/encapsulation! of! bacteriophages! in! an! oil2in2water!nano2emulsion!preparation,!and!the!study!of!the!interactions!between!viruses!and!stabilising! medium! that! this! implies.! The! following! specific! objectives! are!proposed,!and!can!be!directly!linked!with!the!experimental!and!modelling!chapters!in!this!thesis:!!1. Stabilisation!of!bacteriophages!using!nano2emulsions,!taking!into!account!the!available! technologies! such! as! Phase! Inversion! Temperature! (PIT)!emulsification! or! homogenisation.! A! suitable! formulation! in! terms! of!composition,! droplet! size! distribution! and! stability! needs! to! be! found.!Moreover,!the!biocompatibility!for!a!healthcare!application!is!aimed!towards,!and!the!bacteriophage!viability!and!influence!of!nano2emulsions!on!bacterial!growth! need! to! be! assessed.! The! final! outcome! of! these! studies! is! the!formulation! of! an! infective,! stable! over! time! bacteriophage/nano2emulsion!preparation! to! be! tested! for! the! treatment! of! S.; aureus! and! P.; aeruginosa,!initially! as!planktonic! culture! as! a! first! approach! to!bacterial! infection.!The!ideal! outcome! of! this! thesis! would! be! an! emulsion! cream! or! impregnated!dressing! containing! stabilised! bacteriophages! that! would! be! able! to! attack!
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pathogenic!bacteria!present!in!burn!infection!sites.!It!is!therefore!important!to! achieve! a! suitable! shelf2life! for! it! to! be! used! and! stored! within! a!conventional!time!range,!such!as!similar!topical!products!(Chapter!4).!!!2. Study! of! the! mechanisms! and! interactions! within! the! bacteria2emulsion2bacteriophage! system! from! an! experimental! point! of! view.! Once! the!formulation! is! tested! for! different! bacteriophages! and! several! bacterial!strains,!it!is!key!to!understand!how!nano2emulsions!affect!both!infectivity!of!bacteriophages!and!bacterial!growth.!This!will!have!a!significant!role! in! the!design!of!the!final!formulation,!and!needs!to!be!managed!starting!from!a!very!general! approach,! as! the! majority! of! the! factors! that! may! influence! phage!infectivity!and!bacterial!growth!are!unknown.!It! includes!exploring!possible!electrostatic! interactions! within! the! system,! or! modification! of! bacterial!growth!patterns!in!nano2emulsion!preparations!(Chapter!5).!!3. Assessment!of!the!efficacy!of!bacteriophage/nano2emulsion!formulations!for!the!eradication!of!bacterial!biofilms.!Bacterial!biofilms!are!found!in!acute!skin!infections,!and!therefore! it! is!necessary! to!explore! the!viability!of!stabilised!bacteriophages!in!nano2emulsions!when!they!have!to!attack!biofilm2forming!bacteria.!Biofilms!are!complex!systems,!formed!not!only!by!bacteria,!but!also!a!polysaccharide!matrix,!which!might!be!modified!by!the!presence!of!nano2emulsions.!The!approach!to!tackle!this!challenge!consists!of!the!study!of!the!formation! and! eradication! (via! bacteriophage/nano2emulsion! formulations)!of!biofilms! in!a!static! (simple)!model,! followed!by!a!more!complicated! flow!system,!mimicking!the!burn!wound!environment!(Chapter!6).!!4. Theoretical!calculation!of!growth!and!infection!parameters,!and!prediction!of!different! infection! scenarios! via! mathematical! modelling! approaches.!Bacteriophage! infectivity! experiments! are! very! time! consuming,! and,!sometimes,! not! very! accurate! or! reproducible.! A! modelling! strategy! that!allows!the!determination!of!growth!and!infection!parameters!can!be!used!to!design!formulations!and!experiments!in!a!smarter!manner.!It!can!also!help!to!predict! infection!outcomes! in! situations!where! experimental! determination!of! bacterial! concentration! is! very! difficult.! For! example,! S.; aureus! and! P.;
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aeruginosa! coexisting! in! the! wound,! being! attacked! by! different!bacteriophages! and/or! antibiotics! and! influenced! by! the! presence! of! nano2emulsions,! and! additionally! developing! resistance! to! these! anti2microbial!agents!(Chapter!7).!
!
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3.1. Introduction!According( to( the(motivation(and(objectives(presented( in(Chapter! 2,( achieving(the(high8level(goal(of(this(work,(i.e.(the(preparation(of(a(biocompatible(and(efficient(bacteriophage( formulation( for( the( treatment( of( S.# aureus( and( P.# aeruginosa(infections( in( burn( wounds,( requires( several( stages( with( their( corresponding(methodology(associated.(This(chapter(includes(a(comprehensive(description(of(the(materials(and(methods(that(were(necessary(in(pursuit(of(the(main(objectives(of(this(thesis.(((The(first(step(to(achieve(the(understanding(of(the(emulsification(techniques(that(are( applied( to( obtain( a( stabilisation( medium( for( bacteriophages( comprises( the(batch( experiments( that( are( described( in( Sections( 3.2( and( 3.3.( These( techniques(correspond( to( the( Phase( Inversion( Temperature( (PIT)( method,( and( the(emulsification(via(homogenisation.(The(batch(procedures(present(advantages,(such(as( simpler( experimental( set8ups,( relatively( quick( results( and( a( reduction( in( the(amounts(of(materials.(((The(characterisation(of(the(nano8emulsions(produced(by(these(methods(is(also(an(important(factor(in(establishing(the(stability(of(the(droplets(over(time,(and(their(suitability( in( terms( of( droplet( size( and( Zeta( potential.( The( measurement(techniques(and(quantification(methods(can(be(found(in(Section(3.4.((Introduction( of( bacteriophages( into( a( suitable( nano8emulsion( formulation(constitutes( the( core( of( this( thesis.( Bacteriophage( isolation( from( natural( sources,(the( determination( of( their( concentration( (titre),( and( the( quantification( of( their(antibacterial( properties( require( some( basic( microbiological( techniques.( The(standard(agar(plating8based(procedures( for(bacterial(growth((which( is( inevitably(linked( to( bacteriophage( handling( and( quantification),( and( bacteriophage(quantification,( are( described( in( Section( 3.5.( The( protocol( for( the( introduction( of(bacteriophages( into( the( nano8emulsion( formulation( is( presented( in( Section( 3.6,(including(a(schematic(diagram(of(the(possible(spatial(distribution(of( the(different(components.( During( this( work,( plating( techniques( were( found( not( to( be(
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particularly( sensitive( or( accurate,( especially( when( using( bacteriophage/nano8emulsion(formulations,(as(emulsions(themselves(affect(bacterial(growth.(Therefore(more(reliable(protocols(were(required,(such(as(turbidity(measurements,(and(these(are(explained( in(Section(3.7.(Measurements(of( size(and(Zeta(potential(of(bacteria(and( bacteriophages( were( also( conducted( for( mechanistic( purposes,( and( are(analogous(to(those(explained(in(Section(3.4(for(the(study(of(emulsion(droplets.((Bacterial( biofilms( were( grown( to( form( an( artificial( representation( of( a( skin(wound.( The( general( protocols( for( biofilm( formation,( biofilm( treatment( with(bacteriophage( formulations,( and( determination( of( the( attached( biomass( are(explained(in(Section(3.8(for(a(static(model(in(a(multi8well(plate(without(liquid(flow.(((Finally,( a( flow(system( that(mimics( the( slow(movement(of( fluids( in(an( infected(wound(was( set( up,( and( the( action( of( bacteriophage/nano8emulsion( formulations(against( biofilms( formed( in( this( device( (i.e.( Robbins( Device)( was( tested.( The(experimental(set8up(and(procedure(are(explained(in(Section(3.9.(The(quantification(techniques( for( attached( biomass( and( bacteriophage( titre( are( identical( to( those(used(in(Section(3.8(for(the(static(model.(The(only(additional(technique(was(confocal(microscopy,(which(is(also(presented(in(Section(3.9.(Confocal(microscopy(was(used(to( visualise( bacterial( biofilms;( in(particular,( it( is( useful( to(determine( the( ratio( of(living/dead(cells(in(the(biofilm(after(treatment(with(a(bacteriophage(formulation.(
!
3.2. Preparation! of! Emulsions! via! Batch! Phase! Inversion!
Temperature!Method!!
!
3.2.1. Reagents!The( components( for( the( preparation( of( emulsions( via( the( PIT( method( were(selected(according(to(the(previous(experiments(conducted(at(the(University(of(Bath((Marino(2010).(8 Brij®( O10( (Sigma( Aldrich,( Dorset,( UK):( Polyoxyethylene( (10)( oleyl( ether((Emulsifier).(8 Soybean(Oil((Sigma(Aldrich,(Dorset,(UK).(8 Reverse(Osmosis((RO)(Water.((8 SM(buffer((see(Table(3.2(for(preparation),(which(would(eventually(substitute(RO(water(as(the(aqueous(or(continuous(phase.(
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3.2.2. Equipment!Figure(3.1( is(a(schematic(of( the(experimental(set8up( for( the(PIT(emulsification(method.( It( consists( of( a( hot( stirring( plate,( a( glass( water( bath( to( keep( the(temperature( constant,( a( 250( ml( round( bottom( flask( that( contains( the( coarse(emulsion((100(ml(in(total)(and(where(the(phase(inversion(of(said(coarse(emulsion(occurs,( a( magnetic( stirrer( inside( the( flask( in( order( to( prevent( aggregation( of(droplets( and( maintain( a( homogeneous( mixture,( and( a( condenser( linked( to( the(round( bottom( flask( to( prevent( evaporation( while( the( emulsion( is( heated.( The(condenser( is(connected(to( the(tap(and(the(drain,(allowing(cold(water( to(circulate(the(system.(The(water(bath(is(filled(with(ice(instead(of(hot(water(when(the(nano8emulsion(is(being(cooled.(((
(
Figure!3.1:!Experimental!setKup!for!the!batch!PIT!emulsification!method.!(
3.2.3. Methodology!!The( experimental( procedure( was( based( on( work( presented( in( the( literature((Tadros( et( al.( 2004;( Shinoda( &( Saito( 1969).( For( the( different( formulations,( the(emulsifier( was( added( to( the( corresponding( amount( of( RO(water( (or( SM( buffer)(while(stirring.(Then(the(oil(was(incorporated(and(stirring(continued(for(at(least(one(hour(until(a(homogenous(mixture(was(observed,(that(is(to(say,(the(surfactant(was(completely(dissolved(and(the(oil(formed(small(droplets(homogeneously(distributed(
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3.3.1. Reagents!The( components( for( the( preparation( of( emulsions( via( the( homogenisation(method( were( the( same( as( for( the( PIT( method,( in( order( to( achieve( comparable(results.(8 Brij®( O10( (Sigma( Aldrich,( Dorset,( UK):( Polyoxyethylene( (10)( oleyl( ether((Emulsifier).(8 Soybean(Oil((Sigma(Aldrich,(Dorset,(UK).(8 SM(buffer.(










water( emulsion( was( formed( as( small( oil( droplets( were( observed,( indicating( the(presence( of( macro8emulsion( droplets.( These( coarse( emulsions( were( then(homogenised( using( the( Ultra8Turrax( rotor8stator( system( for( 15,( 30( and( 45(minutes,( at( a( specified( rotation( speed( of( 13,500( rpm.( A(white(milky( colour(was(observed(through(the(whole(process.(However,(when(the(homogenisation(process(stopped,(a(separation(of(the(foam(on(top(of(the(almost(transparent(liquid(occurred(in(all(cases.(Similarly( to(nano8emulsions(prepared(via( the(PIT(method,(homogenised(nano8emulsions(were(made( several( times(during( this(work,( and( reproducibility( of( the(emulsification( technique( needs( to( be( established.( Characterisation( of( the( nano8emulsions( and( comparison( amongst( them( regarding( their( transparency,( droplet(size( distribution( (DSD),( and( Zeta( potential( allows( for( determination( of(reproducibility,(and(is(fully(explored(in(Section(3.4.((
3.4. Characterisation!of!Emulsions!Characterisation( of( colloidal( systems,( such( as( the( nano8emulsions( that( were(formulated(in(this(work,(typically(consists(of(the(determination(of(stability(in(terms(of( different( features.( These( characteristics( are( closely( related,( and( include(transparency( (which( also( can( be( important( aesthetically( for( instance( in( food( or(healthcare(applications),(particle(size(distribution,(and(Zeta(potential.(




Figure!3.3:!Transmittance!(T!(%))!of!PIT!nanoKemulsions!vs.!wavelength.!(According( to( Figure( 3.3,( the( transmittance( of( PIT( nano8emulsion( (using( RO(water(as(blank( in( the( instrument)( is(approximately(80(%(of( the( radiation,(which(reassures( their( transparency.( At( 400( nm( an( inflexion( point( was( found.( The(transmittance( value( at( this( particular( wavelength( was( used( to( express( the(variation(of(transmittance(versus(time(for(a(period(of(168(h((one(week),(shown(in(Figure(3.4.(
(
Figure!3.4:!Transmittance!of!PIT!nanoKemulsions!vs.!time.!The(values(of(%(transmittance(at(400(nm(in(Figure(3.4(are(practically(constant(over(a(week(with(variations(that(are(not(considered(significant(at(this(point.(Error(bars( represent( the( standard(deviation(of( independent( triplicates( (nano8emulsion(samples(prepared(independently(in(separate(emulsification(experiments).(
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From( Figure( 3.3( it( can( be( seen( that( PIT( nano8emulsions( are( almost( totally(transparent( at( 600( nm( (transmittance( higher( than( 80( %).( The( optimum(wavelength(for(the(measurement(of(turbidity(of(bacterial(samples(was(found(to(be(at( 600( nm( (see( Section( 3.7);( which( is( ideal,( since( nano8emulsions( will( barely(interfere(in(the(optical(density(of(bacterial(samples.(









Clear( similarities( between( the( results( obtained( from( both(DLS( and(NanoSight(can(be(seen( in(Figure(3.5,( taking( into(account( that(Figure(3.5(A(and(Figure(3.5(B(correspond( to( different( formulations.( The( DLS( results( are( based( on( a( size(distribution( of( the( population,( represented( in( the( form(of( a( peak( (in( the( case( of(monodispersed(samples),(or(several(peaks,(whose(height(depends(on(the(intensity(of(the(scattered(light.(The(value(of(the(intensity(depends(on(the(number(of(particles(that(are(detected((concentration(of(particles),(but(it(is(not(an(intuitive(magnitude,(as(opposed(to(the(result(shown(in(Figure(3.5(B,(where(the(height(of(the(peaks(in(the(population( is( directly( related( to( the( concentration( of( particles( per(millilitre.( The(NanoSight(software(also(provides(a(three8dimensional(plot((Figure(3.5(B),(where(a(clearer( distribution( of( the( population( can( be( observed,( also( facilitated( by( the(colour(code.((Measurements( of( particle( size( distributions( were( performed( using( both(techniques,( but(DLS(was( found( to( be(much( quicker( and(more( reproducible( than(NanoSight(in(terms(of(much(smaller(standard(deviations(of(triplicates(of(the(same(sample(and(standard(deviation(of(three((at(least)(independent(samples(of(the(same(composition( in( identical(measurement( conditions.(Measurements(of( independent(samples(on(different(days(yielded(different(results(using(the(NanoSight(technique.(The(reason( for( the( lack(of( reproducibility(of(NanoSight(measurements( lies( in( the(fact( that( there( is( an( important( element( of( subjectivity,( since( visualising( the(particles( on( the( screen( and( selecting( them( for( the( particle( size( analysis( is( a( key(step(in(the(NanoSight(procedure.((The( DLS( technique( was( therefore( chosen( for( the( characterisation( of( nano8emulsions.(Initially,(different(dispersing(media(were(tested((deionised(water,(TSB,(and(SM(buffer)(so(as(to(determine(if(this(factor(was(significant(for(the(outcome(of(the( measurement.( Triplicates( of( each( sample( were( measured,( and( each(measurement(consisted(of(5(runs.(It(must(be(noted(that(the(value(of(size(that(was(selected(and(presented(in(the(results(sections(corresponds(to(the(main(peak!in!the!




3.4.3. Stability!over!Time!A(microplate(reader((SPECTROstar(Omega,(BMG(LABTECH,(Figure(3.6)(was(used(to( determine( the( variation( of( transparency( over( time,( measured( in( terms( of(absorbance.(Constant(values(of(absorbance(over(time(can(be(considered(indicative(of( stability.( Absorbance( of( nano8emulsions( was( measured( at( the( same( time( as(optical( density( of( bacterial( samples( as( a( negative( control.( Triplicates( of( each(sample(were(measured,(and(the(standard(deviation(was(used(to(quantify(the(errors(in(the(technique.((
(
Figure!3.6:!Microplate!reader!(SPECTROstar!Omega).!(The(change(of(particle(size(over(time(was(also(measured(via(the(light(scattering(technique( (DLS,(Malvern( Instruments).( Potential( changes(of( emulsions(over( time(are( crucial( in( relation( to( the( product( shelf8life,( and( thus( can( affect(encapsulated/stabilised(bacteriophages.(
3.4.4. !Zeta!Potential!and!Mobility!of!Emulsion!Droplets!Zeta(potential(of(suspended(particles,(such(as(emulsion(droplets,(can(be(defined(as(the(difference(in(potential(between(the(bulk(of(the(conducting(medium(in(which(they( are( dispersed( and( the( stationary( layer( of( fluid( surrounding( the( suspended(
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particle.(Zeta(potential(is(closely(related(to(the(surface(charge(of(colloidal(particles,(and( provides( an( indication( of( the( stability( of( emulsion( droplets.( It( is( heavily(affected(by(pH,(and(therefore,(ionic(strength(as(well.((Due( to( the( external( charge( of( emulsion( droplets,( when( such( particles( are(exposed( to( an( external( electrical( field,( they(will(migrate( towards( an( electrode(of(the( opposite( charge( at( a( certain( velocity.( This( velocity( is( the( particle(electrophoretic( mobility,( the( magnitude( of( which( is( measured( using( the(ZETASIZER( Nano( Series( (Malvern( Instruments).( Zeta( potential( is( then(automatically(calculated(using(the(Henry(equation((Delgado(et(al.(2005):(
uE =
2 ε  z f ka( )
3 η ( Equation!3.1!( Where( uE( is( the( electrophoretic( mobility( (μm( cm( V81( s81),( ε( is( the( dielectric(constant,( z( is( the( Zeta( potential( (mV),( f(ka)( is( the(Henry’s( function,( and(η( is( the(viscosity( (cP).( Electrophoretic( determinations( of( Zeta( potential( are( made( in(aqueous(media(and(moderate(electrolyte(concentration.( In(this(context,( the(value(of( f(ka)( is( 1.5,( and( is( referred( to( as( the( Smoluchowski( approximation((Smoluchowski(1921).((The(measurements(were(performed(at(25.0(±(0.1(°C(by(diluting(100(μl(of(nano8emulsion( (previously( filtered( with( a( 0.228μm( filter)( in( 5( ml( of( deionised( water.(Dilution(in(deionised(water(is(necessary,(as(the(presence(of(ions(in(the(dispersing(medium((e.(g.(buffer)(dramatically(affects( the(quality(of( the(results.(Triplicates(of(each( sample(were(measured,( and( each(measurement( consists( of( 10( to(100( runs,(depending( on( the( number( of( runs( that( were( required( to( find( a( stable( reading.(Reproducibility(is(determined(by(the(standard(deviation(of(triplicates.((A( potential( source( of( error( is( the( dilution( of( samples.( Dilution( is( time8consuming,(and(it(can(lead(to(large(errors(in(the(Zeta(potential(if(there(is(a(change(in( the( concentration( of( the( background( electrolyte.( Furthermore,( the( diluted(sample(has(such(a(small(particle(surface(area(that(the(Zeta(potential(can(be(altered(by(trace(amounts(of(surface8active(impurities(in(the(sample.(
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Generally( Zeta( potential( and( size(measurements(were( performed( in( the( same(type(of(cuvette,(called(capillary(cell((shown(in(Figure(3.7).(It(has(two(electrodes(and(holds(approximately(1(ml(of(sample.((
(
Figure!3.7:!Malvern!disposable!capillary!cell!(DTS1070).!!(A) Schematic(representation(of(particles(moving(in(the(capillary(cell;((B)(Image(of(capillary(cell(with(caps(to(prevent(evaporation(for(measurements(at(high(temperature.((
3.5. Bacteria!Cultures!and!Bacteriophage!Handling!In( order( to( test( bacteriophage( infectivity( against( some( of( the( pathogenic(bacteria(that(are(present(in(burn(site(infections,(familiarity(of(propagating(bacterial(culture(and(the(quantification(of(colonies(is(necessary.(Aseptic(techniques(are(vital(to( avoid( external( contamination( of( samples( and( consequent( misleading( results.(Therefore,( all( microbiology( experiments( were( performed( in( a( Class( II( cabinet.(Bacteriophage( isolation,( handling( and( quantification( techniques( also( need( to( be(conducted,(prior(to(the(infectivity(tests(themselves.((





8 Tryptic(Soy(Agar((TSA,(Sigma8Aldrich,(Dorset,(UK):((Preparation:( 40( g( of( TSA( was( suspended( in( 1( litre( of( purified( water( in( a(Duran®( glass( bottle.( The(mixture(was( autoclaved( for( 15(minutes( at( 121( °C(and(then(cooled(to(45850(°C.( It(was(mixed(gently(and(dispensed( into(sterile(Petri( dishes.( It( was( used( for( growth( and( quantification( of( Staphylococcus#
aureus.(8 Yeast(Peptone(Dextrose(Broth((YPD,(Sigma8Aldrich,(Dorset,(UK):(Preparation:(50(g(of(YPD(broth(was(suspended(in(1(litre(of(purified(water(in(a(Duran®( glass( bottle.( The( mixture( was( heated( with( frequent( agitation( and(boiled( for(1(minute.(Then,( it(was( autoclaved( for(15(minutes( at( 121( °C,( and(cooled( to( 45850( °C.( It( was( used( for( growth,( dilution( and( quantification( of(
Pseudomonas#aeruginosa.(8 Luria(Broth((LB,(Sigma8Aldrich,(Dorset,(UK):((Preparation:( 25( g( of( LB( was( suspended( in( 1( litre( of( purified( water( in( a(Duran®( glass( bottle.( The( mixture( was( heated( with( frequent( agitation( and(boiled( for(1(minute.(Then,( it(was( autoclaved( for(15(minutes( at( 121( °C,( and(cooled( to( 45850( °C.( It( was( used( for( growth,( dilution( and( quantification( of(
Pseudomonas#aeruginosa.(8 Luria(Broth(Agar((LBA,(Sigma8Aldrich,(Dorset,(UK):((Preparation:( 40( g( of( LBA( was( suspended( in( 1( litre( of( purified( water( in( a(Duran®( glass( bottle.( The(mixture(was( autoclaved( for( 15(minutes( at( 121( °C(and(then(cooled(to(45850(°C.( It(was(mixed(gently(and(dispensed( into(sterile(Petri( dishes.( It( was( used( for( growth( and( quantification( of( Pseudomonas#
aeruginosa.(8 Host(strains(of(Staphylococcus#aureus:((
S.# aureus( is( a( Gram8positive( spherical8shaped( bacterium,( present( in( many(skin( infections.(All( the(selected(strains(are(sensitive( to(both(bacteriophages(used(in(this(work:(Bacteriophage(K(and(Bacteriophage(DRA88.(In(house(stock(cultures( were( prepared( and( maintained( from( original( ones( supplied( by(Ampliphi(Biosciences( (Bedfordshire,(UK),( stored(at( 880( °C.(A( representative(Scanning( Electron( Microscopy( (SEM)( micrograph( of( S.# aureus( is( shown( in(Figure(3.8(A.((
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a) S.#aureus(H560:((A( strain( of( hospital( acquired(methicillin( sensitive(S.#aureus( (HA8MSSA),(first(isolated(in(Oxford((UK)(in(1998(in(the(blood(of(an(828year(old(male(patient((Enright(et(al.(2002).(b) S.#aureus(H325:((A( strain( of( hospital( acquired(methicillin( resistant( S.#aureus( (HA8MRSA)((Cooper(&(Feil(2006).(c) S.#aureus(Btn766:((A(strain(of(HA8MRSA,(first(isolated(in(Brighton((UK)(in(2002(from(a(blood(sample((Enright(et(al.(2002).(d) S.#aureus(15981:((A(MSSA(clinical(isolate(from(Spain((Toledo8Arana(2005).(8 Host(strains(of(Pseudomonas#aeruginosa:((
P.#aeruginosa(is(a(Gram8negative(rod8shaped(bacterium(also(common(in(burn(wounds(and(skin( infections.(An(example(of( the(appearance(of(P.#aeruginosa(under(the(SEM(can(be(found(in(Figure(3.8(B.(The(strains(studied(in(this(thesis(are(all(sensitive(to(bacteriophages(DL52(and(DL54,(and(they(also(came(from(the(original( stock( cultures( supplied(by(Ampliphi(Biosciences( (Bedfordshire,(UK),(stored(at(880(°C.((a) P.#aeruginosa(PAO1:((Found(in(Melbourne((Australia)(in(1955(in(a(patient’s(wound((From(the(





S.# aureus( and( P.# aeruginosa( were( selected( as( they( are( the( most( common(bacterial( strains( that( are( present( in( burn( site( infections,( and( there( is( plenty( of(information( about( their( growth( and( behaviour.( The( research( group( in( Bath(performed( a( sensitivity( analysis( of( the( strains( used(with( respect( to( the( selected(bacteriophages,(but(it(is(not(included(in(this(thesis.((
3.5.1.1. Bacterial!Growth!Bacterial( strains( were( grown( overnight( for( all( the( experiments( that( are(presented( in( this( thesis.( The( standard( protocol( is( as( follows:( 10( ml( of( the(appropriate(growth(medium((TSB(in(the(case(of(S.#aureus(and(YPD(in(the(case(of(P.#
aeruginosa)(are(placed(in(a(50(ml(centrifuge(tube.(With(a(small(pipette(tip,(a(small(amount(of(the(frozen(stock(was(collected(from(the(frozen(vial(corresponding(to(the(desired( strain,( and( used( to( inoculate( the( aliquot( of( media( within( the( centrifuge(tube.(It(was(incubated(with(orbital(agitation(at(37(°C(overnight.(Alternatively,(if(the(strain(was(previously(grown(in(an(agar(petri(dish,(a(single(colony(is(collected(from(it(using(a(loop,(and(used(to(inoculate(the(respective(media,(with(further(incubation(overnight( at( 37( °C.( Only( one( tube( containing( the( desired( strain( is( incubated(overnight(for(each(experiment.(((








plate!#0( 5(ml( Tip( 8(#1( 9.9(ml( 0.1(ml(from(#0( 8(#2( 9.9(ml( 0.1(ml(from(#1( 8(#3( 1.9(ml( 0.1(ml(from(#2( 0.1(ml((Taking( into(account( the(dilution( factors,( the( final( calculation(of( the(number(of(bacteria(per(millilitre(in(the(initial(sample(is(expressed(in(Equations(3.2(and(3.3.(It(is( important( to( note( that( each(dilution( (if( the( sample( is( perfectly( homogeneous)(implies(pipetting(1/100(of(the(number(of(bacteria(present(in(the(previous(sample,(or(1/20(of(the(previous(number(of(bacteria(in(the(last(dilution.(Finally(100(μl(was(plated,(and(it( is(necessary(to(consider(the(μl(to(ml(dilution(factor(to(calculate(the(number(of(bacteria(per(ml,(known(as(colony(forming(units(per(millilitre,(CFU(ml81.(((
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B1 =Colonies× f1 × f2 × f3 =Colonies×2×105 ( Equation!3.2!








( ( Equation!3.3!(The( serial( dilution( process( involves( large( errors.( With( each( sequential( serial(dilution( step,( transfer( inaccuracies( lead( to( less( accurate( and( less( precise(dispensing.(The( result( is( that( the(highest(dilutions(will(have( the(most( inaccurate(results.(For(example,(even(though(the(pipette(is(set(to(dispense(5(ml(each(time,(the(actual(volume(can(vary(within(18100(μl(depending(on(the(accuracy(of(the(pipette.(The( precision( of( calibration( of( equipment( such( as( pipettes( used( in( the( dilution(process( is(often(expressed(in(terms(of(the(coefficient(of(variation.(A(coefficient(of(variation( of( less( than( two( percent( is( often( claimed.( However,( a( coefficient( of(variation(as( large(as( four(or( five(percent( is(quite(possible(when(the(equipment( is(used.( In( addition,( incomplete( mixing( and( human( error,( often( compounded( by(issues( such( as( a( time( constraint( on( the( process,(may( contribute( to( the( problem.(Errors( of( this(magnitude( can( result( in( dramatic( increases( in( the( variation( of( the(estimate(of(the(initial(concentration.(((Finally,(when( doing( viable( colony( counts,( the( higher( the( dilution( is,( the(more(error( is( found(in(estimating(the(count(of(the(original(volume;(although(the(easier(the( counting:( too( many( colonies( on( a( plate( are( difficult( to( count( due( to( sheer(numbers,( overlapping( of( colonies,( possible( interference,( etc.( For( this,( there( is( an(easy(rule(of(thumb:(the(plate(to(count(should(have(between(30(and(300(colonies.(For( instance,( let( us( imagine( that( a( sample( has( exactly( 42( million( cells( per( ml.(Ideally,(if(the(1:106(diluted(plate(is(counted,(exactly(42(CFU(would(be(found.(But(the(exact(same(thing(would(happen(if(the(initial(sample(started(with(42,000,001(cells,(or( even( 42,100,000( cells.( The( best( approximation( is( that( there( are( between(41,500,000(and(42,500,000(cells.(The(error(is(plus(or(minus(500,000(in(42(million,(which( corresponds( to( about( 1.1( %.( The( standard( operating( procedure( is( to( do(about( 5( or( 6( plates( corresponding( to( different( dilutions( altogether.( Including(triplicates(and(determining(their(average(contributes(to(minimising(this(error.(
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Reagent! Amount! Final!concentration! Specifications!NaCl( 5.8(g( 100(mM( 8(MgSO4·7H2O( 2.0(g( 8(mM( 8(
Tris8Cl(( 50(ml( 50(mM( 1(M,(pH(7.5:(Dissolve(121.1(g(of(Tris(base(in(800(ml(of(water(and(adjust(the(pH(by(adding(concentrate(HCl((approx.(65(ml).(Adjust(volume(to(1(litre(and(autoclave(












counting(of(PFUs( is(not(possible.(A(schematic( representation(and(photographs(of(confluent(lysis(can(be(seen(in(Figure(3.10:(( ( (
( (
















8 Plates( are( incubated( inside( the( Class( II( cabinet( with( gentle( and( periodical(manual(shaking(for(approximately(4(hours(at(room(temperature((18820(°C).(8 The( liquid( is( removed( from( the( plate( using( a( pipette,( and( passed( through(0.228μm(filters(to(eliminate(any(bacterial(debris(that(might(remain.(Bacteria(are(normally(larger(than(0.22(μm(and(they(will(be(retained(by(the(filter.(This(will(constitute(the(phage!lysate,(the(bacteriophage(stock.(It(is(stored(at(4(°C(for(short8term(use,(or(frozen(at(880(°C(for(long8term(storage.!




Figure!3.11:!Schematic!example!of!PFU!counting.!In( Figure( 3.11,( 10( PFUs( on( a( bacterial( lawn( can( be( seen.( The( error( in( the(quantification( is(due( to( several( factors,( including( the(quality(of( the(calibration(of(the(pipettes(used,(together(with(human(error(and(serial(dilutions(uncertainties.(In(order(to(decrease(the(error(in(the(estimation(of(the(original(number(of(PFUs(in(the(sample(before(dilution,( triplicates(of( each(plate(were(made,( and( several( (5(or(6)(dilutions( were( plated( at( the( same( time.( The( reproducibility( of( the( technique( is(given(by(the(standard(deviation(of(the(triplicates(of(each(diluted(plate.(((












Figure!3.12:!Proposed!mechanisms!for!phageKemulsion!droplet!interaction.!Figure(3.12(shows(bacterial(cells(surrounded(by(small(nano8emulsion(droplets,(which(may(also(”encage”(bacteriophages(when(they(are( free( in( the(bulk(solution,(but(also(when(they(interact(with(a(bacterial(cell(surface.(This(mechanism(could(be(of( major( importance( in( terms( of( long( term( product( shelf8life( if( it( provides(protection(of(the(phage.(It(is(important(to(note(that(the(long8term(objective(of(this(project(would(be( the(production(of( a( cream/wound(dressing( that( can(be( stored,(commercialised(and(applied(while(the(bacteriophages(remain(active.(On(the(other(hand,( the( selection( of( dose,( expressed( as( the( number( of( bacteriophages( per(bacteria,(in(bacteriophage(therapy(is(of(major(importance((Payne(&(Jansen(2003),(and(it(has(to(be(carefully(considered.(
!
3.6.1. Selection!of!Bacteriophage!Dose!As(a(first(approach(the(bacteriophage(dose(was(dictated(by(practical(reasons,(so(isolated( plaque( forming( units( could( be( counted.( Serial( dilutions( with( different(percentages(of(buffer(and(emulsion(were(performed.(When(a(particular(dilution(of(the( original( phage( lysate( in( buffer( yields( isolated( plaque( forming( units( that( are(clearly( separated( and( easily( counted,( this( dilution( can( then( be( selected( as( the(appropriate(dose(to(begin(with(in(the(infectivity(tests.(This(would(only(constitute(a(first(approach(in(the(quantification(of(the(effect(of(nano8emulsions(on(the(efficacy(of( bacteriophages.( The( appropriate( amount( of( bacteriophages( that( need( to( be(
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added(to( the(emulsion(system(would(depend(on(the(stabilising(mechanisms.(Size(and(surface(charge(could(become(important(in(the(case(of(stabilisation,(considering(that( bacteriophages( might( be( charged( and( form( micelles( in( the( presence( of(surfactants(and(oil.(((In( a(more( realistic( situation,(when(bacterial( growth( curves(were( obtained( via(measurement( of( turbidity( (see( Section( 3.7),( bacteriophage( doses(must( obey( the(concept( of( proliferation! threshold( (Payne( &( Jansen( 2003).! The( growth( of( the(bacteriophage(population(dramatically(depends(on( the(concentration(of(bacteria.(The(proliferation(threshold( is( the(minimum(concentration(of(bacteria( that(allows(bacteriophage( propagation.( ( If( bacterial( density( is( lower( than( the( proliferation(threshold,( infection(might( occur,( but( it( can( not( be(maintained( and( therefore( the(phage( population( will( decay.( When( bacterial( densities( are( higher( than( the(proliferation( threshold,( primary( bacteriophage( infection( is( allowed,( and( the(released(phage(progeny(can( find(enough(uninfected(bacteria( to(proceed(with( the(secondary(infection,(etc.(The(existence(of(this(threshold(is(due(to(the(active(nature(of( bacteriophage( therapy,( as( bacteriophages( are( self8replicating( antimicrobial(agents(and(need(to(access(the(bacterial(machinery(to(reproduce.(A(sensible(way(of(assuring(that(the(proliferation(threshold(is(overcome(consists(of(allowing(bacterial(growth(to(develop(to(a(certain(point,(and(consequently(adding(the(bacteriophage(formulation.(This(protocol(will(be( further(discussed( in(Section(3.7.( In( the(case(of(biofilm( treatment( with( bacteriophage( formulations,( the( concept( of( proliferation(threshold( is( much( more( complicated,( as( bacteriophages( might( attack( biofilm8forming(bacteria,(and(also(bacterial(cells(present(in(the(supernatant(in(the(form(of(a( planktonic( culture.( Also,( the( phage( progeny( might( be( retained( in( the( biofilm(matrix.( In( this( scenario,( two( situations( are( possible:( a( smaller( dose(would( be( as(effective( as( a( higher( one,( due( to( easier( surface( contact( with( the( surrounding(biofilm;( or( the( biofilm( matrix( would( not( allow( effective( diffusion( through( the(biofilm,(and(the(phage(progeny(would(be(trapped(and(decay.((
3.6.2. Procedure!The( method( of( introducing( bacteriophages( into( the( emulsion( preparation(consisted( of( two( steps:( the( preparation( of( nano8emulsions( according( to( the(procedure( that( was( established( in( Sections( 3.2( and( 3.3,( followed( by( the(
! Chapter(3((
( 110(
introduction( of( bacteriophage.( Different( possibilities(were( contemplated,( namely(the( addition( of( the( appropriate( bacteriophage( concentration( (also( known( as(Multiplicity( of( Infection,( MOI)( prior( to( emulsification,( and( the( addition( of(bacteriophages( after( emulsification,( simply( using( nano8emulsions( as( a( diluent( to(achieve(the(desired(MOI.((PIT(emulsification(involves(relatively(high(temperatures,(while(homogenisation(requires( high( shear( stresses.( Bacteriophages( might( be( damaged( during( the(emulsification(processes((Branston(et(al.(2011;(Iriarte(et(al.(2007).(Therefore,(the(addition(of(phage(post8emulsification(was(chosen.(Dilutions(to(a(desired(MOI(were(conducted(using(nano8emulsion(to(dilute,(as(explained(in(Section(3.5.1.2.((




Figure!3.13:!96Kwell!Costar®!microplate.!The(wavelength(that(was(selected(after(a(preliminary(screening(experiment(was(600(nm(as(a(maximum(in(absorbance(was(observed(at(this(particular(wavelength.(The(preparation(procedure(depended(on(the(initial(concentration(of(bacteria(that(was(used,(and(also(on(the(type(of(experiment(that(was(conducted.(8 For( bacterial( growth( curves( (bacterial( growth( only,( in( the( absence( of(bacteriophage( formulations),( the( overnight( culture( was( diluted( so( its(absorbance(was(approximately(1.0(a.u.((absorbance(units).(This(corresponds(to(a(bacterial(density(of(about(108(colony(forming(units(per(millilitre((CFU(ml81).( 100( μl( of( this( bacterial( dilution(were( placed( in( each(well,( and( 100( μl( of(plain( growth(media(were( added( to( a( final( volume( of( 200( μl.( Note( that( the(concentration( of( bacteria( is( now( half( of( the( original.( After( 15( h( overnight(incubation,(growth(curves(starting(at(the(initial(bacterial(concentration(of(108(CFU(ml81(show(only(the(last(phase(of(the(exponential(growth,(the(stationary(phase( and( in( some( cases,( part( of( the( decay.( This( is( due( to( the( high( initial(bacterial(load(relative(to(the(available(nutrients.(If(the(complete(growth(curve(is(desired,(the(overnight(culture(was(diluted(to(a(final(absorbance(of(0.1(a.u.((106( CFU( ml81).( ( An( example( of( the( results( obtained( using( this( method( is(presented(in(Figure(3.14(A.(The(rest(of(the(protocol(remains(the(same.(For(the(study( of( bacterial( growth( in( nano8emulsions,( 100( μl( of( nano8emulsion(was(added(to(the(bacterial(dilution,(instead(of(100(μl(of(growth(media.(8 For( bacteriophage( infectivity( curves,( two( possibilities( exist.( When( initial(bacterial( absorbance(was( 1.0( a.u.,( 100( μl( of( the( bacteriophage( preparation(
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were( immediately( added( (phage( suspension( in( buffer,( or(bacteriophage/nano8emulsion( formulation),(as( the( initial(concentration(was(considered(to(be(above(the(proliferation(threshold.(On(the(other(hand,(when(the( initial(bacterial(absorbance(was(0.1(a.u.,( the(proliferation(threshold(was(not( reached.( 100( μl( of( the( bacterial( dilution(were( placed( in( each(well,( and(allowed(to(grow(at(37(°C(inside(the(plate(reader(for(two(hours.(At(that(point,(the( bacterial( density( was( high( enough( to( maintain( infection,( so( the( wells(were(filled(with(100(μl(of(the(corresponding(bacteriophage(formulation,(and(the( microplate( was( incubated( overnight.( An( example( of( these( results( is(shown(in(Figure(3.14(B.(( (
( ((
Figure!3.14:!Examples!of!growth!curves!obtained!via!measurement!of!optical!density.!(A)(Growth(of(S.#aureus(H560(in(TSB;((B)(Lysis(of(S.#aureus(H560(by(Bacteriophage(K,(added(after(two(hours(of(incubation(of(bacteria(in(the(absence(of(bacteriophage.(Only(one(in(five(of(the(error(bars((standard(deviation(of(triplicates)(are(shown(for(clarity.(





aureus( H560( with( time( in( the( presence( of( Bacteriophage( K,( inoculated( at(approximately( 2( hours( after( bacteria( started( to( grow.( A( slight( and( short(exponential(growth(phase(is(observed(from(2(h(to(around(3.5(h.(At(this(point,(there(is( a( decay( in( bacterial( OD( due( to( lysis( by( Bacteriophage( K.( At( approximately( 9(hours,(S.#aureus( starts( growing( again,( as( the( concentration(of( bacteriophage(was(not( high( enough( to(maintain( infection.( It( can(be( concluded( that(measurement( of(optical(density(provides(a(lot(of(information(about(the(infection(process.((However,( it( is( necessary( to( relate( the( optical( density( of( bacterial( samples( to(bacterial( concentration.( A( linear( relationship( between( OD( and( bacterial(concentration(was(verified( for(bacterial( growth( in(TSB(or(YPD.(This( relationship(was(extended(to(include(growth(of(bacteria(in(emulsion(due(to(the(lack(of(a(reliable(counting( method( when( emulsion( was( present.( An( example( of( the( relationship(between(bacterial(density((CFU(ml81)(and(OD(for(S.#aureus(H560(is(shown(in(Figure(3.15.((
(( (
Figure!3.15:!Bacterial!density!vs.!OD!for!S.#aureus!H560.!!The(average(of(independent(triplicates(is(shown,(and(error(bars(represent(the(standard(deviation.(A(straight(line(is(fitted,(and(its(equation(and(R2(value(are(presented.((




These( optical( density( experiments( provide( more( information( about( the(mechanisms( of( action( of( bacteriophage( on( bacteria( and( also( allow( selection( of( a(suitable( control( for( the( infectivity( tests.( It( is( important( to( note( that( turbidity(measurements( only( allow( quantification( of( bacteria,( not( bacteriophage,( since(phages(are(transparent(at(600(nm((or(any(other(wavelength).((
3.8. Biofilms!–!Static!Model!Experiments(based(on(liquid(culture((planktonic(culture)(provide(a(basis(for(the(study( of( biofilms.( This( section( refers( to( biofilms( developed( in( microwell( plates((static( model),( and( it( is( divided( into( three( sub8sections:( biofilm( formation,(quantification( of( biomass( present( in( the( biofilm( via( crystal( violet( staining,( and(biofilm(infection(with(bacteriophage(formulations.((
3.8.1. Biofilm!Formation!Biofilm(formation(of(S.#aureus(and(P.#aeruginosa(was(carried(out(in(independent(968well(microplates.(The(wells(in(these(plates(have(flat(bottoms(and(their(surface(is( treated(so( the(biofilm(attachment( is(enhanced((Nunc™(MicroWell™(Plates(with(Nunclon™( Delta( Surface).( The( six( strains( (three( for( S.# aureus( and( 3( for( P.#
aeruginosa)(described(in(Section(3.5.1(were(used.(Wells(were(filled(with(100(μl(of(the(cellular(suspension(with(an(OD600(nm(of(0.1(a.u.( (≈106(CFU(ml81)(and(100(μl(of(plain(medium(or(nano8emulsion.( In( the(case(of(S.#aureus,(TSB(was(supplemented(with( 1%( D8(+)8glucose( and( 1%( NaCl( (TSBg+NaCl)( as( this( improves( biofilm(formation( (Alves( et( al.( 2014).( Negative( controls( including( media( (or( nano8emulsion)(were(also(included.(Triplicates(of(each(well(were(used,(and(independent(experiments(were(performed(in(duplicate.((Biofilms(were(formed(for(24,(48(and(72(h,(with(plates(incubated(at(37(°C(in(an(orbital( shaker( (120( rpm)( for( P.# aeruginosa# (Pires( et( al.( 2011),( and( without(agitation(for(S.#aureus((Alves(et(al.(2014).((
3.8.2. Determination!of!Biomass!Present!in!the!Biofilm!After( the( desired( incubation( time,( the( supernatant( was( removed( and( wells(were( carefully( washed( twice( with( sterile( Phosphate( Buffered( Saline( (PBS)(solution( (Sigma( Aldrich,( UK)( to( remove( any( planktonic( cells.( Microplates( were(
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3.8.3. Biofilm!Infection!Biofilm(infection(was(done(with(a(cocktail(of(the(two(different(phages(for(each(bacterial(strain,(namely(Bacteriophage(K+DRA88(for(S.#aureus,(and(Bacteriophage(DL52+DL54( for( P.# aeruginosa;( both( in( SM( buffer( suspension( and( as( a( part( of( a(bacteriophage/nano8emulsion( formulation.( After( 24( h( of( biofilm( formation( (see(Section(3.8.1),(all(medium(and(planktonic(bacteria(were(removed( from(each(well(and(washed(once(with(PBS( solution.( Following( that,( 200(μl( of( the(bacteriophage(preparation( was( added( to( each( well.( Positive( and( negative( controls( were( also(included.( The( MOI( used( for( both( phages( was( 10( (initial( concentration( of( each(bacteriophage( in( the( phage( cocktail( approximately( 107( PFU( ml81).( The( P.#
aeruginosa( plates( were( incubated( in( an( orbital( shaker( (120( rpm),( while( the( S.#
aureus(plates(were(incubated(without(agitation,(both(at(37°C.(Infection(continued(and(was( tested(24,( 48( and(72(h( after( inoculation.( Similarly( to(biofilm( formation,(triplicate( wells( were( used,( and( the( experiment( was( performed( independently(twice.((Quantification( of( the( remaining( biomass,( after( the( bacteriophage( formulation(infection(occurred,(was(performed(via(colony(and(PFU(counting((see(Sections(3.8.2(and(3.5.2)(and(CV(staining((see(Section(3.8.2).((
3.9. Biofilms!–!Flow!System!The(biofilm( static(model( constitutes( one( step( further( towards( the( real(wound(environment.( However,( flow( systems( are( a( better( approach( to( study( the(attachment( of( bacteria( to( surfaces( (Kharazmi( et( al.( 1999).( A( modified( Robbins(Device( set8up(was( designed( for( this( purpose.( The( following( pieces( of( equipment(were( included,( in( addition( to( the( growth( media,( nano8emulsions,( bacteria( and(bacteriophage(strains,(and(buffers(that(are(previously(described(in(this(chapter:(8 Chemostat((Tyler(Research(Corporation,(Canada):((2(litres(jacketed(glass(reactor(with(magnetic(agitator.(It(is(connected(to(water(from( a( hot(water( bath( at( 37( °C( in( order( to( keep( the( temperature( constant(inside( the( chemostat.( It( has( several( ports( to( connect( a( thermometer,( a( pH(meter,(and(the(inlet(and(outlet(tubes.(8 Stirring(Plate,(that(provides(agitation(for(the(chemostat.(
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8 Ismatec(ICC(4(Channel(8(Roller(Peristaltic(Pump((Cole8Parmer®,(UK):((Four( channel( peristaltic( pump,( with( independent( flow( control( for( each(channel.(The(pump(delivers(continuous(pumping(up(to(35(ml(min81(with(the(capability( of( bidirectional( flow( in( each( channel.( It( is( used( to( feed( the(chemostat(with( fresh(media,( and( to( inoculate( the( bacterial( suspension( and(the(bacteriophage(formulation(into(the(Robbins(Device.((8 LPMR812SS( stainless( steel( 128port( Robbins( Device( (Tyler( Research(Corporation,(Canada):((The(modified(Robbins(device((MRD,(Figure(3.17(A)( is(an(artificial(multiport(sampling(catheter,(designed(for(low(flow(and(low8pressure(conditions((up(to(15( psi).( Twelve( evenly( spaced( sampling( ports( are( devised( so( that( stainless(steel(sampling(plugs((coupons,(Figure(3.17(B)(lie(on(the(inner(surface(without(disturbing( flow( characteristics.( The( coupons( can( be( removed( and( replaced(aseptically.( The( device( can( be( completely( disassembled( for( cleaning( and(autoclaving.(The(stainless(steel(coupons(have(a(surface(area(of(50(mm2.(In(the(Robbins(Device,( the(medium(or( inoculum(flows( through( large(surface(areas(for(bacterial(adhesion.(
(
(




8 Duran®(glass(bottles(or(Erlenmeyer(flasks:((They( contain( autoclaved( fresh( medium( to( feed( the( chemostat( and/or( the(Robbins(Device,(and(they(are(also(used(to(dispose(the(waste(products.(8 Hot(water(baths:((They(provide(hot(water( to(be(pumped( through( the( jacket( of( the( chemostat(and( the( temperature8regulating(module.(Bottles( containing( fresh(media( are(also(placed(inside(the(hot(water(bath(to(achieve(consistent(temperatures.(( The(whole(set8up(comprising(the(main(elements(described(in(this(section(can(be(seen(in(a(schematic(in(Figure(3.18.((






Biofilm(formation(in(the(Robbins(Device(requires(several(steps,(starting(with(the(growth(of( the( inoculum( in( the( chemostat,( followed(by(biofilm( formation( itself( in(the(sampling(plugs.(( The(chemostat(was(initially(filled(with(autoclaved(medium,(and(connected(to(the(hot( water( bath( so( the( temperature( reached( the( desired( 37( °C,( which( was(maintained( over( time.( The( specific( strain( of( bacteria( was( inoculated( and( left( to(grow(for(48(h.(The(chemostat(was(continuously( fed(with( fresh(medium(at(a( flow(rate( of( 500( μl( per(minute.( In( order( to( achieve( steady( state,( the( flow( out( of( the(chemostat(was(also(set(at(500(μl(min81.( It( is( important( to(note( that(all( flow(rates(were( determined( via( the( design( equation( and(determination( of( bacterial( growth(parameters( described( in( Chapter! 6.( Bacterial( density( after( 48( h( was(approximately(108(CFU(ml81.(It(is(important(to(stress(that(the(Robbins(Device(was(not(connected.((Once(this(concentration(of(bacteria,(desirably(growing(in(the(exponential(phase((determined( via( the( design( equation( and( growth( parameters( in( Chapter! 6),( is(attained,( the( Robbins( Device( is( connected( to( the( chemostat.( It( fed( the( Robbins(Device(at(a(flow(rate(of(250(μl(min81(for(24(h,(during(which(the(biofilm(formed(on(the( surface(of( the( sample(disks.( Following( this,( the( chemostat(was(disconnected,(and(the(Robbins(Device(was(fed(with(fresh(autoclaved(medium(for(24(h(at(a(flow(rate( of( 250( μl( min81.( The( moving( liquid( phase( imposed( shear( stresses( on( the(developing( biofilm,( causing( cells( to( be( shed.( These( steps( constitute( the( biofilm(formation,(and(it(is(considered(that(the(biofilm(is(ready(for(infection(at(this(point.(((Two(parallel(Robbins(Devices(were(used,(as(can(be(seen(in(Figure(3.18.(Biofilm(infection( was( performed( by( simply( changing( the( medium( feed( of( the( Robbins(Device( for( the(desired(bacteriophage( formulation(at( the( same( flow(rate.( Samples(were( taken( 24( and( 48( h( after( bacteriophage( inoculation.( One( of( the( Robbins(Devices( was( fed( with( bacteriophage( formulation,( while( the( other( was( fed( with(plain(SM(buffer,(in(order(to(obtain(an(appropriate(control.(((((
! Chapter(3((
( 120(
3.9.2. Biofilm!Quantification:!Confocal!Microscopy!(Biofilm( biomass( quantification( and( bacteriophage( propagation( within( the(biofilm( were( performed( via( colony( and( PFU( counting( respectively.( In( order( to(detach( the( biofilm( forming( cells( and( phage( retained( in( the( biofilm( matrix,( the(sampling(disks(were(extracted(and(replaced(with(autoclaved(fresh(ones,(in(order(to(avoid(leakages.(Three(sampled(disks((triplicates)(were(carefully(washed(twice(with(PBS(solution(to(eliminate(any(planktonic(cells,(and(placed(in(a(small(vial(containing(2(ml(of(PBS.(The(vials(were(sonicated(for(5(minutes(and(the(disks(were(extracted(from(the(vial.(Appropriate(dilutions(and(plating(were(performed(both(for(bacteria(and(bacteriophage(as(explained(in(Sections(3.5.1.2(and(3.5.3.((When(infection(occurs,(cell(viability(is(an(important(factor(to(take(into(account,(that( is( to( say,( determination( of( biofilm( biomass( that( has( not( been( attacked( by(bacteriophage( (alive( cells),( and( biofilm8forming( cells( that( are( lysed( (dead( cells).(This(is(also(significant(when(biofilms(become(“old“(several(days(after(inoculation,(and(bacterial(cells(start(to(deteriorate.(Cell(viability(in(the(biofilms(formed(on(the(surface( of( the( disks( was( determined( using( the( commercial( kit( LIVE/DEAD®(BacLightBacterial( Viability( Kit( for(microscopy( (InvitrogenTM,( UK)( (Berney( et( al.(2007).( This( provides( a( two8colour( fluorescence( assay( that( can( be( observed( via(confocal(microscopy.(The(kit(consists(of(a(mixture(of(the(green(fluorescent(nucleic(acid( stain( SYTO®( 9,( and( propidium( iodide,( a( red8fluorescent( nucleic( acid( stain.(These( stains( differ( in( their( spectral( characteristics( and( more( importantly( their(ability(to(penetrate(healthy(bacterial(cells.(When(used(alone,(SYTO®(9(stain(labels(all( bacteria( in( a( population,( both( cells( with( intact( membranes( and( those( with(damaged( membranes.( On( the( other( hand,( propidium( iodide( penetrates( only(bacteria(with(damaged(membranes,(causing(a(reduction( in(SYTO®(9( fluorescence(when(both(dyes(are(present.( In( this(manner,( living(cells(remain(stained( in(green,(while( the( dead( ones( appear( in( red.( The( stains( were( prepared( according( to( the(manufacture’s( instructions,(mixing(both(components,(and(then,(after(washing(the(sampled(disks(twice(with(PBS(solution,(the(disks(were(placed(in(a(vial(containing(both(stains(and(incubated(in(the(dark(for(15(minutes.(After(this,(disks(were(washed(again( and( fluorescent( emission( was( determined( by( confocal( microscopy( (Zeiss(
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LSM510META).( An( example( of( the( images( obtained( via( confocal( microscopy( is(shown(in(Figure(3.19.(
( ((
Figure!3.19:!Example!images!of!biofilms!seen!in!the!confocal!microscope!Zeiss!LSM510META.!(A)(Biofilm(stained(with(green(fluorescent(nucleic(acid(stain(SYTO®(9;((B)(Biofilm(stained(with(propidium(iodide,(a(red8fluorescent(nucleic(acid(stain.((Stacked(images(can(be(obtained(and(mounted(using(Bitplane((Imaris(Software).(An(example(of(the(stacked(images(result(is(represented(in(Figure(3.20((Reprinted(with( permission( from( copyright( holder,( see( (Grade( et( al.( 2011)).( Living( cells(forming(the(body(of(the(biofilm(are(represented(in(green,(while(cells(whose(outer(membrane(has(been(damaged,(and(can(be(considered(dead,(are(shown(in(red.(
((
Figure!3.20:!Confocal!microscopy!stacked!image!of!a!sample!treated!with!LIVE/DEAD®!




biofilm( biomass.( At( the( same( time,( this( can( be( compared(with( the( PFU( and( CFU(counts.((
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4. FORMULATION! OF! BACTERIOPHAGE! /! NANO8EMULSION!
PREPARATIONS!
!
4.1. Introduction!This! chapter! describes! the! initial! steps! in! the! development! of! the!bacteriophage/nano;emulsion!formulations,!which!are!presented!in!chronological!order.! Firstly,! the! preparation! and! characterisation! of! the! different! oil;in;water!nano;emulsions!that!will!be!used!through!this!thesis!are!described.!Emulsions!are!characterised! in! terms!of! their! visual! appearance,! their!droplet! size!distribution,!and! zeta! potential.! The! second! phase! of! this! work! involves! incorporation! of!bacteriophage!into!the!emulsion!formulations.!Initially,!only!Bacteriophage!K!was!used;!however,!a!novel!polyvalent!S.#aureus!phage!(DRA88)!(Alves!et!al.!2014)!was!isolated! by! the! research! group! during! the! programme,! and! therefore! integrated!into! this!work.! Similarly,! two!P.#aeruginosa! bacteriophages!were! also! found! and!introduced! into! the! emulsion! formulations.! Results! regarding! bacteriophage!viability! and! infectivity! in! the!presence! of! nano;emulsions! constitute! the! core! of!this! chapter,! in! addition! to! the! evaluation! of! the! shelf;life! of! the! formulation.!During!this!work!it!was!discovered!that!nano;emulsions!have!an!effect!on!bacterial!growth! patterns,! and! the! results! and! hypothesis! about! this! phenomena! are! also!summarised.!!
4.2. Emulsion!Characterisation!Nano;emulsion! functionality! and! properties! are! heavily! influenced! by! their!droplet!size!distribution!and!zeta!potential,!in!terms!of!their!stability!over!time!and!suitability! for! an! applicable! formulation.! The! different! characterisation!methods!and! results! for! the!oil;in;water!nano;emulsions! that!were!used! in! this! thesis! are!explained!in!this!section.!!




Homogenisation! method! (as! in! some! recent! representative! examples! (Lee! &!Norton!2013;!Lee!et!al.!2014)).!!
4.2.1.1. PIT!The!selected!formulation!had!the!following!composition:!5!%!(w/w)!soybean!oil!as! the! organic! phase,! 15!%! (w/w)!Brij!O10®! as! surfactant,! and!80!%! (w/w)! SM!buffer! (100!mM!NaCl,!8!mM!MgSO4·7H2O,!50!mM!Tris;Cl,!0.002!%!(w/v)!gelatin,!pH! 7.5)! as! the! aqueous! phase.! However,! originally! Reverse! Osmosis! (RO)!water!was!used!as!the!aqueous!phase.!The!reasons!for!the!choice!of!composition!include!the! relatively! high! concentration! of! emulsifier,! which! allowed! the! more!pronounced! effects! on! bacterial! growth! and! bacteriophage! infectivity! to! be!detected! during! a! shorter! storage! time;! and! the! presence! of! SM! buffer! as! the!aqueous! phase,!which! resulted! in! smaller! emulsion! droplets! (via! the! salting! out!effect),!and!stabilised!environment!to!appropriate!levels!for!bacteriophage!storage.!Regarding! the! suitable! storage! conditions! for! bacteriophage,! SM! buffer;based!nano;emulsions!provide!a!similar!concentration!of!salts!and!pH!to!SM!buffer!alone!(which! is! the! standard! storage! method! as! stated! in! the! literature! (Fortier! &!Moineau! 2009)),! and! therefore! a! fairer! comparison! can! be! achieved.! Nano;emulsions!were!produced!according!to!the!method!described!in!Section!3.2.!!!
4.2.1.2. Homogenisation!The! same! formulation! as! for! PIT! emulsification!was! chosen! in! order! to! allow!direct! comparison! of! the! results.! The! general! procedure! for! homogenisation!emulsification! can! be! found! in! Section! 3.3.! In! this! way,! the!formulation/composition!is!excluded!from!any!possible!influence!that!size!or!zeta!potential! may! have! on! bacterial! growth! or! bacteriophage! performance! against!bacteria.!!Batch! membrane! emulsification! was! also! tested! for! different! formulations,!number! of! passes! through! the! membrane,! pre;wetting! of! the! membrane,! pre;stirring! of! the! coarse! emulsion,! and! emulsification! temperatures.! Hydrophilic!polycarbonate! membranes! and! polyester! drain! disks! (AMD! Manufacturing! Inc.)!were!used.!However,!poor!results! in!terms!of!stability,!creaming!and!coalescence!were!achieved.!Therefore,!the!membrane!emulsification!set;up!was!discarded!as!a!
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reliable! method! to! obtain! oil;in;water! nano;emulsions! for! the! purposes! of! this!thesis.!!









B! show!more!opaque! formulations!due! to! the! shorter!homogenisation! times! (15!and! 30! minutes! respectively),! in! comparison! to! Figure! 4.1! C,! where! the!emulsification!time!was!45!minutes.!This!relates!to!the!extended!exposure!of! the!coarse! emulsion! to! shear! forces! that! break! bigger! droplets! down! to! smaller!droplets.!PIT!emulsions!(Figure!4.1!D)!were!even!more!transparent!due!to!smaller!droplet!sizes.!!No!creaming,! coalescence!or! cloudiness!was!observed,! reassuring! the! stability!of!these!formulations.!Transmittance!(or!absorbance)!was!measured!in!the!range!of!the!visible!region.!Nano;emulsions!transmit!80!%!of!the!radiation!in!the!range!400!nm!–!800!nm.!In!addition,!transmittance!was!constant!over!time,!which!can!be!considered!as!a!sign!of!stability!(Mason!et!al.!2006)!together!with!the!insignificant!variation!in!droplet!size!over!time!that!will!be!discussed!in!Section!4.2.3.!!!





























influence!on!the!results,!since!the!first!three!values!are!practically!the!same!as!the!second!three!values!(data!not!presented!here).!Nano;emulsions!prepared!using!the!homogenisation!method!have!higher!PdIs,!which!results!from!the!presence!of!two!main!peaks!corresponding!to!two!different!main!particle!sizes!(see!Figure!4.2!A).!PIT!nano;emulsions!are!very!monodispersed,!as!indicated!by!their!small!PdI!value,!which!is!quite!close!to!0,!and!the!presence!of!a!single!narrow!peak!as!can!be!seen!in!Figure!4.2!B.!Also,!regarding!the!different!homogenisation!times!in!Table!4.1,!it!is!clear!that!after!45!minutes,! the!percentage!of!smaller!droplets! increased!while!the!percentage!of!bigger!droplets!decreased!in!comparison!to!the!sizes!that!were!obtained! after! 15! and! 30! minutes.! The! resulting! nano;emulsion! is! a! bimodal!distribution!of!droplets,!where! the!highest! size! value! is! approximately! ten! times!bigger!than!the!smallest,!and!the!proportion!of!sizes!is!nearly!1:1.!This!correlates!with!the!more!transparent!emulsions!as!was!seen!in!Figure!4.1,!where!the!visually!detected!transparency!of!homogenisation!nano;emulsions!seems!to!increase!from!Figure!4.1!A!to!Figure!4.1!C.!!ANOVA!(Analysis;Of;Variance)!analysis!was!performed!using!Origin8®!software!(OriginLab,! Northampton,! MA)! in! order! to! determine! if! the! independent!experiments!were! statistically! significantly!different.!The! independent! repeats!of!the! different! formulations! (PIT! and! homogenisation)! were! not! statistically!different!regarding!particle!size!distribution!in!any!of!the!cases!with!a!confidence!of! 95! %.! This! confirms! the! reproducibility! and! reliability! of! the! emulsification!methods.!!















adhere.! Moreover,! the! values! of! zeta;potential! close! to! zero! are! perfectly!reasonable;!taking!into!account!that!the!surfactant’s!nature!is!non;ionic.!!For! the! four! formulations,! both! the! composition! and! pH! remain! exactly! the!same.!In!aqueous!media,!pH!and!concentration!of!salts!(conductivity)!of!the!sample!are!the!most!important!factors!that!affect!its!zeta!potential.!However,!variations!in!zeta! potential! amongst! our! formulations! can! not! be! explained! by! differences! in!composition,!pH!or!conductivity,!since! the!experimental!measurement!procedure!was!performed!in!the!same!manner!for!all!of!them.!It!is!worth!mentioning!that!the!standard!deviation!obtained!after!six!measurements!of!three!independent!samples!is! relatively! high,! which! makes! the! values! of! zeta! potential! for! the! four!formulations!be!in!approximately!the!same!range!and!close!to!zero.!!!
4.2.5. Comparison!of!Formulations!and!Conclusions!Nano;emulsion!formulations!prepared!using!PIT!and!homogenisation!methods,!and! SM! buffer! as! aqueous! phase! were! found! to! be! stable! in! terms! of! optical!activity,! size! and! zeta! potential:! their! optical! density,! particle! size! and! zeta!potential!remained!constant!over!a!prolonged!period!of!time.!Both!methods!were!proven!to!be!reliable!and!statistically!reproducible,!yielding!similar!enough!droplet!size!distributions!amongst! the!different!repeats.!Oil;in;SM!buffer!nano;emulsions!formulated! via! the! PIT! method! and! homogenisation! after! 45! minutes! are!transparent!and!present!consistent!particle!size!distributions.!Therefore!they!are!good!model!candidates!to!be!used!in!the!stabilisation!of!bacteriophage!particles!for!topical! applications.! They! are! different! in! terms! of! droplet! size! distribution!(monodispersed! and! bimodal! respectively)! so! this! variable! can! be! studied!independently!of!chemical!composition!and!pH.!Homogenisation!emulsions!exhibit!a! peak! at! the! same! size! as! for! PIT! emulsions,! with! an! additional! population! of!droplets!approximately!ten!times!bigger,!in!a!1:1!ratio.!!!!!!!
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4.3. Introduction!of!Phages!in!Emulsion!Formulations!The! introduction! of! bacteriophages! into! emulsions! required! dilution! of! the!phage! lysate! to! a! certain! concentration,! as!was! explained! in! Section! 3.6.! This! is!oriented!to!the!preparation!of!formulations!that!present!desirable!properties!to!be!used!as!antimicrobial!agents,!allowing!for!the!delivery!of!phage!or!‘phage;cocktail’!to! the! point! of! infection!without! losing! efficacy,! either! during! delivery,! or! prior!storage.!Depending!on!the!different!experiments!performed,!this!leads!to:!; A! noticeable! number! of! plaques! when! bacteriophage! in! emulsion! and!bacteria!were!plated.!; !A! noticeable! decrease! in! bacterial! growth,! as! indicated! by! a! reduction! in!optical!density!when!optical!density!was!measured!in!the!initial!experiments.!; And! lastly,! a!desired!MOI! in!order! to!observe!bacterial!killing,!but!avoiding!regrowth! phenomena.! The! final! concentration! of! bacteriophage! used! for!infectivity!tests!corresponded!to!a!multiplicity!of!infection!(MOI)!of!about!0.1.!!Dilutions! were! made! using! emulsion! as! both! diluent! and! storage! media.!Bacteriophage/emulsion!preparations!were!kept!either!at!room!temperature!(18;20!°C)!or!cold!temperature!(4!°C)!over!varying!periods!of!time,!depending!on!the!experiment,!and!their!ability!to!infect!bacteria!was!tested!regularly.!!
4.3.1. PIT!Emulsion!Prepared!with!RO!Water!–!Loss!of!Infectivity!of!




control!plates,!with!the!equivalent!amount!of!freely!suspended!phage!in!SM!buffer!after!the!selection!of!dose.!Triplicates!of!each!plate!were!prepared!and!incubated!overnight.!!Figure!4.3!shows!the!average!number!of!plaque! forming!units!(PFU)!per!plate!when!S.#aureus!MSSA467!and!H560!were!challenged!with!Bacteriophage!K/nano;emulsions.!Bacteriophage!K!was!stored! in!oil;in;water!PIT!nano;emulsion! for! six!hours,! and! samples! were! taken! and! plated! together! with! the! corresponding!bacterial!strain!at!time!0,!1!h,!2!h,!3.5!h,!4!h,!5!h,!5.5!h!and!6!h.!!
!
Figure!4.3:!Loss!of!infectivity!of!Bacteriophage!K!in!PIT!oil8in8water!nano8emulsion.!!Absolute!values!are!shown;!lines!are!drawn!to!guide!the!eye.!As! can! be! seen! in! Figure! 4.3,! when! a! PIT! oil;in;water! emulsion! was! used! as!storage! medium! for! Bacteriophage! K,! the! decay! in! the! number! of! PFUs! was!extremely!rapid.!It!was!observed!that!even!at!the!time!0,!the!number!of!PFUs!was!much!smaller!than!the!one!for!the!positive!control,!which! is!not!shown!in!Figure!4.3! because! of! the!difference! in! scale! (the!number! of! PFUs! is! 10! times!bigger! at!time!0!in!the!positive!control).!!!!Bacteriophage! K! inactivation! in! oil;in;water! nano;emulsions! fits! a! first! order!kinetic!decay,!as!shown!in!Equation!4.1:!
P
P0
= a e−bt ! Equation!4.1!
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Where!P!is!the!concentration!of!Bacteriophage!K!(PFU!ml;1!or!PFU!per!plate),!P0!is!the!initial!concentration!of!Bacteriophage!K!(PFU!ml;1!or!PFU!per!plate),!a!is!the!pre;exponential! factor!(dimensionless),!b! is! the!decay!rate!(h;1),!and!t#is! the!time!(h).!!In! addition! to! the! decay! rate,! b,! another! parameter! that! allows! to! determine!how!fast!Bacteriophage!K!loses!its!infectivity!in!oil;in;water!nano;emulsions!is!the!
half8inactivation! time! of! Bacteriophage! K! infecting! bacteria,! that! is! to! say,! the!time! taken! to! reduce! the! concentration! of! active! bacteriophages! to! half! of! the!initial!value.!The!half;!inactivation!time,!t1/2!(h)!is:!!
P
P0
= 0.5→ t1/2 = −
ln 0.5 / a( )







According! to! the! data! presented! in! Figure! 4.4,! an! exponential! decay! equation!can!be!easily!fitted,!and!the!kinetic!parameters!can!be!calculated.!They!are!shown!for!both!strains!in!Table!4.3.!!!
Table!4.3:!Exponential!decay!parameters!for!Bacteriophage!K!infecting!S.#aureus#MSSA467!
and!S.#aureus#H560.!
P P0 = a e−bt !
Infected!Strain!! Parameter!a!(8)! Parameter!b!(h81)! t1/2!(h)! R2!
S.#aureus!MSSA476# 0.9988! 0.536! 1.3! 0.973!
S.#aureus!H560# 1.122! 0.819! 1.0! 0.951!! Looking!at!Figure!4.4!and!Table!4.3,!it!can!be!concluded!that!phage!K!infecting!MSSA467! takes! a! longer! time! to! be! inactivated! than! phage! K! infecting! H560.!Bacteriophage! K! is! rapidly! inactivated! and! becomes! less! infective! at! a! fast! rate!when! infecting! S.# aureus! MSSA476! and! H560,! as! confirmed! by! the! decreasing!number!of!PFUs!observed.!There!are!several!references!in!the!literature!regarding!inactivation! of! bacteriophages! due! to! environmental! conditions! such! as! salinity!and!osmotic!pressure!(Jończyk!et!al.!2011;!Mylon!et!al.!2010)!and!several!chemical!compounds! (Reinhardt! et! al.! 1978;! Sands! et! al.! 1979;! Williams! et! al.! 1940;!Matsubara!et!al.!2007)!and!this!might!be!one!of!those!cases.!
!Bacteriophage! K/oil;in;water! nano;emulsions! are! therefore! not! suitable! for!future!applications.!One!of!the!main!aims!of!this!work!is!to!develop!a!vehicle!and!storage! medium! for! bacteriophages! to! be! delivered! to! wound! infection! sites!without! losing! efficacy,! and! these! kinds! of! formulations! enable! bacteriophage!complete!inactivation!in!a!very!short!period!of!time!(6!h).!Therefore,!slight!changes!in!the!formulation!must!be!performed.!!
4.3.2. PIT!Emulsion!Prepared!with!SM!Buffer!–!First!Evidence!of!
Enhanced!Infectivity.!Limitations!of!the!Technique!Emulsions! using! buffer! as! the! aqueous! phase! instead! of! RO! water! were!proposed!on!the!basis!that!they!should!have!the!following!advantages:!; In!relation!to!bacteriophages,!the!concentration!of!salts!in!the!aqueous!phase!of!emulsions!may!be!a!critical!point!for!their!inactivation!and!SM!buffer!might!soften!the!environmental!conditions.!
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; Salts! present! in! SM! buffer! might! have! a! stabilising! effect! on! emulsion!droplets,!due!to! the!charged! ions!present! in! the!aqueous!phase.! It!may!also!have!an!effect!on!droplet!size.!!A!pilot!experiment!was!conducted!within!six!hours,!the!same!period!of!time!as!for! experiments! in! Section!4.3.1,! storing!Bacteriophage!K! in!PIT! oil;in! SM!buffer!nano;emulsion! both! at! normal! storage! temperature! in! the! fridge! (4! °C)! and! at!room!temperature!(20!°C).!Figures!4.5!and!4.6!show!the!average!number!of!plaque!forming!units!(PFU)!per!plate!when!S.#aureus!MSSA467!and!H560!were!challenged!with! Bacteriophage! K/oil;in;SM! buffer! nano;emulsions! at! 4! °C! and! at! 20! °C!respectively.! Bacteriophage!K!was! stored! for! six! hours,! and! samples!were! taken!and!plated! together!with! the! corresponding! bacterial! strain! every! hour.! Positive!controls! in! Figures! 4.5! and! 4.6! refer! to! the! correspondent! strain! of! bacteria!together!with!Bacteriophage!K!stored! in!SM!buffer!(red!and!black!triangles! for!S.#









emulsion!at!room!temperature!(20!°C).!Absolute!values!of!PFUs!per!plate!are!shown.!!Figures! 4.5! and! 4.6! demonstrate! that! replacing! water! with! SM! buffer! in! the!emulsification!process! is! a! valid!method! to! retard! inactivation! of! phages! against!bacteria.! For! the! first! 6! hours! there! is! a! variation! in! the! number! of! PFUs,! but! it!never! falls! below! the! positive! control,! which! includes! a! simple! suspension! of!Bacteriophage!K! in!buffer.! In! fact,! the!absolute!number!of!PFUs! is!always!around!20! %! higher! than! that! of! the! positive! control! at! both! storage! temperatures.! In!addition! to! this,! if! the! absolute! number! of! PFUs! per! plate! is! compared! between!Figures! 4.3! and! 4.5! (both! obtained! under! the! same! storage! conditions! of!Bacteriophage! K! in! nano;emulsion,! but! varying! the! aqueous! phase! of! the!formulation,!RO!water!in!the!former!and!SM!buffer!in!the!latter)!it!can!be!seen!that!for!S.#aureus!H560!approximately!175!PFUs!per!plate!could!be!counted!after!one!hour!of!storage!(Figure!4.3),!versus!the!860!PFUs!per!plate!for!S.#aureus!H560!after!one! hour! of! storage! in! Figure! 4.5.! This! enormous! difference! is! seen! for! all! time!points.! It! can! be! concluded! that! salinity! has! an! effect! on! phage! infectivity!when!stored! in!nano;emulsions!over! time,!and,!more! importantly,! that!nano;emulsions!enhance! bacteriophage! infectivity! when! they! are! used! as! storage! medium.!Although!production!costs!would!potentially!increase,!changing!the!aqueous!phase!
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is!an!acceptable!way!of!reducing!inactivation.!Since!the!activity!of!Bacteriophage!K!stored!in!PIT!oil;in;SM!buffer!nano;emulsions!did!not!change!significantly!and!was!maintained!highly!over! the!positive!control,!as!shown! in!Figures!4.5!and!4.6,! the!time! of! contact! was! extended! to! seven! days,! and! the! same! trend! was! observed!(data!not!shown).!
!
4.3.3. Emulsion!Prepared!with!SM!buffer!–!Influence!on!Bacterial!




The!measurements!of!bacterial!OD!were!all!performed!in!triplicate.!One!in!five!of!the!error!bars!(representing!standard!deviation!of!the!replicates)!are!presented!for!clarity,!with! the!remainder!of! the!bars!removed.!PIT!nano;emulsion,!TSB!and!YPD! are! virtually! transparent! at! 600! nm;! however,! their! baseline! OD! was!subtracted! from! the! raw! data! and! appropriate! propagation! of! errors! was!performed.!!!!Average! values! are! plotted! in! Figures! 4.7! A,! B! and! C! for! the! three! different!strains!of!S.#aureus!growing!in!various!dilutions!of!PIT!emulsion.!Equivalent!plots!were!obtained! for! the! three!different! strains!of!P.#aeruginosa! in! Figures!4.8!A,!B!and!C.!!!Figures!4.7!A,!B!and!C!allow!an!analysis!of!the!influence!of!PIT!nano;emulsions,!and! its! concentration,! on! the! growth! of! three! strains! of# S.# aureus! in! liquid!(planktonic)!culture.!!
! !
!
Figure! 4.7:! Concentration! of! S.# aureus# over!
time,!expressed!as!Optical!Density!at!600!nm!
at!37!°C.!(A)# S.# aureus#H560;! (B)! S.# aureus#H325;! (C)# S.#





S.# aureus#H560! (Figure! 4.7! A)! grew! at! approximately! the! same! initial! rate! in!both!TSB! (control)! and! in!1:10!diluted!PIT!nano;emulsion.!When!S.#aureus#H560!was! grown! in! more! concentrated! emulsion! (1:1! dilution)! the! growth! rate! was!slower!than!the!control!in!TSB,!with!a!slight!decrease!in!concentration!at!about!six!hours.!No!noticeable!difference!in!final!bacterial!concentration!was!observed!for!S.#






Figure! 4.8:! Concentration! of! P.# aeruginosa#
over! time,! expressed! as! Optical! Density! at!
600!nm!at!37!°C.!(A)# P.# aeruginosa# PAO1;! (B)! P.# aeruginosa#PAB45291;!(C)#P.#aeruginosa#BC00907.!In!YPD!( ),! in!undiluted!PIT!emulsion!( ),!and!in!diluted!PIT!emulsion!( ).!Data!points!are!the!mean! value! of! triplicates,! after! discounting! the!OD! of! YPD! and! emulsion.! Error! bars! are! the!standard! deviation! of! experimental! values;! one!in!five!error!bars!are!shown.!!





phase! at! approximately! 10! hours,! and! then! starts! to! decay! by! the! end! of! the!incubation!time.!When!P.#aeruginosa!PAB45291!is!grown!in!undiluted!emulsion,!its!growth!rate!is!slightly!slower,!and!it!does!not!reach!the!stationary!phase!after!14!hours!of!growth,!showing!a!final!concentration!of!bacteria!practically!the!same!as!that!of!the!control.!! The! growth! pattern! in! undiluted! (1:1! dilution)! emulsion! for! P.# aeruginosa!BC00907!(Figure!4.8!C)!differs!from!those!of!PAO1!and!PAB45291!growing!in!the!same!conditions!in!terms!of!its!carrying!capacity.!!It!grows!slower!than!the!control!and!than!BC00907!in!diluted!PIT!nano;emulsion!(1:10!dilution),!but!by!the!end!of!the! incubation!period,! it!reaches!a!bacterial!density!58!%!higher!than!that!of! the!control.!For!P.#aeruginosa!PAO1!and!PAB45291,!the!final!concentration!of!bacteria!after! 14! hours! in! undiluted! nano;emulsion! is! always! lower! than! the! control.!BC00907! growing! in! normal! YPD! medium! and! diluted! nano;emulsion! shows! a!growth!pattern!that!corresponds!to!perfect!logistic!curves!(lag!phase,!exponential!phase! and! stationary! phase),! but! BC00907! in! diluted! nano;emulsion! grows!significantly! faster! and! reaches! a! much! higher! carrying! capacity! than! the! same!strain!growing!in!YPD.!!!To! summarise,! strains! S.# aureus! H560,! S.# aureus! H325,! S.# aureus! Btn766,! P.#





1999;!Kim!et!al.!1983;!Tessler!et!al.!1992).!The!different!growth!patterns! for! the!different!bacterial!strains!suggest!that!variations!in!growth!might!be!related!to!the!specific!metabolism!of!each!strain.!Bacteria!tend!to!grow!in!the!aqueous!phase!of!food;related! emulsion! formulations,! and! the! presence! and! concentration! of!emulsion! droplets! constitutes! an! important! factor! that! can! influence! bacterial!growth! (Parker!et!al.!1995;!Brocklehurst!et! al.!1995).!The!observed!decelerating!effect!of!emulsions!on!bacterial!growth!is!supported!by!published!work,!where!E.#
coli!is!shown!to!grow!slower!when!higher!concentrations!of!emulsion!are!present!in! the! growth! medium! (Prachaiyo! &! McLandsborough! 2003).! These! authors!summarise!possible!explanations!for!this!phenomenon!as!being!impeded!diffusion!of! nutrients! through! the! organic! phase,! spatial! limitations! between! bacteria! and!emulsion! droplets,! and! facilitated! accumulation! of! waste! products,! leading! to!growth!inhibition.!!! Interactions!between!emulsion!droplets!and!bacteria!have!been!shown!to!take!place!mainly!due! to!electrostatic! interactions! (Li!et!al.!2001).!Their!paper!shows!that! emulsions! formulated! with! non;ionic! surfactants! did! not! show! changes! in!droplet! size,! and! concludes! that! interactions! between! bacteria! and! emulsion!droplets!did!not!affect!emulsion!stability.!In!this!thesis,!a!non;ionic!surfactant!was!used! and! the! emulsion! droplet! size! was! in! the! range! of! 18! nanometres.! This!explains! the! lack! of! variation! in! emulsion! transparency! when! bacteria! were!present.!!!It! is! clear! that! appropriate! controls! are! required! when! bacteriophage! and!bacteriophage;emulsion! formulations! are! tested! against! S.# aureus# and! P.#
aeruginosa,#if!they!are!to!be!effectively!compared.!When!bacteriophage!infectivity!was! tested,! bacterial! growth! in! TSB! or! YPD! was! selected! as! the! control,! whilst!bacterial! growth! in! emulsion! was! chosen! as! the! control! for! bacteriophage;emulsion!formulation!testing.!In!this!way!the!killing!effects!of!phage,!measured!via!reduction! in! bacterial! OD,! may! be! effectively! compared.! The! influence! of! nano;emulsions!on!bacterial!growth!also!prevented!the!use!of!standard!plaque!forming!unit! assays! for! the!quantification!of!bacteriophage! infectivity.!This! restricted! the!CFU! and!PFU! counting!methods! to! the!determination! of! initial! concentrations! of!bacteria!and!bacteriophage.!
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!In! order! to! determine! the! influence! of! nano;emulsion! droplet! size,! S.# aureus!strains! H560,! H325! and! Btn766! were! grown! in! Homogenisation! (45! minutes)!nano;emulsion,! since! it! shows! a! bimodal! distribution! including! droplets! of!approximately!the!same!size!as!PIT!nano;emulsions,!and!droplets!about!ten!times!bigger!(see!Section!4.2.3).!The!growth!curves!are!shown!in!Figures!4.9!A,!B!and!C.!!
! !
!
Figure! 4.9:! Concentration! of! S.#aureus#over!
time,! expressed! as! Optical! Density! at! 600!
nm!at!37!°C.!(A)# S.# aureus#H560;! (B)! S.# aureus#H325;! (C)# S.#






control,! therefore! the! results! can! still! be! comparable);! however! the! trends! in!growth! are! the! same,! with! growth! in! undiluted! emulsion! yielding! the! slowest!growth! rate!and! smallest! carrying! capacity.! It! can!not!be!directly! concluded! that!emulsion!droplet!size!distribution!has!an!effect!on!bacterial!growth,!as!opposed!to!concentration!of!droplets,!whose!influence!is!clear!in!Figures!4.7,!4.8!and!4.9,!even!when!a!very!small!dilution!factor!(1:10)!was!used.!!!
4.3.4. Emulsion!Prepared!with!SM!Buffer!–!Enhanced!Antimicrobial!
Activity!of!Bacteriophage!K!and!Bacteriophage!DRA88!The!main!objectives!of!this!chapter!are!the!preparation!of!an!effective!and!stable!antimicrobial! formulation! formed! by! bacteriophages! stabilised! in! oil;in;water!nano;emulsions,! and! its! assessment! in! terms! of! infectivity! against! strains! of! S.#
aureus#and!P.#aeruginosa,!bacteria!normally!present! in!burn!wound! infections.! In!Section!4.3.2! it!was!proven!that!plating!experiments!suggest!enhanced!infectivity!of!Bacteriophage!K!against!S.#aureus,!demonstrated!by!increased!number!of!PFUs!after!6!hours!of!storage! in!PIT!nano;emulsions.! It! is!now!necessary!to!determine!the!infectivity!of!these!formulations!in!the!long!term!via!quicker!and!more!reliable!methods! (turbidity! measurements),! taking! into! account! the! effect! that! nano;emulsions!have!on!bacterial!growth!itself.!Two!different!bacteriophages!were!used!independently!against!S.#aureus:!Bacteriophage!K!and!Bacteriophage!DRA88!in!this!section.! Two! different! bacteriophages,! DL52! and! DL54,! were! tested! against! P.#
aeruginosa!in!Section!4.3.5.!The!MOI!was!approximately!0.1.!Bacteria!were!allowed!to!grow!for!2!hours,!and!then!bacteriophages!or!bacteriophage!formulations!were!added.!! Measurements!of!OD!were!performed!in!triplicate!and!error!bars!represent!the!standard!deviation!of!triplicates.!However!for!clarity!only!1!in!5!of!the!error!bars!are!displayed!on!the!graphs,!with!the!rest!removed.!!!Results!for!S.#aureus!H560,!H325!and!Btn766!challenged!with!Bacteriophage!K!and!Bacteriophage!K/PIT!nano;emulsion!formulation!are!shown!in!Figures!4.10!A,!B!and!C.!Similarly,!Figures!4.11!A,!B!and!C!show!the!growth!curves! for! the!same!strains! of! S.# aureus! tested! with! Bacteriophage! DRA88! and! Bacteriophage!DRA88/PIT!nano;emulsion! formulation.!When!S.#aureus!H560,!H325!and!Btn766!
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time,! expressed! as! Optical! Density! at! 600!
nm!at!37!°C.!(A)# S.# aureus#H560;! (B)! S.# aureus#H325;! (C)# S.#






H560! starts! growing! again! at! about! 8! hours! when! it! was! treated! with!bacteriophage! stored! in! SM!Buffer.! Similarly,! in! Figures! 4.10!B! and!C,!H325! and!Btn766! regrow! at! about! 12! hours! –! this! did! not! occur! when! bacteriophage;emulsion!formulations!were!used,!demonstrating!the! important!role!of! the!nano;emulsion!in!the!antimicrobial!activity!of!the!bacteriophage!formulation.!!!The! same! experiment! was! conducted! varying! the! bacteriophage! that! was!introduced!into!the!nano;emulsion!formulation!(now!Bacteriophage!DRA88),!and!the!results!are!shown!in!Figures!4.11!A,!B!and!C.!!
! !
!
Figure! 4.11:! Concentration! of! S.# aureus# over!
time,!expressed!as!Optical!Density!at!600!nm!
at!37!°C.!(A)# S.# aureus# H560;! (B)! S.# aureus# H325;! (C)# S.#














time,! expressed! as! Optical! Density! at! 600!
nm!at!37!°C.!(A)# S.# aureus#H560;! (B)! S.# aureus#H325;! (C)# S.#








time,! expressed! as! Optical! Density! at! 600!
nm!at!37!°C.!(A)# S.# aureus#H560;! (B)! S.# aureus#H325;! (C)# S.#







terms! of! size! (see! Figure! 3.6! A! and! B)! as! Bacteriophage! K! and! Bacteriophage!DRA88! are! approximately! 150! nm! in! length,! and! also! with! reference! to! their!hydrophobicity.!S.#aureus! is!generally!hydrophobic!(Reifsteck!et!al.!1987),!and!its!bacteriophages! will! be! also! hydrophobic;! although! it! depends! on! the!hydrophobicity!of! their!environment! since! their! structures!are!basically!proteins!(Thompson! &! Yates! 1999).! Once! bacteriophages! are! encapsulated! in! a! lipid!droplet,!it!is!less!likely!that!they!will!leave!the!hydrophobic!environment!to!infect!bacteria;! they! are! virtually! trapped.! Another! possible! explanation! is! spatial!impediment:! big! droplets! prevent! the! contact! between! bacteriophages! and!bacterial!surfaces,!or!make!diffusion!of!bacteriophages!towards!bacterial!surfaces!more!difficult,!eluding! infection.!Bacteriophages!are!self;replicating!antimicrobial!agents:!if!they!do!not!replicate!within!the!bacterial!cell,!they!decay!and!are!not!able!to! generate! further! infections.! None! of! these! phenomena! occur! when! nano;emulsion!droplets!are!smaller!than!bacteriophages,!i.e.!PIT!nano;emulsions.!!
4.3.5. Emulsion! Prepared! with! SM! Buffer.! Enhanced! Antimicrobial!
Activity!of!Bacteriophage!DL52!and!Bacteriophage!DL54!Validating! the!bacteriophage/PIT!nano;emulsion! formulations!requires! testing!them! against! different! bacteria,! not! only! Staphylococcus# aureus.! Another!pathogenic! bacterium! present! in! wound! infections! is! Pseudomonas# aeruginosa,!which!is!Gram!negative!(as!opposed!to!Gram!positive!S.#aureus).!!!It! appears! that! the! antibacterial! properties! of! bacteriophage/nano;emulsion!formulations!are!heavily!influenced!by!surface!characteristics,!surface!charge!and!hydrophobicity! as! demonstrated! in! Sections! 4.3.3! and! 4.3.4.! These! mechanisms!will!be!further!studied!in!Chapter!5.!It!is!coherent!then!to!assess!the!infectivity!of!these! formulations! against! bacteria! that! show!different! surface! composition! and!properties!compared!to!S.#aureus.!In!addition,!if!the!formulations!are!also!effective!against!P.#aeruginosa,!they!can!prove!to!be!extremely!useful!from!a!practical!point!of!view!in!a!real!medical!condition,!where!both!species!of!bacteria!may!coexist.!!!Two! different! bacteriophages! (Bacteriophage! DL52! and! Bacteriophage! DL54)!were!used!independently!against!three!strains!of!P.#aeruginosa:!PAO1,!PAB45291!
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over! time,! expressed! as! Optical! Density! at!
600!nm!at!37!°C.!(A)# P.# aeruginosa# PAO1;! (B)! P.# aeruginosa#PAB45291;!(C)#P.#aeruginosa#BC00907.!In!YPD!( ),! in!undiluted!PIT!emulsion!( ),! in!the!presence!of!Bacteriophage!DL52! ( ),! and!in! the! presence! of! Bacteriophage! DL52/! PIT!emulsion! preparation! ( ).! All! preparations!were!stored!at!4!°C!and!tested!after!9!days!of!storage.!Data!points!represent!the!mean!value!of! triplicates,!after!discounting! the!OD!of!YPD!and!emulsion!or!SM!buffer.!Error!bars!are!the!standard! deviation! of! experimental! values;!one!in!five!error!bars!are!shown.!!The!most!important!fact!that!needs!to!be!highlighted!in!Figures!4.14!A,!B!and!C!is!that!Bacteriophage!DL52!is!practically!non;infective!against!P.#aeruginosa!PAO1,!PAB45291! and!BC00907!neither! in! normal! SM!buffer! suspension! nor! in! the! PIT!nano;emulsion! formulation! when! the! MOI! is! 0.1.! For! PAO1! (Figure! 4.15! A)! the!growth! curves! in! PIT! nano;emulsion! ( )! and! treated! with! Bacteriophage!DL52/PIT!nano;emulsion!formulation!( )!are!identical.!Even!more!importantly,!P.#





preparation.! This! is! promising! in! terms! of! enhanced! antimicrobial! activity! of!Bacteriophage!DL52!in!PIT!nano;emulsions.!!Figure! 4.15! shows! the! infectivity! of! Bacteriophage! DL54! and! Bacteriophage!DL54/PIT!nano;emulsion!preparations! against! the! three! considered! strains! of!P.#
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Enhanced!lytic!activity!of!bacteriophages!against!S.#aureus!and!P.#aeruginosa!has!been! demonstrated! when! stored! in! PIT! nano;emulsions.! When! emulsion! was!present,!regrowth!of!bacteria!was!prevented!but!also!bacterial!eradication!started!earlier.!No!similar!effect!has!been!reported!in!the!literature,!except!for!the!mention!of! a! higher! bacteriophage! titre! achieved! within! an! emulsion! (Kiss! et! al.! 2011).!Bacteriophages! may! be! protected! against! inactivation! due! to! “charge! shielding”!between! bacteriophage! surface! proteins! and! nano;emulsion! droplets! (Fujito! &!Lytle!1996).!This!shielding!mechanism!(which!could!preserve!lytic!activity),!when!combined! with!more! favourable! contact! between! bacteriophage! and! bacteria! in!the!presence!of!emulsion,!could!result!in!an!enhanced!killing!effect.!The!literature!suggests! that! certain! surfactants! (e.g.! emulsan)! do! not! interfere! with! phage!binding! to! bacterial! surfaces;! moreover! the! binding! occurs! at! the! emulsion!interface!(Pines!&!Gutnick!1984).!!
4.3.6. Shelf8Life!of!Bacteriophage/!Emulsion!Formulations!!In!Sections!4.3.4!and!4.3.5!it!was!demonstrated!that!bacteriophage!infectivity!is!preserved!when!they!are!stored!in!PIT!oil;in;water!nano;emulsions.!In!addition!to!this,!if!the!formulations!are!to!be!commercialised,!it!is!key!to!determine!if!they!are!stable! over! long! periods! of! time.! The! assessment! of! the! shelf;life! of! the!formulations!constitutes!the!core!of!this!section.!!In!order!to!quantify!the!effect!of!bacteriophage/nano;emulsion!formulations!on!different! strains! of! S.# aureus! and! P.# aeruginosa# over! a! certain! storage! time,! a!relative! killing! effect! was! defined,! Equation! 4.3,! to! compare! the! lytic! activity! of!bacteriophage!in!buffer!suspension!with!bacteriophage;emulsion!formulations.!
Relative killing effect =OD20h (control)−OD20h (within phage preparation)OD20h (control)!
Equation!
4.3!!Optical!density!(OD)!is!equivalent!to!bacterial!concentration.!Hence,!the!relative!killing!effect!is!the!difference!in!OD!between!normal!bacterial!growth!(control)!and!bacterial! growth! in! the! presence! of! bacteriophage,! normalised! to! 20! hours! of!treatment.!The! controls!were!different! in! the!normal! growth!medium!and! in! the!emulsion!environment.!The!relative!killing!effect!will!have!values!between!0!and!1,!where! 0! corresponds! to! no! killing! at! all! (for! bacteria! in! the! presence! of!
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bacteriophage! or! bacteriophage/nano;emulsion! preparation! with! or! without!bacteriophage),!and!a!value!of!1!means!a!total!kill,!irrespective!of!the!treatment.!It!is! essential! to! highlight! that! the! storage! time! is! different! to! the! treatment! time:!bacteriophage! suspensions! or! bacteriophage/nano;emulsion! preparations! were!stored!for!10!days,!and!samples!were!taken!regularly!over!this!period,!and!tested!against!the!different!strains!of!bacteria!in!a!20!h;treatment.!!Figures!4.18!A,!B!and!C!show!the!relative!killing!effect!of!Bacteriophage!K/PIT!nano;emulsion! formulations! against! the! three! S.# aureus# strains! over! a! period! of!storage!of!10!days.!The!antimicrobial! formulation!was!added!when!the!OD!of!the!bacterial!culture!was!approximately!1.0!a.u.,!equivalent!to!108!CFU!ml;1.!!!
! !
!
Figure! 4.18:! Bacteriophage! K! infectivity!
against!S.#aureus.!(A)#S.#aureus#H560;! (B)!S.#aureus#H325;! (C)#S.#











Figure! 4.19:! Bacteriophage! K! infectivity!
against!S.#aureus.!(A)#S.#aureus#H560;! (B)!S.#aureus#H325;! (C)#S.#









Figure! 4.20:! Bacteriophage! K! infectivity!
against!S.#aureus.!(A)# S.# aureus#H560;! (B)! S.# aureus#H325;! (C)# S.#









Figure! 4.21:! Bacteriophage! DRA88!
infectivity!against!S.#aureus.!(A)#S.#aureus#H560;! (B)!S.#aureus#H325;! (C)#S.#
aureus!Btn766.!The! initial! concentration! is! equivalent! to!approximately! 0.1! a.u.,! over! a! period! of! ten!days,! expressed! as! Relative! Killing! Effect,!when!stored!in!SM!buffer!at!18;20!°C!( ),!in!undiluted!PIT!emulsion!at!18;20! °C! ( ),! in!SM!buffer!at!4!°C!( ),!and!in!undiluted!PIT!emulsion!at!4! °C!( ).!The!bar!height! is! the!mean! value! of! triplicates;! error! bars! are! the!standard!deviation!of!replicates.!
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against!S.#aureus.!(A)# S.# aureus#H560;! (B)! S.# aureus#H325;! (C)# S.#





To! summarise,! for! all! the! different! cases! shown! in! Figures! 4.18! to! 4.22!bacteriophage/emulsion! formulations! show! enhanced! antibacterial! activity!(relative!killing!effects!close!to!1)!against!the!three!strains!of!S.#aureus!when!stored!in! PIT!nano;emulsions! at! room!and! cold! temperatures,! but! they! completely! lose!their! antimicrobial! properties! when! stored! in! Homogenisation! (45! min)! nano;emulsions! (relative! killing! effects! close! to! 0).! It! has! been! shown! that! emulsion!influenced! bacterial! growth,! but! this! effect! is! eliminated! by! the! use! of! bacterial!growth! in! undiluted! emulsion! as! an! appropriate! control.! Figures! 4.18,! 4.19! and!4.21!show!no!significant!variations!of!bacteriophage/emulsion!activity!over!a!10;day! period,!while! bacteriophage! lytic! activity! shows! oscillations,! giving! different!results! for! every! day! of! treatment,! and! for! each! temperature! of! storage.! Figures!4.18! and! 4.19! show! that! the! higher! killing! effect! that! bacteriophage/emulsion!preparations!becomes!less!obvious!if!the!initial!concentration!of!bacteria!is!too!low!to! sustain! the! initial! bacteriophage! infection! (Payne!&! Jansen! 2001;! Payne! et! al.!2000;!Payne!&!Jansen!2002)!since!sometimes!bacterial!regrowth!is!observed.!!Equivalent! plots! for! the! shelf;life! of! P.# aeruginosa! Bacteriophages! DL52! and!DL54!against!strains!PAO1,!PAB45291!and!BC00907!can!be!found!in!Figures!4.23!and!4.24.!Despite!the!different!nature!and!morphology!of!bacteria,!as!P.#aeruginosa!is!Gram;negative!and!rod;shaped!(while!S.#aureus!is!Gram;positive!and!spherical),!the! same! pattern! of! enhanced! infectivity! was! observed.! However,! higher! MOIs!were!required!as!explained!in!Section!4.3.5.!This!means!that!the!selected!strains!of!







against!P.#aeruginosa.!!(A)# P.# aeruginosa# PAO1;! (B)! P.# aeruginosa#PAB45291;!(C)#P.#aeruginosa#BC00907.!The! initial! concentration! is! equivalent! to!approximately! 0.1! a.u.,! over! a! period! of! ten!days,!expressed!as!Relative!Killing!Effect,!when!stored! in! SM! buffer! at! 18;20! °C! ( ),! in!undiluted! PIT! emulsion! at! 18;20! °C! ( ),! in!SM!buffer!at!4! °C! ( ),!and! in!undiluted!PIT!emulsion! at! 4! °C! ( ).! The!bar!height! is! the!mean! value! of! triplicates;! error! bars! are! the!standard!deviation!of!replicates.!








against!P.#aeruginosa.!!(A)# P.# aeruginosa# PAO1;! (B)! P.# aeruginosa#PAB45291;!(C)#P.#aeruginosa#BC00907.!The! initial! concentration! is! equivalent! to!approximately! 0.1! a.u.,! over! a! period! of! ten!days,!expressed!as!Relative!Killing!Effect,!when!stored! in! SM! buffer! at! 18;20! °C! ( ),! in!undiluted! PIT! emulsion! at! 18;20! °C! ( ),! in!SM!buffer!at!4! °C! ( ),!and! in!undiluted!PIT!emulsion! at! 4! °C! ( ).! The!bar!height! is! the!mean! value! of! triplicates;! error! bars! are! the!standard!deviation!of!replicates.!







4.4. Conclusions!In! conclusion,! the! experiments! regarding! the! formulation! of!bacteriophage/nano;emulsion! preparations! presented! in! this! chapter! provide!initial! insights! into! their! mechanisms! of! action! and,! most! importantly,! confirm!their!efficacy!against!bacterial! infections.!The!main!results!can!be!summarised!as!follows:!1. Two! reliable! and! reproducible! emulsification! methods! were!explored! and! validated,! in! order! to! create! a! biocompatible! vehicle! for!stabilisation,!storage!and!delivery!of!bacteriophages!to!treat!S.#aureus!and!P.#
aeruginosa! infections! in! planktonic! (liquid)! culture.! PIT! emulsions!themselves! were! stable! and! non;toxic! for! bacteriophages,! and! it! was! also!found! that! particle! size! distribution! of! oil;in;water! nano;emulsions! has! a!dramatic!effect!on!bacteriophage!viability.!Moreover,!several!bacteriophages!stored! in! PIT! nano;emulsions! present! enhanced! antibacterial! performance!against! different! strains! of! Staphylococcus# aureus! and! Pseudomonas#
aeruginosa# over! time.! The! enhancement! of! bacteriophage! activity! when!delivered! via! nano;emulsions! constitutes! a! novel! finding! which! has! been!published!(Esteban!et!al.!2014).!!! 2. Further!to!this,! it!was!demonstrated!that!both!PIT!and!Homogenisation!(45!min)!nano;emulsions!slow!down!bacterial!growth!for!both!Gram;positive!and!Gram;negative! bacteria.! This! effect! is! attenuated!when! nano;emulsions! are!diluted.!Several!hypotheses!for!these!findings!have!been!proposed!within!the!literature,! however! there! is! a! need! for! understanding! the!mechanisms! that!drive! these! phenomena,! regarding! bacterial! proliferation! and! also!bacteriophage! infectivity.! These! questions! will! be! addressed! from! an!experimental! point! of! view! in!Chapter! 5! and! from!a!modelling/theoretical!approach!in!Chapter!7.!!!3. Lastly,! the! shelf;life! of! bacteriophage/nano;emulsion! formulations! was!assessed.! It! can! be! concluded! that! PIT! formulations! are! more! suitable! for!storage!and!delivery!of!bacteriophages!to!the!point!of! infection,!rather!than!the!simple!suspension!of!bacteriophages!in!SM!buffer,!whilst!Homogenisation!
Chapter!4! !!
! 169!
formulations!yield! inactivation!of!bacteriophages!within! the!storage!period.!Some! additional! improvements! have! also! been! suggested,! such! as! the!formulation! of! a! bacteriophage! cocktail! instead! of! a! single! bacteriophage!formulation,! which! would! be! preferably! stored! in! PIT! nano;emulsions! or!equivalent!nano;emulsions!with!smaller!droplet!sizes!than!bacteriophages.!!! In!general,!the!results!presented!here!prompt!further!investigation!into!the!use!of!these!bacteriophage/nano;emulsion!formulations!for!the!development!of!novel!antimicrobial!wound!management!strategies.!!
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5.1. Introduction!The(effect(that(nano2emulsions(have(on(bacterial(growth(for(both(Gram2positive(and( Gram2negative( bacteria,( as( well( as( the( enhanced( bacteriophage( infectivity(against( S.# aureus( and( P.# aeruginosa( in( planktonic( culture( was( established( in(
Chapter! 4.( However,( the( reasons( why( bacteria( grow( at( a( slower( rate( in( the(presence( of( nano2emulsions,(without( growth( being( completely( inhibited,( are( not(completely( clear,( and( only( suggestions( of( the( possible( causes( are( found( in( the(literature.( The(mechanisms( of( enhancement( of( bacteriophage( infectivity( are( not(specifically(understood(either.(((This(chapter( focuses(on( the( investigation(of( the(possible( interactions(between(emulsion(droplets(and(bacterial( cells,(emulsion(droplets(and(bacteriophages,(and(lastly( the( complete( system( including( the( three( components:( nano2emulsion(droplets,(bacteria,(and(bacteriophages.(PIT(nano2emulsions(are(considered(for(all(the( studies( in( this( chapter,( as( they( yield( the(most( favourable( results( in( terms(of(improved(bacteriophage(infectivity,(and(also(because(the(differences(between(the(influence(of(PIT(nano2emulsions(and(Homogenisation(nano2emulsions(on(bacterial(growth( were( found( to( be( practically( non2existent( (see( Section( 4.3.3).(
Staphylococcus#aureus(was( again( selected(as( the(model(organism( for(most(of( the(experiments(in(this(particular(piece(of(work.((Initially,(a(Response(Surface(Method((RSM)(design(of(experiments(was(selected(to( give( an( indication( and/or( confirmation( of( the( influence( of( potential( variables(that(might(influence(bacterial(growth(and(antimicrobial(phage(activity.(A(RSM(was(selected(since(the(interactions(amongst(variables(are(completely(unknown(to(start(with.( The( experiments( that( were( presented( in( Chapter! 4( can( be( considered( as(screening(tests(to(determine(if( the(design(variables(have(little(or(no(effect(on(the(responses,(i.e.(bacterial(growth(parameters,(and(final(bacterial(concentration(after(treatment(with( the( bacteriophage/nano2emulsion( formulation.( In( the( case( of( the(study(of(bacterial(growth,(these(variables(are(the(initial(concentration(of(bacteria,(and( the(concentration( ratio(of(bacteria( to(nano2emulsion(droplets.( In(addition( to(
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these( two( variables,( the( concentration( of( bacteriophage( that( is( included( in( the(formulation(constitutes(the(third(design(variable(in(the(determination(of(the(final(concentration(of(bacteria(after(exposure(to(phage.((Once(the(influence(of(these(variables(is(confirmed(via(design(of(experiments,(a(more( comprehensive( investigation( is( conducted.( As( a( result( of( the( observations(obtained( from( RSM( analysis,( (Sections( 5.2.1.1( and( 5.2.1.2)( a(modification( of( the(standard(bacterial(growth(model(is(proposed(and(tested(in(Section(5.2.2,(and(it(can(be(generalised(for(the(presence(or(absence(of(nano2emulsions.(((As( far( as( the( bacteriophage( infection( cycle( is( concerned,( there( are( several(parameters( that( may( be( affected( by( the( presence( of( nano2emulsions,( such( as(adsorption(and( lysis( rates,(burst( size,(and( lysis( time.(These( factors(are(described(and(studied(in(the(presence(and(absence(of(nano2emulsions(in(Section(5.3,(in(order(to(elucidate(the(reasons(why(bacteriophage(infectivity(is(enhanced(by(the(presence(of(nano2emulsions.((Finally,( considering( the( complex( system( formed( by( nano2emulsion( droplets,(bacteriophages( and( bacterial( cells,( an( additional( hypothesis( needs( to( be( tested.(Stabilisation( of( bacteriophages( due( to( electrostatic( forces( and( interaction( with(nano2emulsion( droplets( is( suspected,( since( bacteriophages( may( be( protected(against(inactivation(due(to(‘’charge(shielding’’.(Moreover,(nano2emulsions(may(lead(to(more( favourable( interactions(between(bacteriophages(and(bacteria,(enhancing(the(killing(effect.(Zeta(potential(was(measured(for(the(individual(components,(and(for(all(of(them(combined.(These(results(can(be(found(in(Section(5.4.((
5.2. Initial!Investigation!of!the!Mechanisms!The(mechanisms( that(generate(modifications( to(bacterial(growth(patterns(and(bacteriophage( lytic( activity( when( nano2emulsions( are( present( are( initially(unknown.( However,( preliminary( estimations( of( relative( sizes,( volumes,( surface(areas,( and( concentrations( of( the( three( constituents( in( the( system,( i.e.( nano2emulsion(droplets,(bacteriophages(and(bacterial(cells,(can(give(an(idea(of(the(most(likely(spatial(distribution(of(the(components(of(the(system.((
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Where(ndroplets(is(the(number(of(droplets((dimensionless(ratio(of(volumes),(Voil(is(the(volume(of(oil(that(was(added(to(the(nano2emulsion((ml),(Vdroplet(is(the(volume(of(a(single(droplet((ml),(and(r(is(the(droplet(radius((cm).(The(result(corresponds(to(5(ml(of(oil(with(a(droplet(radius(of(9(nm.((Lastly,( the( concentration( of( emulsion( droplets( per( millilitre( in( the( nano2emulsion(is(as(follows:(




































! 1.6×1016  droplets ! ! ! !
S.#aureus!cells! ! 1.0×106  CFU ! ! ! !
Bacteriophage!
K! ! 1.0×10
5  PFU ! ! ! !(Based( only( on( size/volume/surface( area,( it( is( spatially( impossible( that(bacteriophages(are(encapsulated(or(sitting(on(the(surface(of(emulsions.(The(same(can( be( applied( to( bacterial( cells.( Bacteriophage( K,( according( to( Table( 5.1( is( a(thousand(times(more(voluminous(than(a(nano2emulsion(droplet,(and(a(single(cell(of( S.# aureus( is( a( hundred( thousand( times( bigger( than( a( droplet.( Based( on( these(values,( the( most( probable( situation( is( that( both( bacteria( and( bacteriophage( are(“covered”( or( “shielded”( by( a( large( amount( of( emulsion( droplets.( This( fact( is(supported(by(the(concentration(ratios,(concentration(of(droplets(to(concentration(of(bacterial(cells,(and(concentration(of(droplets(to(concentration(of(Bacteriophage(K,(as(seen(in(Table(5.1:(there(are(approximately(ten(thousand(million(droplets(per(bacterial(cell,(and(a(hundred(thousand(million(droplets(per(bacteriophage(particle.(This(is(shown(schematically(in(Figure(5.1.(
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5.2.1. Response!Surface!Method!–!Design!of!Experiments!A( mixture( containing( emulsion( droplets,( bacteriophage,( and( bacteria( could(result( in( complex( interactions( between( any( pair( of( components,( or( all( three.(Factorial( experimental(design( followed(by(RSM(analysis(was(used( to( identify( the(most( influential( variables( in( the( system( on( bacterial( growth( and( bacteriophage(infectivity.((Response( surface( methodology( (RSM)( is( a( collection( of( mathematical( and(statistical( techniques( for( empirical( model( building.( By( careful( design( of(experiments,( the( objective( is( to( optimise( a( response( (output( variable),( which( is(influenced(by(several(independent(variables((input(variables).(An(experiment(is(a(series( of( tests,( called( runs,( in(which( changes( are(made( in( the( input( variables( in(order(to(identify(the(reasons(for(changes(in(the(output(response.((Originally,(RSM(was(developed(to(model(experimental(responses((Box(&(Draper(1987;( Greenwell( 1989)( and( then( migrated( into( the( modelling( of( numerical(experiments.(The(difference( is( in( the( type(of(error(generated(by( the(response.( In(physical(experiments,(inaccuracy(can(be(due,(for(example,(to(measurement(errors(while,( in( computer( experiments,( numerical( noise( is( a( result( of( incomplete(convergence(of(iterative(processes,(round2off(errors(or(the(discrete(representation(of(continuous(physical(phenomena.(In(RSM,(the(errors(are(assumed(to(be(random.((To(understand( the( relative( influence(of( the( three(components( (nano2emulsion(droplets,(bacteriophage,(and(bacteria),(experiments(were(designed(using(RSM.(The(main( objective( is( to( evaluate( the( effect( of( emulsion( droplet( concentration( on(bacterial( growth( under( different( growth( conditions,( and( to( detect( variations( in(bacteriophage(infectivity(when(emulsion(was(present.(RSM(was(selected(since(the(relationship( between( these( variables( was( initially( unknown.( Experiments( were(designed( using(Minitab16®( (Minitab( Statistical( Software),( and( experiments(were(
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randomised( to( meet( the( statistical( assumptions( and( reduce( the( effects( of( other(factors.(Sections(5.2.1.1(and(5.2.1.2(show(the(RSM(results(for(bacterial(growth(and(bacteriophage(infectivity(separately.((


















' ( Equation!5.5!Where( N(t)( is( the( concentration( of( bacteria( (CFU( ml21),( t( is( the( time( while(bacteria(grow((h),(a(is(the(growth(rate(of(the(bacterial(population((h21),(and(C(is(the(carrying(capacity(or(maximum(population(size((CFU(ml21).(As(a(first(approximation,(the( concentration( of( bacteria( is( considered( to( be( proportional( to( absorbance,( as(was( explained( in( Figure( 3.15,( and( N(t)( and( C( are( defined( in( terms( of( OD((absorbance( units,( a.u.).( The(RSM( is( a( pilot( experiment,( and( therefore( the( linear(approximation(in(Figure(3.15(was(chosen,(and(absorbance(values(were(fitted(to(the(logistic(model.(It(will(be(seen(later(on(that(the(logistic(model(is(not(a(perfect(model(when(nano2emulsions(are(present.((Bacterial( growth( was( measured( by( turbidity( assays( (600( nm)( at( 37( °C( with(orbital(agitation(for(20(hours,(under(the(conditions(specified(by(the(experimental(design((Table(5.2),(using(six(replicates.(Optical(density(growth(curves(were(used(to(estimate(the(parameters( in(the( integrated(form(of(the(Vershulst(model((Equation(5.6)(using(Origin(8(software((OriginLab,(Northampton,(MA)((Lindqvist(2006).(
















Figure!5.4:!Example!of!residuals!plots!for!the!carrying!capacity!of!S.#aureus!H560.!( Normal(Probability(Plots(in(both(Figures(5.3(and(5.4(show(a(normal(distribution(of( the( residuals( between( RSM( predictions( and( experimental( data( for( the( two(responses:( bacterial( growth( rate,( and( bacterial( carrying( capacity.( The( residuals(
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align(to(a(straight(line(with(R2(=(0.99(as(can(be(seen(in(the(Normal(Probability(Plot(on( the( top( left( corner,(with( a( slightly( better( fit( for( the( residuals( of( the( carrying(capacity.( The( random( distribution( of( the( residuals( (in( the( Residuals( versus( Fits(Plot,( top( right( corner)( demonstrates( agreement( with( the( desired( normal(distribution,( although( some( outliers( were( found( as( can( be( observed( in( the(Histogram(of(Residuals((bottom(left(corner).(The(presence(of(outliers(is(not(enough(to( assume( that( the( distribution( is( skewed,( although( the( preferred( bell2shaped(curve(is(clearer(in(Figure(5.3(for(the(growth(rate.(Both(Residuals(versus(Order(Plots(seem(randomly(distributed(in(Figures(5.3(and(5.4.(This(statistical(analysis(gives(an(idea(of( the(effectiveness(of(RSM(for( the(evaluation(of( the(responses((growth(rate(and(carrying(capacity)(as(a(function(of(the(input(factors((Table(5.2),(initial(bacterial(concentration,(and(bacteria(to(emulsion(droplets(ratio.((It"has"been"established"that"the"RSM"analysis"is"statistically"appropriate"for"the"study& of& the& interactions! between& factors& influencing$ bacterial$ growth,$ and$conclusions( can( be( drawn( from( the( results( obtained( from( the( Design( of(Experiments+ regarding+ which+ factors+ or+ interactions+ between+ factors+ have% a%greater& influence& on& the! responses.( Bacterial) growth) may) be) influenced) by)attachment(of#emulsion#droplets# to# the#outer#cell#membrane,# causing#a#switch# in#metabolism,+for+instance+inducing+anaerobic+behaviour+due+to+the+lack+of+available+oxygen,(or(depriving(bacteria(of(nutrients(present(in(the(medium.(The(significance(of#the#experimental#factors'was'determined'by'the'Fisher'test,'which'compares'the'p2values' from' the' statistical' software' with' a' fixed' value,' α,# at# the# desired#confidence( level.( In( this( case( 95! %" confidence" was" selected" (α# =# 0.05),# and$ the$influence(of(any(factor(was(considered!significant)if)its)corresponding)p2value&was&<"0.05."((The$ most$ influential$ factors$ on$ bacterial$ growth$ rate$ determined( by( RSM(analysis'were$the$initial$concentration$of$bacteria$(p2value=0.000)*and*the*dilution*factor'of'emulsion' (p2value=0.000).*The$physical&and&biological&meaning&of& these&factors(is#explained!later&on,&and&their!relationships,are,confirmed,in,Figures"5.5"A,"5.6! A! and$ 5.7$ A! for$ the$ three$ strains$ of$ S.# aureus," H560," H325" and" Btn766"respectively.(
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Maximum(bacterial(growth(rates(for(strain(H560,(in(Figure(5.5(A,(are(observed(for(lower( concentrations( of( emulsions( and( for( smaller( initial( concentrations( of(bacteria.(Competition( for(resources( is( less(acute(when(a(reduced(number(of(cells(coexist(during(their(initial(growth(phase.(The(maximum(growth(rate(for(H560(was(1.46(–(1.73(h21(in(1:10(diluted(emulsion.(The(most(effective(emulsion(concentration((dilution(factor(of(1:10)(was(the(same(for(all(strains,(as(shown(in(Figures(5.6(A(and(5.7( A( for( strains( H325( and( Btn766.( For( the( more( concentrated( emulsion( (1:1(dilution)(the(large(number(of(droplets(could(inhibit(nutrient(uptake(by(the(bacteria((Brocklehurst( et( al.( 1995;( Brocklehurst( &( Wilson( 2007;( Parker( et( al.( 1995).((However,(the(maximum(growth(rate(varies(from(strain(to(strain(depending(on(the(initial(bacterial(concentration.(For(all( initial(concentrations(of(bacteria,(growth(in(more(dilute(emulsions(yielded(higher(growth(rates.(((The( dilution( factor( of( emulsions( had( a( slight( effect( on( bacterial( carrying(capacity,( supporting( a( greater( capacity( for( the(most(diluted(emulsion.( In(Figures(5.5(B,(5.6(B(and(5.7(B,(H560(achieved(the(maximum(number(of(bacteria(with(the(higher(dilution(factor((1:100)(leading(to(a(higher(carrying(capacity.(A(less(obvious(effect(is(seen(with(Btn766(in(Figure(5.7(B.((To(summarise,(emulsion(formulations(with(the(least(effect(on(bacterial(growth(were( those( that( were( diluted,( supporting( the( hypothesis( that( droplets( might(inhibit( the(uptake(of(oxygen(or(nutrients(by(bacterial( cells.( If( the(killing(effect(of(bacteriophage(in(diluted(emulsions(is(high(compared(to(the(enhanced(lytic(activity(seen(with(more( concentrated( emulsion( (1:1( dilution),( then( diluted( formulations(would(be(selected(as(they(affect(bacterial(growth(less.((
5.2.1.2. Bacteriophage!Enhanced!Infectivity!As(demonstrated(in(Chapter!4,(PIT(nano2emulsions(enhance(bacteriophage(lytic(activity.( Emulsion( droplets( may( shield( bacteriophages( against( damaging(environmental( agents,( but( they( may( also( contribute( to( more( effective( bacteria2bacteriophage( interaction,( creating( a( framework( that( reduces( adsorption(distances.( These( effects( may( combine( to( influence( both( bacterial( growth( and(phage2bacterial(binding(mechanisms.(
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Figure!5.8:!RSM!contour!plots!for!the!final!concentration!of!S.#aureus.!Final(concentration(of(bacteria(versus:((A)(dilution(factor(of(emulsion(and(bacteriophage(for(an(initial(concentration(of(H560(of(0.5(a.u.;((B)(dilution(factor(of(bacteriophage(and(initial(concentration(of(H560(at(a(dilution(factor(of(emulsion(of(1:10;((C)(dilution(factor(of(emulsion(and(initial(concentration(of(H560(at(a(dilution(factor(of(bacteriophage(of(1:104;((D)(idem(to((A)(for(H325;((E)(idem(to((B)(for(H325;((F)(idem(to((C)(for(H325;((G)(idem(to((A)(for(Btn766;((H)(idem(to((B)(for(Btn766;(and((I)(idem(to((C)(for(Btn766.(Six(replicates(were(performed(for(each(of(the(factor(combinations.!When( the( final( bacterial( concentration( was( tested( against( varying(bacteriophage2emulsion( preparations,( the( most( important( factor( affecting( final(bacterial( concentration( was( the( initial( bacterial( concentration( (p2value=0.000).(The( interaction( of( these( factors( is( shown( in(Chapter! 4( via( different( patterns( of(
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growth,( and( also( supported( by( the( literature( due( to( density( (concentration)(dependent( phenomena( (Payne( &( Jansen( 2001;( Ross( 2009).( Interaction( between(initial(bacteria(concentration(and(emulsion(dilution(factor(was(also(significant((p2value=0.001),( suggesting( that( bacterial( growth( is( partially( inhibited( by( emulsion(during(early(growth.(((Figure( 5.8( shows( the( minimum( final( bacterial( concentration( (OD)( values,(corresponding(to(a(maximum(killing(effect.(For(H560((0.5(a.u.),(Figure(5.8(A(shows(minimal(final(concentrations(of(bacteria(at(a(bacteriophage(dilution(factor(of(stock(of(about(1×1023((approximately(1×1010)(PFU(ml21( for(1:100(diluted(emulsion,(and(about( 1×1024( for( 1:10( diluted( emulsion( and( undiluted( emulsion.( For( H325( (0.5(a.u.),(Figure(5.8(D(shows(a(minimal(final(bacterial(concentration(at(a(bacteriophage(dilution(of(1×1023(for(all(dilution(factors(of(emulsion.(For(Btn766((0.5(a.u.),(Figure(5.8( G,( the(minima(were( found( at( the(most( diluted( bacteriophage( preparation( in(undiluted( emulsion.( For( all( diluted( emulsions( a( dilution( factor( of( 1×1025( seems(optimal.( The( fact( that( the( optimal( concentration( of( bacteriophage( for( efficient(bacterial(killing(corresponds(to(the(higher(value(of(MOI(agrees(once(more(with(the(literature.(Similar(patterns(were(observed(for(all(initial(concentrations(of(the(three(strains,(although(the(figures(are(not(shown(here.((Figures(5.8(B,(5.8(E(and(5.8(H(show(similar(patterns(for(the(initial(concentration(of( bacteriophage( for( H560,( H325( and( Btn766( respectively.( For( all( initial(concentrations( of( bacteria,( highest( initial( concentrations( of( bacteriophage( (1023(dilution( factor)(seem(to(have( the(highest(killing(effect,(except( for(Btn766((Figure(5.8(H)(where(the(optimum(can(be(seen(between(dilution( factors(of(1024(and(1025.(The(same(patterns(were(observed(for(all(dilution(factors(of(emulsion,(although(this(data( is(not(shown.(For(smaller( initial( concentrations(of(bacteria,( in(Figures(5.8(D(and( 5.8( E,( there( is( a( regrowth( effect( indicates( a( threshold( below( which( active(therapy( of( bacteriophage( is( not( possible( (Payne(&( Jansen( 2003;( Payne(&( Jansen(2003;(Payne(et(al.(2000;(Payne(&(Jansen(2002).((Figures( 5.8( C( and( 5.8( I( show( that( for( an( initial( bacteriophage( concentration(corresponding(to(a(dilution(factor(of(1×1024,(diluted(emulsions(give(greater(killing(effect( for( medium( to( high( initial( concentrations( of( H560,( and( medium( initial(
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concentrations( of( Btn766.( The( killing( effect( of( H325( at( medium( to( high( initial(concentrations(of(bacteria( is(not( affected(by( the(emulsion(dilution( factor( (Figure(5.8(F).((The(highest(and(medium(initial(concentrations(of(bacteria(gave(the(lowest(final( bacteria( concentration,( so(more( concentrated( emulsions( generally( give( the(highest(killing(effect.((To( conclude,( RSM( analysis( has( confirmed( the( influence( of( emulsion(concentration(on(the(growth(patterns(of(S.#aureus,(and(identified(important(system(interactions.(Also,(the(interactions(between(emulsion(droplets(and(bacteria(require(a(better(model(than(the(logistic(growth(curve,(since(the(fitting(of(experimental(data(of( bacteria( growing( in( diluted( and( undiluted( nano2emulsions( deviates( from( the(Verhulst(model(to(a(greater(extent(than(S.#aureus(growing(in(normal(TSB(medium.(Lastly,( RSM( analysis( of( the( final( concentration( of( bacteria( in( the( presence( of(bacteriophage/nano2emulsion( preparations( shows( the( potential( to( optimise( the(concentration( rations( of( the( components( to( reach( a( balance( between( desired(killing(effect(and(stable(emulsion(formulation.((
5.2.2. Growth!Rate!and!Carrying!Capacity!as!a!Function!of!the!
Proportion!CFU!/!Number!of!Nano1emulsion!Droplets!The(fitting(of(experimental(data(to(the(logistic(growth(curve(that(was(used(in(the(RSM( analysis( (Section( 5.2.1.1)( for( quantification( of( growth( rate( and( carrying(capacity(of(S.#aureus(growing(in(diluted(and(undiluted(nano2emulsions(was(shown(to( be( inaccurate,( particularly(when( undiluted( PIT( nano2emulsions(were( present.(Therefore(there(is(a(need(to(adapt(the(growth(model(for(situations(where(growth(rate( and( carrying( capacity(might( be( affected( by( environmental( conditions.( ( This(can(also(contribute( to( the(understanding(of( the( influence(of( the(concentration(of(nano2emulsion(droplets(on(bacterial(growth(parameters.((Regarding( growth( rate,( a( (h21),( it( has( been( assumed( that( it( is( a( density2independent(parameter,(that(is(to(say,(it(is(not(influenced(by(the(concentration(of(bacteria(at(a(certain(time,(t.((This(facilitates(the(use(of(optical(density(experimental(data( regardless( of( the( linear/logarithmic( relationship( that( it( might( have( with(respect(to(bacterial(concentration.(For(simplicity(of(calculations(and(based(on(the(shape(of(growth(curves(shown(in(Figure(5.2,(and(all(growth(curves(in(Chapter!4,(a(
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logical( statement( would( be( to( assume( that( the( growth( rate( corresponds( to( the(
slope( of( the( quasi2straight( line( that( is( observed( in( the( initial( moments( of( the(growth( curves.( However,( this( assumption( can( be( proved( wrong( from( a(mathematical(point(of(view,(as(follows:((The(Verhulst((logistic)(model(of(growth(is(presented(in(Equation(5.7:((
dN(t)








' ( Equation!5.7!Where(N(t)(is(the(concentration(of(bacteria(at(time(t((CFU(ml21),(a(is(the(growth(rate((h21),(and(C(is(the(carrying(capacity((CFU(ml21).((If( the( variable( N(t)( is( substituted( for( simplicity( by( the( variable( y,( which(corresponds(to(C#×#N(t),(Equation(5.7(is(as(follows:(
dy
dt =








'= a y 1− y( ) ( Equation!5.8!Separating(variables(and(integrating(Equation(5.8(gives(Equation(5.9:(
dy
a y 1− y( )∫








)= t ( Equation!5.9!Therefore:(
y = e
a t



















= a ( Equation!5.11!















Another(simple(approximation(for(the(calculation(of(bacterial(growth(rate(is(the(simplification( of( the( Verhulst( equation( (Equation( 5.7),( assuming( that( in( the(beginning( of( the( growth( curve,( only( exponential( growth( is( occurring;( hence( the(value(of(the(exponent!would(correspond(to(the(growth(rate,(a((h21).(( If(only(the(initial(moments(of(bacterial(growth(are(considered,(then(the(logistic(growth(equation(can(be(simplified(as(follows:(
dN(t)













N(t) = N0ea t ( Equation!5.15!Where( N(t)( is( the( concentration( of( bacteria( at( time( t( (CFU( ml21),( N0( is( the(concentration(of(bacteria(at(time(0((CFU(ml21),(and(a(is(the(growth(rate((h21).((From(the(observation(of(the(growth(curves(obtained(during(RSM(analysis,(and(also(in(Chapter!4,(it(was(considered(that(from(t(=(0(h(to(t(=(4.5(h(bacterial(growth(is( exclusively( exponential,( and( therefore( bacterial( growth( rate( can( be( calculated(from( fitting( an( exponential( curve( to( the( experimental( data,( and( determining( the(value(of( the( exponent.(This( is( valid( for(S.#aureus( growing( in(TSB(and(also( in(PIT(nano2emulsions(with(varying(levels(of(dilution,(and(hence(different(concentration(of( nano2emulsion(droplets(per(bacterial( cell.( Therefore,( it( is( proposed( that( there(exists(a(relationship(between(the(amount(of(droplets(per(bacteria(and(the(value(of(bacterial( growth( rate.( This( can( also( be( expressed( as( a( relationship( between( the(dilution( factor( of( emulsion,(D( (dimensionless),( and( the( value(of( bacterial( growth(rate,(a((h21):(a = f (D) ((The( three( strains( of( S.# aureus( (H560,( H325( and( Btn766)( were( grown( in( PIT(nano2emulsions(presenting(diverse(dilution(factors,(from(1((completely(undiluted(nano2emulsion),(to(0.01((1(in(100(dilution),(including(a(control(formed(by(bacteria(growing( in( normal(medium,( TSB.( Growth( curves( were( constructed( via( turbidity(
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0((Bacteria(growing(in(TSB)( 0.62( 0.924(1((Bacteria(growing(in(undiluted(nano2emulsion)( 0.45( 0.920(0.95( 0.49( 0.879(0.9( 0.48( 0.897(0.8( 0.50( 0.908(0.7( 0.50( 0.913(0.6( 0.55( 0.908(0.5( 0.58( 0.911(0.25( 0.69( 0.947(0.16( 0.75( 0.965(0.125( 0.73( 0.953(0.1( 0.74( 0.962(0.0625( 0.66( 0.947(0.0475( 0.83( 0.958(0.0385( 0.87( 0.949(0.0325( 0.75( 0.953(0.028( 0.82( 0.955(0.025( 0.83( 0.957(0.02( 0.84( 0.953(0.013( 0.82( 0.963(0.01( 0.80( 0.970(( Table( 5.5( and( Figure( 5.10( show( the( same(patterns( for( the( initial( growth( of( S.#





























Figure! 5.12:! Growth! rate! (a)! versus! dilution! factor!
of!PIT!nano1emulsions!(DF).!(A)(For(S.#aureus(H560;((B)(For(S.#aureus(H325;((C)(For(
S.# aureus( Btn766.( The( points( represent( the( resulting(values(of(growth(rate( from(the( fitting(of( the(average(of(triplicate( growth( curves.( Error( bars( are( not( shown( for(clarity.(An(exponential(and(a(linear(fit(are(included,(as(a(continuous(line(and(a(discontinuous(line(respectively.((




a =m+ n D ( H560( 0.88055( 0.80(±(0.02( 20.52(±(0.04(H325( 0.82161( 0.79(±(0.02( 20.35(±(0.04(Btn766( 0.81871( 0.60(±(0.02( 20.36(±(0.04(Exponential(
a =m en D ( H560( 0.89861( 0.81(±(0.02( 20.99(±(0.09(H325( 0.82854( 0.79(±(0.02( 20.57(±(0.06(Btn766( 0.84028( 0.61(±(0.02( 20.85(±(0.10(( The( proposed( relationship( for( the( growth( rate( versus( the( dilution( factor( of(emulsion(can(be(either(a(straight(line(with(negative(slope,(n,(and(whose(intercept,(





strains(are(considerably(similar(and(close(to(unity.(It(can(be(concluded(that(there(is(definitely(a( relationship(between(bacterial( growth( rate(and( the(dilution( factor(of(nano2emulsions,(or(the(concentration(of(nano2emulsion(droplets.((Therefore,(there(are(four(possibilities(for(the(modification(of(the(growth(rate(in(the(Verhulst(model,(shown(in(Equations(5.16(and(5.17:(
a = amax + n D  or  a = amax + n 
Cdroplets
N(t) ( Equation!5.16!
a = amaxe−n  D  or  a = amaxe−n  Cdroplets N (t ) ( Equation!5.17!Where(a( is( the( growth( rate( (h21),(amax( is( the( growth( rate( in(TSB( (h21),(n( is( the(parameter(obtained(from(the(linear(or(exponential(fit((2),(D(is(the(dilution(factor(of(emulsion( (2),( Cdroplets( is( the( number( of( nano2emulsion( droplets( per( millilitre((droplets( ml21),( which( would( be( constant( with( time( assuming( that( they( are( not(destroyed(by( the(action(of(bacterial( cells(or( any(other(environmental( factor,( and(
N(t)(is(the(concentration(of(bacterial(cells(at(time(t((CFU(ml21).(((The(modified(model( for( the( linear(relationship( is(shown(in(Equation(5.18,(and(for(the(exponential(relationship(in(Equation(5.19:(
dN(t)








'  or 
dN(t)


















'  or 
dN(t)
dt = amaxe








(In(relation(to( the(carrying(capacity,(C,( it(can(also(be(considered(that( there( is(a(relationship(between(the(dilution(factor(of(emulsion(and(the(value(of(the(carrying(capacity:(C = f (D) (( According( to( the( experimental( growth( curves( obtained( for( the( RSM( analysis,(three(possible(situations(were(observed.( It( is( important( to( take( into(account( that(the(same(reference(of(time((e.g.(from(8(hours(of(growth(onwards,(called(tlimit(from(now(on)(was(considered(for(all(situations.(
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2 At( t( =( tlimit,( S.# aureus( cells( in( the( stationary( phase:( the( carrying( capacity( is(constant(and(can(be(approximated(to(a(straight(horizontal(line:(N(t) =C (2 At( t( =( tlimit,( bacteria( were( still( growing:( the( carrying( capacity( can( be(approximated(to(a(straight(line(with(positive(slope:( N(t) =C +γ  D t (2 At( t(=( tlimit,( the(concentration(of(bacteria( is(decreasing((for(any(reason):( the(carrying(capacity(can(be(approximated(to(a(straight(line(with(negative(slope(
N(t) =C −γ  D t ((Using( these( observations,( an( additional( modification( of( the( logistic( model( is(proposed(in(terms(of(carrying(capacity(in(Equation(5.20:(
dN(t)
dt = a N(t) 1−
N(t)








Growth!in!the!Presence!of!Nano1emulsions!Section( 5.2.2( explores( the( observations( regarding( the( influence( of( nano2emulsion( droplets( on(S.#aureus( growth( curves.( The(modifications( to( growth( rate(and(carrying(capacity(are(described(by(Equation(5.21:((
dN(t)
dt = amax + n D( )  N(t) 1−
N(t)






' ( Equation!5.21!Where(amax(is(the(growth(rate(in(TSB((h21),(n(is(the(parameter(obtained(from(the(linear(or(exponential(fit((2),(D(is(the(dilution(factor(of(emulsion((2),(C(is(the(carrying(capacity((CFU(ml21),(γ((CFU(ml21(h21)(is(a(parameter,(and(N(t)(is(the(concentration(of(bacterial(cells(at(time(t((CFU(ml21).(((It( is( important( to( note( that( Equation( 5.21( includes( the( linear( relationship(between( bacterial( growth( rate( and( nano2emulsion( dilution( factor,( given( its(simplicity(for(further(calculations,(since(the(correlation(coefficients(with(respect(to(the(exponential(fit(are(not(significantly(lower(for(linear(fits.(In(addition(to(this,(the(simplest(model( is(chosen,(without( including( the(variable(Cdroplets,( as( there(are(not(
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experimental( techniques( available( to( accurately( determine( the( number( of( nano2emulsion(droplets(per(millilitre.(The(dilution(factor(of(emulsions,(D,(is(used(instead,(since(it(is(easily(calculated(and(only(subjected(to(errors(in(the(dilution(process.(((Furthermore,( the( biological/physical(meaning( of( the( included( parameters( can(be( explained.( Firstly,( the( parameter( n( is( the( proportionality( constant( that(quantifies( the( influence( of( the( dilution( factor( of( nano2emulsions( on( bacterial(growth(rate.(It(has(a(negative(value,(since(the(smaller(the(dilution(factor,(the(closer(the( bacterial( growth( rate( is( to( its( maximum( value,( as( observed( experimentally.(Higher( values( of(n( would( imply( a( stronger( dependence( of( growth( rate,(whereas(very( low(values(of(n(would(mean(that( the(growth(rate( is(practically( independent(from( the( dilution( factor( of( nano2emulsions.( Secondly,( the( parameter( γ( can( be(interpreted(as(a(‘’pseudo2growth(rate’’(or(‘’pseudo2death(rate’’((CFU(ml21(h21).(This(means(that(once(the(carrying(capacity,(C,(is(reached,(bacteria(can(continue(growing(linearly((γ(>(0),(they(can(remain(in(the(stationary(phase,((γ(=(0),(or(they(can(decay(at(a(certain(rate((γ(<(0).(The(value(of(γ(not(only(influences(the(prolonged(growth(or(early(death(of(the(bacterial(population,(but(it(is(also(affected(by(the(dilution(factor(of(emulsion,(D.#The(higher(the(value(of(D,(the(higher(the(value(of(the(product(γ#×#D,(and(therefore(a(larger(effect(on(the(stationary(phase(is(observed.((In(order(to(determine(if(the(proposed(modified(logistic(model(in(Equation(5.21(is( appropriate( to( reproduce( the( observed( phenomena( in( the( experiments( in(




Parameter! Value!(units)! Origin!of!value! Required!in!
amax# 0.80((h21)( Fitting(for(S.#aureus(H560(in(Figure(5.12( Equation(5.21(
n# 20.52((2)( Fitting(for(S.#aureus#H560(in(Figure(5.12( Equation(5.21(
D# Variable(from(0.0(to(1.0((2)( Experimental(data(in(Tables(5.4(–(5.6( Equation(5.21(
C# 1(×(108(((CFU(ml21)( Example(value( Equation(5.21(
γ# ±(3(×(106(((CFU(ml21(h21)( Example(value( Equation(5.21(
t0# 0((h)( Experimental(data(in(growth(curves( ode45((MATLAB),(time(span(
tf# 20((h)( Experimental(data(in(growth(curves( ode45((MATLAB),(time(span(












(the( curves( present( smaller( growth( rates( progressively( even( starting( from( the(same(initial(concentration(of(bacteria).(It(can(also(be(seen(that(for(dilution(factors(of( 0.2( onwards,( there( is( a( small( decay( in( bacterial( density( by( the( end( of( the(incubation(period( (20(h).( The( time(when( this( decay( starts( to(be(noticeable,( tlimit,(depends(on(the(value(of(γ(by(definition.(((Besides,(Figure(5.13(B(represents(a(hypothetical(situation(where(the(less(diluted(emulsions(are(beneficial(for(bacterial(growth,(that(is(to(say,(the(more(droplets(per(bacterial( cell,( the( higher( the( carrying( capacity.( However,( this( does( not( imply( an(increase(in(the(growth(rate,(since(the(negative(linear(relationship(between(growth(rate(and(emulsion(dilution( factor(still(applies.(For(values(of( the(dilution( factor(of(emulsion,(e.g.(0.6(and(0.8,(the(final(concentration(reached(after(20(hours(of(growth(is(higher(than(that(of(growth(in(normal(TSB((D(=(0),(although(the(growth(is(visibly(slower.(As( an( example,( at( t( =( 10(h,( the( concentration(of( bacteria( that( is( reached(with(D( =( 0( is( approximately( 1.0( ×( 108( CFU(ml21,(while( for( D( =( 0.6,( the( bacterial(density(is(around(8.0(×(107(CFU(ml21,(20(%(smaller.((After( comparing( the( results( obtained( with( the( modified( model( with(experimental( data,( it( can( be( concluded( that( the( model( is( appropriate( for( the(growth(of(S.#aureus(when(the(value(of(the(parameter(γ(is(negative((Figure(5.13(A),(and( a( linear( correlation( between( bacterial( growth( rate( and( dilution( factor( of(emulsion(is(considered.(It(has(also(been(shown(that(the(model(is(versatile(and(can(be( applied( for( diverse( environmental( situations,(where( the( presence( of( external(agents( favours( the(development(of(higher(carrying(capacities(as(shown( in(Figure(5.13(B.(The(model(can(be(modified(to(include(a(positive(linear(correlation(between(bacterial(growth(rate(and(concentration(of(a(certain(element(in(the(system,(or(an(exponential(relationship.(((
5.3. Experimental!Determination!of!Infectivity!Parameters!
5.3.1. Adsorption!Rate!and!Adsorption!Efficiency!
Chapter!4(and(the(second(part(of( the(RSM(analysis( in(Section(5.2.1.2( focus(on(the( explanation( of( the( enhanced( infectivity( of( bacteriophages( in( the( presence( of(PIT(nano2emulsions.(This(phenomenon(is(not(reported(in(the(literature(except(for(our( paper( (Esteban( et( al.( 2014),( and( a( minor( suggestion( of( increased( titres( of(
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bacteriophages(in(emulsions((Kiss(et(al.(2011).(The(reasons(why(the(lytic(activity(of(bacteriophages(stored( in(nano2emulsions( is( superior( (and(constant(over( time)( to(that( of( bacteriophages( suspended( in( SM( buffer( is( yet( to( be( understood.( Several(hypotheses(have(been(proposed(in(this(thesis((Chapter!4),(including(protection(or(‘’shielding’’( of( the( virus( particles( via( emulsion( droplets,( without( encapsulating(them.(This(might(explain( the(extended(shelf2life(of(bacteriophage/nano2emulsion(preparations( with( respect( to( phage( suspensions( in( buffer.( However,( the( main(question( is(why(bacteriophages(are(more( infectious(against(both(S.#aureus(and(P.#
aeruginosa(when(nano2emulsion(droplets(are(present(in(the(system.(((One( of( the( possible( explanations( of( the( differences( in( infectivity( of(Bacteriophage( K( with( and( without( PIT( nano2emulsions,( but( also( amongst( the(different(strains(of(S.#aureus,(could(imply(variations(in(phage(infection(parameters,(such( as( its(adsorption! rate! and(adsorption! efficiency.( Bacteriophages(need( to(recognise(the(specific(receptors(on(the(bacterial(surface,(and(attach((or(adsorb)(to(it( before( ‘’injecting’’( their( genetic( material( into( the( cytoplasm.( The( influence( of(external(factors(on(this(very(first(step(of(bacteriophage(infection(of(a(bacterial(cell(has( been( widely( explained( in( the( literature,( for( instance,( the( effect( that( the(presence(or(absence(of(salts(in(the(environment(has(on(bacteriophage(adsorption((Puck(et(al.(1951).(((The(kinetics(of(bacteriophage(adsorption(were(studied(and(reviewed(by(Storms(et( al.( (Storms( et( al.( 2012;( Storms( et( al.( 2010),( proposing( a( modification( of( the(conventional( model,( which( is( based( on( the( same( principle( as( the( irreversible(enzyme2substrate(model(of(adsorption:(the(bacteriophage(acts(as(the(enzyme(that(binds( irreversibly( to( the( substrate,( the( bacterial( surface.( It( is( very( unlikely( that(once(bacteriophages(attach(to(the(bacterial(surface(they(become(unattached,(hence(the( irreversibility(of( the(process.(This(model(of( adsorption( is( shown( in(Equation(5.22:(
dP(t)




P(t) = P0  e−b N0  t ( Equation!5.23!Where(P0(is(the(concentration(of(bacteriophage(at(t(=(0(min((PFU(ml21).((Storms( et( al.( considered( that( only( phage( particles( that( have( been( properly(activated(are(able(to(perform(adsorption(to(the(host(surface.(They(proposed(a(way(to(quantify(the(adsorption(capability(of(a(specific(virus(population(by( including(a(new( term( to( Equation( 5.22,( and( they( named( this( new( parameter( adsorption(efficiency((ε).(It(represents(the(fraction(of(bacteriophages(that(are(able(to(attach(to(the(host(with(respect(to(the(total(population.(The(new(equation(is:(
dP(t)
dt = −b N0  P(t)− P0 1−ε( )
"# $% ( Equation!5.24!Where(ε( is( the(adsorption(efficiency((dimensionless,(as( it(represents(a(ratio(of(bacteriophage(concentrations).((By( substituting( P(t)( with( (P(t)# –# P0(1I# ε)),( the( inactive( bacteriophages( are(discounted(from(the(total(of(the(population.(Equation(5.24(yields(Equation(5.25(by(integration(and(rearrangement:(
P(t)
P0
=  1−ε  1− e−b N0  t( ) ( Equation!5.25!The( adsorption( rate,( b,( and( the( adsorption( efficiency,( ε,( can( be( determined(experimentally.( The( main( objective( of( this( section( is( the( comparison( of( these(parameters(in(the(presence(and(absence(of(PIT(nano2emulsions.(For(this(particular(work,( it( is( considered( that( the( adsorption( rate( and( adsorption( efficiency( are( the(parameters( in( the(whole( lytic( cycle( which( are(most( affected( by( the( presence( of(droplets( in( the( system.( It( seems( a( logical( approach,( after( the( explanation( and(demonstration( in( Section( 5.2( that( droplets( are( surrounding( both( bacteria( and(bacteriophages.((The( experimental( protocol( was( followed( for( the( three( strains( of( S.# aureus(considered(in(this(thesis,(H560,(H325,(and(Btn766,(and(is(as(follows:(an(overnight(culture(of( the(selected(strain(containing(approximately(108(CFU(ml21(was(used(as(the( host.( Before( performing( the( adsorption( experiment,( a( small( sample( of( said(
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Figure! 5.14:! Decay! in! the! concentration! of! free!
(unadsorbed)! Bacteriophage! K! relative! to! its!
initial! concentration,!P0! in! SM!Buffer! and! in!PIT!
nano1emulsion.!(A)(Adsorption(of(Bacteriophage(K(to(S.#aureus(H560;((B)(Adsorption(of(Bacteriophage(K(to(S.#aureus(H325;((C)( Adsorption( of( Bacteriophage( K( to( S.# aureus(Btn766.( The( average( of( triplicates( is( shown.( Error(bars( represent( the( standard(deviation(of( triplicates.(An( exponential( decay( is( fitted( to( the( experimental(data(for(both(adsorption(in(SM(buffer((discontinuous(curve)(and(PIT(nano2emulsion((continuous(curve).((
Figure( 5.14( represents( the( relative( concentration( of( free( unadsorbed(Bacteriophage(K,(with( respect( to( its( initial( concentration,(before(adsorption( to(S.(








y = y0 + a '  e−b '  x ≡ P(t)
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2! Parameter!y0( Parameter!a’( Parameter!b’(
H560! 1.0000( 0.0003(±(0.0004( 0.9997(±(0.0008( 0.3553(±(0.0028(
H325! 1.0000( 0.0025(±(0.0010( 0.9975(±(0.0021( 0.3652(±(0.0082(




2( Parameter!y0! Parameter!a’! Parameter!b’!
H560# 0.9985( 0.0159(±(0.0114( 0.9827(±(0.0220! 0.1465(±(0.0097!
H325# 1.0000! 0.0012(±(0.0008( 0.9988(±(0.0018! 0.3260(±(0.0048(
Btn766# 0.9659( 0.0662(±(0.0380( 0.9304(±(0.0876( 0.3458(±(0.1041(( The( values( in( Table( 5.9( can( be( used( to( extract( the( values( of( the( adsorption(parameters,( using( the( following( relationships,( which( were( obtained( by( the(comparison(of(equations(shown(in(the(heading(of(Table(5.9.(
y0
a ' =  
1−ε
ε
 ⇒  ε = 11+ y0 a '( )
( Equation!5.26!
b ' = b N0  ⇒  b=
b '
N0











H560! 0.3553(×(1028( 0.9997( 0.1465(×(1028( 0.9841(
H325! 0.3652(×(1028( 0.9975( 0.3260(×(1028( 0.9988(
Btn766! 0.8383(×(1028( 0.9970( 0.3458(×(1028! 0.9336((
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Comparing( the(values( in(Table(5.10,( the(observations( from(Figure(5.14(can(be(confirmed.(The(adsorption(rate(is(slower(in(PIT(nano2emulsions(than(in(SM(buffer,(especially(for(S.#aureus#H560(and(Btn766.(This(can(be(easily(explained(taking(into(account(the(potential(barrier(that(a(bacteriophage(may(encounter(when(trying(to(approach(the(bacterial(surface(if(nano2emulsion(droplets(are(covering(the(host(cell.(This(supports(the(hypothesis(shown(in(Figure(5.1(regarding(the(spatial(distribution(of(the(components(of(the(system.(Regarding(the(adsorption(efficiency,(all(values(for(the(three(strains(for(both(Bacteriophage(K(in(SM(buffer(and(Bacteriophage(K(in(PIT(nano2emulsions( are( very( similar( and( close( to( unity,( meaning( that( most(bacteriophages( in( the( population( are( properly( active( and( able( to( infect( bacterial(cells.( However,( it( does( not( clarify( the( fact( that( bacteriophage( infectivity( is(enhanced(by(nano2emulsions.(The(study(of(some(of(the(other(infection(parameters(in(the(lytic(cycle(may(elucidate(the(mechanism(for(enhanced(infectivity,(and(this(is(presented(in(Section(5.3.2.(((
5.3.2. Burst!Size,!Eclipse!Period!and!Lysis!Time!The(bacteriophage(lytic(cycle(consists(of(several(steps(as(shown(in(Figure(3.12.(The( first( step,( adsorption( of( the( virus( particle( to( the( bacterial( host( surface,(was(explored( in( the( presence( and( absence( of( nano2emulsions( in( Section( 5.3.1.( Once(bacteriophages( inject( their( genetic( material( into( the( cytoplasm( of( the( host(bacterium,( synthesis( of( phage( components( and( their( assembly( occur,( before( the(phage( progeny( are( released( when( the( bacterial( cell( is( lysed.( The( time( between(adsorption( and( lysis( is( called( the( latent! period.( The( time(when(production( and(assembly( of( new( phage( particles( occurs( is( called( the( eclipse! period.( Another(important(factor(in(bacteriophage(infectivity(is(the(number(of(new(phage(particles(that( are( released(after( cell( lysis,(which( are( able( to( infect(new(bacterial( cells( in( a(secondary( infection,( the( burst! size( (Abedon( &( Culler( 2007).( These( three(parameters( can( be( experimentally( calculated( for( bacteriophages( in( the( presence(and(absence(of(nano2emulsions,( aiding( in( the( interpretation(of( the(differences( in(infectivity(when(PIT(nano2emulsions(are(incorporated(into(the(system.(((Hyman(and(Abedon(developed(the(experimental(protocol(for(the(determination(of( the( latent( period,( eclipse( period( and( burst( sized( (Hyman(&( Abedon( 2008).( It(
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requires( the( determination( of( the( number( of( free( and( total( bacteriophages( via(constructing(a(one2step(growth(curve.(The(protocol(is(described(as(follows:(10(ml(of(an(overnight(culture(were(centrifuged(at(7,000(rpm(for(10(minutes(at(4(°C(and(re2suspended(in(5(ml(TSB(to(obtain(a(sample(presenting(an(optical(density(at(600(nm( of( approximately( 1.0( a.u.( 5( ml( of( bacteriophage( suspended( in( SM( buffer( or(bacteriophage/nano2emulsion( formulation( were( added,( giving( a( multiplicity( of(infection(of(0.001.(Phages(were(allowed(to(adsorb(for(5(min(at(room(temperature.(The(mixture(was(centrifuged(again,( and( the(pellet(was( re2suspended( in( 10(ml( of(fresh( TSB( medium( in( a( conical( flask,( with( constant( shaking.( Two( samples( were(taken(every(5(min(over( a( period(of(1(h( at( 37(°C.(The(experiment(was(conducted(twice:( the( first( time,( samples( were( conveniently( diluted( and( plated( directly(following(the(protocol(in(Section(3.5.3,(obtaining(the(number(of(free(phages(in(the(system,( to( calculate( the( latent( period.( Secondly,( the( samples( were( plated( after(treatment(with(1(%((v/v)(chloroform(in(order(to(burst(the(remaining(bacteria(and(release( the( intracellular( bacteriophages,( hence( obtaining( the( total( number( of(bacteriophages( in( the( population.( This( allows( for( the( calculation( of( the( eclipse(period.(An(example(of(the(results,(using(bacteriophages(in(SM(buffer(is(presented(in(Figure(5.15.(
(
Figure!5.15:!One1step!growth!curve!for!Bacteriophage!K!in!SM!buffer.!!Extracted(from((Alves(et(al.(2014).((●)(Represents(the(number(of(free(PFUs,(and((○)(corresponds(to(the(total(number(of(PFUs.(E(is(the(eclipse(period((min);(L(is(the(latent(period((min),(and(B(is(the(burst(size((PFU(ml21).(The(mean(of(triplicates(is(shown,(and(error(bars(correspond(to(the(standard(deviation.((It(is(worth(noting(that(previously(in(this(thesis,(the(eclipse(period(was(referred(to( as( e,( the( latent( period(was(T,( and(L( represented( the( burst( size.( However,( the(
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different( nomenclature( was( used( here( in( order( to( preserve( the( original( figures(from((Alves(et(al.(2014).(((Figure(5.15(shows(that(the(eclipse(period(of(Bacteriophage(K(is(around(15(min,(while(the(latent(period(is(20(min.(Bacteriophage(K(releases(approximately(125(PFU((burst( size)( in( SM( buffer.( These( values( are( in( agreement(with( others( previously(reported(in(literature(for(similar(phages((Ripoll(et(al.(2009;(Beretta(&(Kuang(2001;(Beretta(&(Kuang(1998).(The(results(for(both(bacteriophages(in(PIT(nano2emulsions(did( not( yield( significantly( different( values,( resulting( in( inconclusive( results(regarding( the( influence( of( nano2emulsions( on( these( infection( parameters.(Modelling( strategies( will( be( explored( in( Chapter! 7( in( order( to( provide( clarity(concerning(the(mechanisms(of(enhanced(infectivity.(
!
5.4. Influence!of!Nano1Emulsions!on!Bacteriophage!
Infectivity!The(reasons(why(bacteriophage(infectivity( is(enhanced(by(PIT(nano2emulsions(is(still(unclear.(The(experiments(in(Chapter!4(and(in(the(RSM(in(Section(5.2(suggest(stabilisation(of(bacteriophages(due(to(electrostatic(forces,( ‘’charge(shielding’’,(and(interaction(with(nano2emulsion(droplets.( Further( investigation( is(needed,(mainly(due( to( the( novelty( of( the(work( and( the( lack( of( references( in( the( literature,( and(therefore( new( techniques( need( to( be( applied( to( study( the( system.( Transmission(Electron(Microscopy((TEM)(and(Cryo2TEM(were(tested(in(order(to(determine(the(exact(spatial(distribution(of(the(components,(but(this(technique(was(not(successful:(the( sample( treatment( that( is( required( for( TEM( of( bacteriophages( destroyed( the(nano2emulsion(droplets,(which(were( therefore( not( visible.(Measurements( of( size(and(Zeta(potential(are(presented(here;( first,( for(all(of( the(components(separately,(followed( by( combinations,( and( finally( all( the( elements( of( the( system( together:(bacteria,(bacteriophages(and(nano2emulsion(droplets.(((
5.4.1. Zeta!Potential!and!Size!Measurements!of!Complex!Samples!
5.4.1.1. Bacterial!Cells!The(measurements( of( size(were( performed(using( the( ZETASIZER(Nano( Series(ZSP((Malvern(Instruments)(for(all(strains(of(S.#aureus(at(25(°C(by(diluting(100(μl(of(bacterial( overnight( culture( in( 10(ml( of( deionised(water,( so( the( concentration( of(
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water.!( Concentrated( samples( show( diameters( that( are( almost( double( the( size( of( the(more(diluted(samples,(as(shown( in(Figure(5.16,(when(comparing( the(non2shaded(bars( to( the( shaded(bars.( Thus,( a( statistical( analysis( of( the(difference( of( averages(was( performed,( between( the( average( cell( size( of( the( particular( strain( and( its(average( size( for( a( concentration( multiplied( by( four.( The( cell( diameters( were(compared(in(terms(of(their(average,(using(the(tItest( for(two(samples,(or(the(tItest(for( paired( samples,( included( in( the( statistical( software( Origin( 8.( The( null(hypothesis(assumes(that(both(averages(are(the(same((difference(of(averages(equals(zero),(while(the(alternative(hypothesis(accepts(that(the(difference(between(the(two(averages( is( less( than( or( more( than( zero.( From( the( statistical( analysis,( it( can( be(concluded(that(the(concentration(of(bacteria(is(a(critical(factor(in(order(to(measure(cell( size( in( deionised( water.( It( is( possible( that( the( lack( of( salts( results( in( cell(aggregation.(Smaller(concentrations(of(bacteria(yield(results( that(are(comparable(to(values(found(using(other(techniques,(such(as(microscopy((see(Figure(3.8).(This(is(important( in( order( to( select( the( appropriate( cell( concentration( for( the(measurement(of(Zeta(potential.((
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S.#aureus(Btn766( 234.7(±(0.7( 22.723(±(0.055((The(Zeta(potential(of(the(three(strains(is(very(similar,(and(very(negative,(and(the(standard( deviation( is( small.( The( Zeta( potential( of( bacteria( is( much( higher( (in(absolute(value)( than(that( for(nano2emulsions((see(Table(4.2),(and(therefore( their(electrophoretic( mobility( is( much( higher.( High( values( of( Zeta( potential( indicate(stability(with( respect( to( coalescence,( sedimentation,( etcetera.(However,( bacterial(cells(are(very(big,(and(gravitational(forces(might(produce(aggregation(despite(their(electrostatic(stability.(
!




Figure!5.17:!Summary!of!average!sizes!of!Bacteriophage!K!in!deionised!water.!( It( should(be( remembered( that(Bacteriophage(K( is(not( spherical,( and( therefore(the( results( obtained( from(DLS(would( correspond( to( the( larger( dimension( of( the(phage((its(length).(The(detected(size(for(the(more(diluted(samples(is(approximately(2.5(times(the(size(of(less(diluted(samples,(suggesting(aggregation.(Bacteriophage(K(samples(with(a(concentration(of(106(PFU(ml21(have(a(size(of(154.8(±(5.1(nm,(with(a(PdI(of(0.265(±(0.057.(Bacteriophage(samples(are(not(as(polydispersed(as(bacterial(samples,(meaning(that(the(size(of(phages(is(more(uniform.(A(concentration(of(106(PFU( ml21( was( selected( for( measurements( of( Zeta( potential,( as( their( size( was( in(better(agreement(with(TEM(pictures((Figure(3.9).(( The( measurements( of( Zeta( potential( were( performed( using( the( ZETASIZER(Nano( Series( ZSP( (Malvern( Instruments)( at( 25( °C( by( diluting( 100( μl( of( each(Bacteriophage( K( sample( of( different( concentration( in( 10(ml( of( deionised(water.(Triplicates(of(each(sample(were(measured,(and(each(measurement(consists(of(10(to(100( runs,(depending(on( the(number(of( runs( that(are( required( to( find(a( stable(reading.( The( pH( of( the( samples( was( 7.0( ±( 0.2( in( all( cases.( The( results( for(Bacteriophage(K(with(a(concentration(of(106(PFU(ml21(are(a(Zeta(potential(of(213.9(±( 1.4( mV( and( an( electrophoretic( mobility( of( 21.091( ±( 0.115( μm( cm( V21( s21.(Bacteriophage(K( shows( negative( Zeta( potential,( but( not( as( negative( as(S.#aureus.(This( suggests( that,( apart( from( the( obvious( biochemical( interaction( between(
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bacteriophages( and( the( cell( surface( receptors,( there( is( an( electrostatic( repulsion(that(makes(the(contact(between(the(two(species(less(effective.(
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(nm)!2072( 2141( 988( 1456( 1014( 391( 956( 1251( 280(3162( 715( 1513(1190( 870( 1284(
Peak!2!(Bacteriophage!K)!
D!
(nm)( Average!D!(nm)( SD!D!(nm)( D!(nm)( Average!D!(nm)( SD!D!(nm)( D!(nm)( Average!D!(nm)( SD!D!(nm)(0( 251.6( 435.7( 156.1( 121.7( 32.2( 104.0( 101.3( 2.4(754.7( 92.3( 100.5(0( 116.7( 99.5(
! The(concentration(of(all(strains(of(bacteria(and(bacteriophages(was(106(CFU(ml21(and( 106( PFU( ml21( respectively.( The( two( observed( peaks( for( each( sample( were(completely( separated( (resolved),( and( the( results( are( coherent( with( the(independent( measurements( for( the( two( species( involved,( as( shown( in( Sections(5.4.1.1( and( 5.4.1.2.( An( exception( was( S.# aureus( H560,( which( shows( a( very( high(value(of(size,(indicating(aggregation(of(cells.(The(fact(that(the(size(values(are(very(similar( to( those( of( the( independent( elements( indicates( that( there( is,( in( fact,( no(binding(while( the(measurement( took( place.( This( fact( is( significant( regarding( the(
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(mV)!242.0( 241.3( 0.7( 241.2( 240.7( 1.5( 233.8( 233.9( 0.1(240.7( 241.8( 234.0(241.2( 239.0( 233.9((The(global(value(of(Zeta(potential(for(the(system(is(slightly(higher(than(that(for(bacterial(samples(alone(compared(to(Table(5.12,(but(it(is(clear(that(Zeta(potential(is(predominantly( influenced(by( the(Zeta(potential(of(bacterial( cells.(Table(5.14(also(shows(very(little(variability(in(the(data,(as(indicated(by(the(small(values(of(standard(deviation((SD).!
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D!(nm)! Average!D!(nm)! SD!D!(nm)!16.61( 16.80( 0.20(16.87(16.93(
Peak!2!(Bacteriophage!K)!
D!(nm)( Average!D!(nm)( SD!D!(nm)(281.4( 269.7( 10.1(264.1(263.6(





ZP!(mV)! Average!ZP!(mV)! SD!ZP!(mV)!21.19( 21.31( 0.17(21.51(21.24(( Clearly,( the( presence( of( nano2emulsions( makes( the( Zeta( potential( of(Bacteriophage( K( much( less( negative( (compared( to( 213.9( ±( 1.4( mV( for(Bacteriophage( K( alone).( The( literature( suggests( that( different( environmental(conditions( may( alter( the( Zeta( potential( of( bacteriophages( due( to( electrostatic(interactions( (Zemb( et( al.( 2013).( This( is( a( significant( finding,( and( it( provides( the(reason(why(Bacteriophage/nano2emulsion(preparations(are(much(more(effective(against(bacteria.(The(electrostatic( repulsion(between( two( species( that( are(highly(negatively(charged((bacteria(and(bacteriophage)(is(almost(totally(eliminated(by(the(presence( of( nano2emulsions.( It( can( be( interpreted( as( follows:( in( the( absence( of(nano2emulsions(two(different(kinds(of( forces(act( in(the(system:( firstly,(a(positive,(attractive( force( that( brings( bacteria( and( bacteriophage( together,( such( as( the(biochemical(interaction(between(the(bacteriophage(tail(fibres(and(the(receptors(on(the(bacterial(cell(surface;(and(secondly,(a(negative,(repulsive( force(that(separates(
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bacteria( and( bacteriophage,( purely( an( electrostatic( repulsion.( When( PIT( nano2emulsions( are( included,( the( electrostatic( repulsion( is( eliminated,( favouring( the(interaction( between( bacteriophages( and( bacteria( in( a( much(more( efficient( way.(This( is( further( confirmed( in( the( next( section,(where( the( Zeta( potential( of( all( the(components(is(measured(together.(
!
5.4.1.5. Bacterial!Cells!+!Bacteriophage!K!+!Nano1emulsion!
Droplets!Finally,( the( Zeta( potential( of( the( complete( system( (S.# aureus( +( Bacteriophage(K/PIT( nano2emulsions)( was( measured( using( a( concentration( of( bacteria( and(bacteriophage( of( 106( CFU( ml21( and( 106( PFU( ml21( respectively.( The( results( are(shown(in(Figure(5.18(for(the(three(strains(of(S.#aureus.(
(
Figure!5.18:!Zeta!potential!distribution!of!S.#aureus!strains!plus!Bacteriophage!K!in!PIT!
nano1emulsion!formulations.!( The(global(Zeta(potential(is(less(negative(than(that(for(bacteria(+(Bacteriophage(K,( Section( 5.4.1.3,( confirming( the( attenuated( electrostatic( repulsion( between(bacteria( and(bacteriophages(due( to( the(presence(of(nano2emulsion(droplets.(The(hypothesis( of( ‘’charge( shielding’’( of( bacteriophages( via( PIT( nano2emulsions,( has(therefore(been(proven,(and(the(enhanced(infectivity(has(been(explained.((
5.5. Conclusions!The(main(aim(of(this(chapter(was(the(study(of(the(mechanisms(and(interactions(in( the( bacteria2emulsion2bacteriophage( system( from( an( experimental( point( of(view.(The(most(important(findings,(related(to(the(specific(objectives(are:(
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1. The(spatial(distribution(of( the(components( in( the(system(was(estimated(via(simple( calculations( of( size,( volume,( surface( area( and( concentration( of(bacteria,( droplets( and( bacteriophages.( It( was( found( that( encapsulation( of(bacteriophages( was( impossible( due( to( steric( impediments,( in( conjunction(with( hydrophobicity( of( bacteriophages( in( some( cases( as( stated( in( the(literature((Thompson(&(Yates(1999),(and(that(nano2emulsion(droplets(cover(the(surface(of(bacterial(cells(and(are(surrounding(bacteriophages( in(a(much(higher( number( (approximately( a( hundred( thousand( million( droplets( per(bacteriophage).((2. A(response(surface(design(of(experiments(was(used( to(gain( insight( into( the(relative( effects( of( the( emulsion( formulation( on( bacterial( growth( and( phage(lytic(activity.(More(diluted(emulsions(had(a(less(significant(effect(on(bacterial(growth,( and( diluted( bacteriophage/emulsion( preparations( yielded( greater(antibacterial(activity.(These(results(are(coherent(with(the(findings(in(Chapter!
4,(and(encourage(further(investigation(of(bacterial(growth(in(nano2emulsions,(and(infectivity(of(bacteriophage(formulations.(( 3. Regarding(bacterial(growth,(relationships(between(the(growth(parameters(of(
S.#aureus#(growth(rate(and(carrying(capacity)(and(the(concentration(of(nano2emulsion( droplets( were( obtained.( This( allowed( for( modification( of( the(conventional( logistic(growth(model,( including(new(parameters( that(account(for( the( influence( of( nano2emulsions,( or(more( generally( any( external( factor(that(influences(bacterial(growth.(The(new(model(was(successfully(compared(to( experimental( data( in( nano2emulsion( preparations.( To( conclude,( the(improved( logistic( model( is( a( good( approximation( to( quantify( delayed( or(partially( inhibited( growth,( but( also( enhanced( growth( in( hypothetical(situations(where(the(carrying(capacity(is(increased.(( 4. Values( for( important( parameters( in( the( bacteriophage( lytic( cycle( were(obtained( experimentally,( namely( the( adsorption( rate( and( adsorption(efficiency,(the(eclipse(and(latent(period,(and(the(burst(size.(The(experimental(determination(of( the( infection(parameters(was(performed( for( systems(with(and( without( nano2emulsion( droplets( in( order( to( observe( differences( that(
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would( allow( for( explanation( of( the( infection( mechanisms.( The( adsorption(rate( was( found( to( be( slower( in( PIT( nano2emulsions( than( in( SM( buffer,(because( of( the( potential( spatial( impediment( that( a( bacteriophage( may(encounter(when(approaching(the(bacterial(surface(if(nano2emulsion(droplets(are(covering(the(host(cell.(The(results(for(the(remaining(infection(parameters(were( not( significantly( different( in( the( presence( or( absence( of( nano2emulsions,( and( they( were( not( useful( to( clarify( the( fact( that( bacteriophage(infectivity(is(enhanced(by(nano2emulsions.(( 5. The(enhanced( infectivity(of(bacteriophage/nano2emulsion( formulations(was(explained( via( measurement( of( Zeta( potential.( It( can( be( concluded( that(electrostatic( interactions(play(a(vital(role( in( this(particular(system,(which( is(supported(by(the(literature.(Values(of(Zeta(potential(of(Bacteriophage(K/PIT(nano2emulsion( compared(with( the(values(of(Bacteriophage(K(alone( suggest(that( the( presence( of( nano2emulsions( eliminates( possible( electrostatic(repulsion( between( bacteria( and( bacteriophages( (both( very( negatively(‘’charged’’),( causing( a( more( effective( contact( that( results( in( the( enhanced(killing(effect(of(our(bacteriophage(formulations.(( A(comprehensive(study(of(the(mechanisms(in(this(complex(system(is(very(useful(for( the( optimisation( of( the( formulation,( and( to( transfer( the( use( of( such(formulations(to(more(realistic(wound(environments,(where(bacteria(are(generally(forming(biofilms.(This(will(be(addressed(in(Chapter!6.((
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6. BIOFILM! DEVELOPMENT! AND! ERADICATION! USING! OIL;IN;
WATER!NANO;EMULSION!FORMULATIONS!!
!
6.1. Introduction!The( experimental( chapters( so( far( have( focused( on( the( understanding( of(bacteriophage/nano<emulsion( formulations( against( S.# aureus( and( P.# aeruginosa(infections(in(planktonic((liquid(culture).(The(PIT(nano<emulsion(formulations(have(shown( to(be( extremely( effective( against( these(pathogenic(bacteria( in(Chapter! 4,(and( have( shown( an( improved( and( constant( shelf<life( both( at( room( temperature(and( 4( °C.( The( effect( of( nano<emulsions( on( bacterial( growth,( in( order( to( select(appropriate(control(experiments,(has(also(been(verified(via(several(experimental,(statistical( and(modelling( techniques( in(Chapter! 5.( The(mechanism( of( enhanced(infectivity( of( bacteriophage/nano<emulsion( preparations( has( been( demonstrated(in( Chapter! 5,( giving( a( strong( basis( for( the( next( steps( in( the( development( of( a(commercial(product(for(the(treatment(of(burn(wound(infections.(((The(high( level( objective(of( this( thesis( is( the(preparation(of(novel( and( suitable(formulations( including( bacteriophages( to( treat( infections( in( burns.( Bacteria( in(wounds(are(mainly(present(in(the(form(of(biofilms.(Bacteria(prefer(to(form(biofilms(rather( than( remaining( in( suspension( for( several( reasons:( they( can( try( to(protect(themselves(from(adverse(environmental(conditions,(and/or(they(can(benefit(from(belonging( to( a( community( in( terms( of( nutrient( availability( or( defence( against(antibiotics,( for( instance( (Jefferson( 2004).( There( are( fundamental( physiological(differences( between( cells( in( planktonic( culture( and( biofilm<forming( cells.( Apart(from( the( obvious( interactions( between( cells( within( the( biofilm,( there( is( an(additional( complication( in( the( eradication( of( bacterial( biofilms:( the( polymeric(matrix(in(which(bacterial(cells(are(embedded.(Several(factors(such(as(the(adhesion(of( bacteria( towards( certain( surfaces,( and( the( existence( of( certain( molecules( or(nano<emulsion( droplets( in( the( system( need( to( be( taken( into( account( in( the(development(and(eradication(of(biofilms.((( This( last( experimental( chapter( explores( the( formation( of( S.# aureus( and( P.#
aeruginosa( biofilms( in( a( simple( static( model,( including( staining( techniques( and(viable( counts( (Merritt( et( al.( 2005)( in( Section( 6.2.( The( presence( of( PIT( nano<
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emulsions( is( explored,( considering( their( role( in( the( attachment( of( cells( to( the(surface(of(the(96<well(plate(where(the(experiments(took(place,(and(the(possibility(of(their(anti<biofilm(action.(This(constitutes(the(equivalent(of(the(study(of(bacterial(growth( in( planktonic( culture( in( PIT( nano<emulsions( shown( in( Chapter! 4.( The(differences( between( the( development( of( Gram<positive( and( Gram<negative(bacterial(biofilms(are(also(explained.((Section(6.3(investigates(biofilm(eradication(using(a(bacteriophage(‘’cocktail’’(and(a(bacteriophage(‘’cocktail’’/PIT(nano<emulsion(formulation(via(staining(techniques(and( viable( counts.( Differences( between( both( antibacterial( agents( are( expected,(similar( to( those( observed( in( planktonic( culture.( If( bacteriophage/nano<emulsion(preparations(prove(to(be(more(efficient(than(simple(suspensions(of(bacteriophages(in( buffer( in( the( eradication( of( bacterial( biofilms( in( the( static( model,( these(formulations(could(be(suitable(for(the(treatment(of(burn(wound(infections.((Section( 6.4( further( approximates( a( realistic( wound( environment( via( a( flow(system:(a(modified(Robbins(Device((MRD).(The(system(was(designed(from(scratch,(starting(with(the(design(of(the(chemostat(that(feeds(the(Robbins(Device.(The(mass(balance( for( a( bioreactor( was( developed,( and( the( bacterial( growth( parameters(needed( for( the( design(were( experimentally( determined.( The( required( flow( rates(and(wash<out(rate(were(calculated(in(order(to(obtain(a(constant(bacterial(density(in( the( chemostat,( growing( in( steady( state.( Once( the( set<up( of( the( system( was(completed,( the(MRD(was(tested( for( the(development(and(eradication(of(S.#aureus(biofilms( using( a( bacteriophage( cocktail/PIT( nano<emulsion( formulation.( The(experimental( techniques( are( also( based( on( viable( counts( for( both( bacteria( and(bacteriophages,( and( additionally,( confocal( microscopy( was( used( for( the(visualisation(and(quantification(of(the(results.((
6.2. Static!Biofilm!Model!–!Formation!Previous(experiments(based(on(planktonic(culture(provide(a(basis(for(the(study(of( biofilms.( This( section( summarises( the( experimental( procedures( and( results(regarding( bacterial( biofilms( developed( in( microwell( plates,( also( known( as( the(static(model.((
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24(h,( than(after(48(h(and(72(h( for( the( three( strains( (when( the(biofilm(density( is(approximately(105(CFU(ml<1).(This(can(also(be(observed(by(comparing(the(intense(purple(colour(in(the(wells(in(the(24(hours(picture(with(those(for(48(h(and(72(h.(This(is( because( there( is( a( deprivation( of( nutrients( due( to( the( static( conditions( in( the(experiment((nutrients(were(not(continuously(supplied)((Merritt(et(al.(2005).((The( formation( of( S.# aureus( biofilms( in( PIT( nano<emulsions( is( represented( in(Figure(6.1(B.(The(first(observation(is(that(mostly,(the(biomass(present(in(biofilms(in(a(PIT(nano<emulsion(is(less(dense(than(for(biofilms(formed(in(normal(media((TSB),(especially( for( S.# aureus( H560,( reaching( lower( density( limits( corresponding( to(nearly( 104( CFU(ml<1( after( 72( h.( This( is( also( evident( in( the( pictures( of( the(wells,(comparing( the( left( part( of( the( pictures( (no( emulsion),( where( the( colour( of( the(crystal( violet( stain( is( quite( intense,(with( the( right( part( of( the( pictures( (with( PIT(nano<emulsion)(where(the(colour(is(faded.(There(is(evidence(in(the(literature(of(the(anti<biofilm(effect(of(micro(and(nano<emulsions.(For(instance,(it(has(been(reported(that( oil<in<water( micro<emulsions( with( a( composition( of( 15( %( Tween( 80,( 6( %(pentanol,(and(3(%(ethyl(oleate(in(water(present(antimicrobial(activity(both(against(planktonic(cultures(and(biofilms((Al<Adham,(Al<Hmoud,(Khalil,(Kierans,(&(Collier,(2003;( Al<Adham,( Khalil,( Al<Hmoud,( Kierans,( &( Collier,( 2000).( Different( nano<emulsion(formulations(with(droplet(sizes(ranging(from(100(to(800(nm(have(shown(antibacterial(properties(against(clinical(strains(of(A.#baumannii(biofilms(and(have(been( proposed( as( an( alternative( to( antibiotics( for( topical( treatment( of( skin(infections((Hwang(et(al.(2013).(Several(other(examples(are(shown(in(the(literature(for(biofilms(in(different(environments,(such(as(food(pathogenic(bacteria((Teixeira(et( al.( 2007)( and( cariogenic(bacteria( in(dental( biofilms( (Ramalingam(et( al.( 2012).(However,(there(is(a(lack(of(understanding(regarding(the(reasons(and(mechanisms(that( produce( biofilm( eradication( due( to( micro( and( nano<emulsions.( The( most(reliable(justification(was(proposed(by(Ramalingam(et(al.(and(Al<Adham(et(al.,(who(suggested(that(nano<emulsions(disrupt(the(bacterial(cell(membranes.(They(showed(excellent(electron(micrographs(of(the(damaged(membranes(in(P.#aeruginosa(when(exposed( to( micro<emulsions( (Al<Adham( et( al.,( 2003;( Al<Adham( et( al.,( 2000;(Ramalingam( et( al.,( 2012).( It( is( important( to( note( that,( despite( proving( the(disruption(of(the(external(cell(wall,(the(antimicrobial(effect(is(not(completely(clear,(
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because( the( damage( could( be( produced( by( the( chemical( components( of( the(emulsion( independently,( being( toxic( to( the( cells(without( forming(micro(or(nano<emulsion( droplets.( The( inhibited( growth( agrees( with( findings( in( Chapter! 5( for(planktonic( cultures,( but( it( does( not( fully( explain( eradication( of( biofilms,( since(factors( such( as( the( potential( existence( of( a( protective( polymeric(matrix( are( not(considered.( Although,( it( is( clear( that( nano<emulsions( partially( inhibit( S.# aureus(biofilm(formation.(((The(results(concerning(P.#aeruginosa(biofilms(are(shown(in(the(next(subsection.(It(is(interesting(to(compare(whether(there(are(differences(between(Gram<positive((S.#aureus)(and(Gram<negative((P.#aeruginosa)(biofilm(forming(organisms.(((
6.2.2. Pseudomonas, aeruginosa! Biofilm! Formation! with! and! without!










formation.!(A)(Without(PIT(nano<emulsion;((B)(In(PIT(nano<emulsion.(Average(of(independent(triplicates(is(shown,(and(error(bars(represent(the(standard(deviation.(( Figure( 6.2( A( indicates( that( P.# aeruginosa( is( a( better( biofilm<former( than( S.#



















Figure( 6.2( B( shows( that( P.# aeruginosa( biofilms( are( not( affected( by( PIT( nano<emulsions(when(compared(with(Figure(6.2(A.(The(optical(density(of(biofilms(in(PIT(nano<emulsions( is( comparable,( and( in( some( cases( higher,( for( the( three( strains.(Special( attention( should( be( paid( to( BC00907,( which( appears( to( grow( and( form(denser( biofilms( in( the( presence( of( nano<emulsions,( avoiding( biomass( decay( in(comparison(to(its(development(in(YPD(medium.(The(differences(between(S.#aureus(in(Figure(6.1(and(P.#aeruginosa(in(Figure(6.2(are(evident,(with(the(former’s(biofilms(being( inhibited( by( PIT( nano<emulsions( and( the( latter( maintaining( its( biofilm(biomass,( and( in( some( cases,( showing( enhanced( biofilm<forming( capability.( The(inhibition( of( P.# aeruginosa( biofilm( formation( via( emulsions( and( surfactants( has(been(demonstrated(in(the(literature,(and(explained(on(the(basis(of(the(appearance(of(mutations( that(allow(overexpression(of( specific(enzymes((Teixeira(et(al.(2007;(Toutain<Kidd( et( al.( 2009).( However,( this( inhibition( depends( on( the( particular(growth(patterns( and(biofilm( tendencies( of( the( specific(P.#aeruginosa( strains.(Our(three( strains( are( strong( biofilm<formers( as( evidenced( in( Figure( 6.2( A( in( YPD(medium.( Therefore,( the( possible( effect( that( nano<emulsions( could( have( on( their(biofilm( development( is( diminished( and( practically( unnoticeable.( These( findings(may( prove( fundamental( when( eradication( of( biofilms( using( bacteriophage(formulations(is(tested.((
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Figure!6.4:!Biomass!quantification!of!S.,aureus!H560,!H325!and!Btn766!biofilm!eradication!

















in( SM( buffer( suspensions( are( very( good( antimicrobial( agents( against( S.# aureus(biofilms(for(the(three(strains(studied.((However,( the( bacteriophage( ‘’cocktail’’/PIT( nano<emulsion( formulations( were(not( as( effective( against( biofilms( as( the( simple( suspension( of( bacteriophages,( as(shown(in(Figure(6.4(B.(If(Figure(6.4(B(is(compared(with(Figure(6.1(B,(the(OD(values(are( practically( the( same( for( all( time( points( after( treatment.( A( slightly( higher(eradication( is( observed( after( 72( hours( of( treatment( with( bacteriophage(‘’cocktail’’/PIT( nano<emulsion( formulations,( but( not( comparable( to( the( killing(effect( observed( in( Figure( 6.4( A.( It( can( be( concluded( that( practically( the( whole(reduction( of( biofilm( biomass( is( due( to( nutrient( limitation( and( inhibited( biofilm(development( due( to( nano<emulsions( alone.( There( are( considerable( errors(associated(with( colony( counting( and( crystal( violet( staining,( since( serial( dilutions(are(involved(for(the(former,(and(many(steps(of(washing(and(dilution(are(required(for( the( latter.(Nevertheless,( it( is(possible( that(since(one(of( the(main(reasons(why(biofilms(are( formed( is( their(defence(against(external(agents,(S.#aureus(biofilms( in(PIT(nano<emulsions(present( an( extra<protection( against( bacteriophages.(Another(possibility( is( the( impeded( diffusion( of( bacteriophages( due( to( the( presence( of(droplets(in(the(system.((
6.3.2. P.,aeruginosa!Biofilm!Eradication!with!and!without!Nano;




























Figure(6.5(B( shows( the( attack( of(P.#aeruginosa( biofilms(using( a( bacteriophage(‘’cocktail’’/PIT(nano<emulsion(formulation.(In(the(first(24(hours(there(is(significant(decay(in(the(biomass,(and(after(48(hours(there(is(almost(a(total(eradication(of(the(biofilm( using( the( nano<emulsion( formulation.( In( this( case,( it( is( clear( that( nano<emulsions( and( bacteriophages( present( a( ‘’synergistic( effect’’( in( the( attack( of( P.#
aeruginosa( biofilms,( with( only( 102( CFU(ml<1( after( 72( hours( of( treatment( for( the(three(strains.(The(killing(of(biofilms(is(even(more(significant,(since(nano<emulsions(alone(did(not(show(a(strong(inhibiting(effect(on(biofilm(formation(as(in(Figure(6.2.((To( conclude,( the( combination( of( PIT( nano<emulsions( and( a( bacteriophage(‘’cocktail’’( is( a( very( interesting( and( effective( alternative( to( antibiotics( for( the(treatment(of(bacterial(biofilms( in( the(static(model,(especially( for(P.#aeruginosa.(S.#
aureus(biofilms(show(resistance(to(bacteriophages(in(nano<emulsions(to(a(certain(extent,(but(despite( this,( their(biomass( is(significantly(reduced(by(nano<emulsions(alone.( Increasing( the( initial( concentration( of( bacteriophages( in( the( formulation(may( be( a( possibility( to( overcome( this( minor( degree( of( resistance( in( S.# aureus.(Therefore,( our( formulations( have( been( proven( to( be( effective( against( biofilm(infections( in( the( static(model,( and( are( ready( to( be( tested( in( a( flow( system(–( the(modified(Robbins(Device.((
6.4. Flow!System!–!Robbins!Device!!Many( different( devices( for( biofilm( study( in# vitro( in( a( controlled( environment(have( been( previously( described( in( the( literature( (Deines( et( al.( 2010),( including(various( types( of( reactors( (rotating( disc,( annular,( PropellaTM( reactor,( etcetera).(These(systems(have(been(found(to(be(unsuitable(because(they(fail( in(reproducing(the( experimental( conditions( of( the( real( system,( for( instance,( in( pipelines.( In( this(sense,(the(modified(Robbins(Device((MRD)(reviewed(by(Kharazmi(et(al.((Kharazmi(et( al.( 1999),(was( found( to( be(more( appropriate( to(mimic( in#vivo( flow( conditions((Nickel( et( al.( 1985).( The( MRD( constitutes( a( good( approximation( to( the( real(situation( in( a(wound( environment( for( several( reasons:( the( flow(passing( through(the(MRD(is(very(slow((as(will(be(calculated( in(Section(6.4.2),(mimicking(the(slow(flow(of(exudate(in(a(wound;(also,(the(existence(of(a(moving(fluid(allows(bacteria(to(exist(either(in(planktonic(culture,(in(a(biofilm,(or(a(combination(of(both;(and(lastly,(
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(The( experimental( procedure( can( be( briefly( explained( as( follows:( a( bacterial(culture( growing( in( steady( state( in( the( chemostat( is( continuously( supplied( to( the(MRD( together(with( fresh(medium( in( order( to( avoid( nutrient( limitation.( Biofilms(form(inside(the(MRD,(which(has(different(sampling(points(that(allow(quantification(via(colony(counting(and(confocal(microscopy((see(Section(3.9).(The(MRD(was(also(used( for( the( study( of( biofilm( eradication( using( a( bacteriophage( ‘’cocktail’’/PIT(nano<emulsion( preparation,( via( substituting( the( bacterial( feed( (that( comes( from(the(chemostat)(once(mature(biofilms(are( formed,(by(a( treatment( feed(containing(our(formulations.(((The(key(steps(for(the(design(of(the(experimental(set<up(include(the(design(of(the(chemostat(to(achieve(steady(state(conditions(of(growth,(and(the(determination(of(the(flow(rates(that(are(required(both(in(the(chemostat(and(in(the(MRD.(These(are(explained(in(Section(6.4.1.(The(operating(conditions(are(listed(in(Section(6.4.2,(and(the( results( regarding( biofilm( formation( and( eradication( are( summarised( in(Sections(6.4.3(and(6.4.4(respectively.((
6.4.1. Design!and!Set;up!of!Chemostat!The(chemostat(is(a(bioreactor,(and(as(such(it(needs(to(be(appropriately(designed(in(order(to(achieve(the(desired(operating(conditions.(The(first(step(in(the(design(of(a( reactor( is( obtaining( the( ‘’design( equation’’( (Doran( 2012),( which( consists( of( a(mass(balance.(In(this(case,(only(bacteria(inside(the(reactor(are(considered((nutrient(consumption(is(neglected(since(it(is(assumed(that(more(than(enough(nutrients(are(supplied);( thus( the( mass( balance( will( refer( to( the( concentration( of( bacteria(exclusively.( The(mass( balance( per( unit( of( time( is( developed:( instead( of( bacterial(concentration,( it( will( be( expressed( in( terms( of( rates( (CFU( per( hour,( CFU( h<1)( as(shown(in(Equation(6.1.(
Rate of accumulation of bacteria CFU h−1( ) =
= Rate of bacteria entering the chemostat CFU h−1( )  -
- Rate of bacteria leaving the chemostat CFU h−1( )  + 
+ Rate of generation of bacteria CFU h−1( )  - 




(The( rate( of( accumulation( of( bacteria( is( expressed( as( the( derivative( of( the(concentration( of( bacteria( with( respect( to( time,( multiplied( by( the( volume( of( the(reactor,(for(unit(consistency:(
V  dN(t)dt ( Equation!6.2!Where(V(is(the(volume(of(the(reactor((ml),(N(t)(is(the(concentration(of(bacteria(at( time(t( (CFU(ml<1),(and(t( is( the( time((h).(The(reactor(used( in( these(experiments(has(a(volume(of(2(litres,(but(it(was(only(filled(up(to(1.5(litres,(1500(ml.(( The( rate(of(bacteria(entering( the( chemostat( is( equal( to( zero,(because( the( feed(inlet(contains(only( fresh(medium,(assuming( that( there( is(no(contamination(at(all.(The(bacterial(inoculum(is(added(initially,(and(no(other(bacteria(are(included(after(that.(( The(rate(of(bacteria(leaving(the(chemostat(is(represented(by(the(outlet(flow(rate,(
F((ml(h<1),(multiplied(by(the(concentration(of(bacteria(at(time(t,(N(t)((CFU(ml<1):(
F N(t) ( Equation!6.3!( The( rate( of( generation( of( bacteria( can( be( expressed( according( to( different(growth(equations(as(was(explained( in(Chapter! 5.(A(simple(and(reliable(model( is(the( logistic(curve(of(growth((Verhulst(model),(used(throughout(this(thesis,(where(the( growth( parameters( are( the( bacterial( growth( rate,( a( (h<1),( and( the( carrying(capacity,(C( (CFU(ml<1),(which( is( the(maximum(bacterial(density(that( is(reached( in(the( stationary( phase( of( growth.( In( order( to( obtain( unit( consistency,( the( logistic(equation(needs(to(by(multiplied(by(the(volume(of(the(reactor(as(shown(in(Equation(6.4.(






' ( Equation!6.4!( The(death(rate(of(bacteria(is(normally(expressed(as(a(first(order(kinetic(process,(that(is(to(say,(a(kinetic(constant(kd((h<1)(multiplied(by(the(concentration(of(bacteria,(
N(t)# (Doran( 2012).( The( constant,( also( known( as( the( death( rate,( indicates( how(quickly(bacteria(die(in(the(chemostat.(This(term(also(needs(to(be(multiplied(by(the(volume(of(the(reactor(for(dimensional(consistency.(
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V  kd  N(t) ( Equation!6.5!( Taking( into( account( all( the( terms( defined( in( Equations( 6.2( –( 6.5,( the( mass(balance(for(biomass(in(the(chemostat(is(as(follows:(








'−V  kd  N(t) ( Equation!6.6!Where(V(is(the(volume(of(the(reactor((ml),(N(t)(is(the(concentration(of(bacteria(at(time(t((CFU(ml<1),(F(is(the(outlet(flow(rate((ml(h<1),(a(is(the(bacterial(growth(rate((h<1),(C(is(the(carrying(capacity((CFU(ml<1),(kd(is(the(bacterial(death(rate((h<1),(and(t(is(the(time((h).((Equation(6.6(can(be(expressed(in(terms(of(the(wash<out(rate,(D,(by(dividing(the(equation(by(the(volume(of(the(reactor,(as(D=F/V:((
dN(t)








'− kd  N(t) ( Equation!6.7!(When(the(system(is(operating(at(steady(state,(the(accumulation(rate(is(equal(to(zero.( That( is( to( say,( the( generation( of( bacteria( (growth)( is( equal( to( the( rate( of(bacteria(abandoning(the(chemostat(and(dying,(as(shown(in(Equation(6.8.(






'− kd  N(t) ( Equation!6.8!( In(order(to(determine(the(operating(conditions(for(the(chemostat,(it(is(necessary(to(calculate(the(wash<out(rate(that(is(required(to(achieve(a(certain(concentration(of(bacteria(in(the(chemostat(at(steady(state.(Once(the(wash<out(rate(is(calculated,(it(is(possible( to( establish( the( outlet( flow( rate.( The( growth( parameters( are( easily(calculated,( as( was( shown( in( Section( 5.2.1.1,( via( fitting( the( experimental( data( of(bacterial(growth(to(the(logistic(curve.((Bacterial( growth( was( measured( by( turbidity( assays( (600( nm)( at( 37( °C( with(orbital(agitation(for(30(hours.(The(optical(density(growth(curve(is(shown(in(Figure(6.7,( and( it( was( used( to( estimate( the( parameters( in( the( integrated( form( of( the(Vershulst(model,( according( to( Equation( 6.9,( using( Origin( 8( software( (OriginLab,(Northampton,(MA)((Lindqvist(2006).((
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OD(t) = C1+B e−a  t ( Equation!6.9!Where(OD(t)(is(the(optical(density(of(bacteria((a.u.),(t(is(time((h),(a(is(the(growth(rate(of(the(bacterial(population((h<1),(B( is(an(integration(constant((<),(and(C( is(the(carrying(capacity(or(maximum(population(size((a.u.).(((
!
Figure!6.7:!S.,aureus!15981!growth!curve!for!the!determination!of!growth!parameters!in!










' ( Equation!6.10!Where# D( is( the( wash<out( rate( (h<1),( a( is( the( growth( rate( of( the( bacterial(population((h<1),(Nss#is( the(desired(concentration(of(bacteria(at(steady(state((a.u.),(and(C(is(the(carrying(capacity(or(maximum(population(size((a.u.).(The(results(from(the(calculations(based(on(Equation(6.10(are(summarised(in(Table(6.1,(including(the(growth(parameters(obtained(from(the(fitting(to(the(logistic(curve.((
Table!6.1:!Growth!parameters!and!operating!conditions!for!the!chemostat.!
Parameter! Value!(units)!Growth(rate,(a( 0.30((h<1)(Carrying(capacity((OD),(C( 2.97((a.u.)(Desired(concentration((OD)(of(bacteria(in(the(late(stationary(phase,(Nss( 2.75((a.u.)(Volume(of(reactor,(V( 1500((ml)(Wash<out(rate,(D( 0.02((h<1)(Flow(rate,(F( 30((ml(h<1)(( To(conclude,(in(order(to(maintain(a(constant(density(of(S.#aureus(15981(growing(in( the( late( exponential( phase,( a( wash<out( rate( of( 0.02( h<1( is( required,( which(involves( an( outlet( flow( rate( of( 30(ml( h<1,( equivalent( to( 500(µl(min<1.( In( order( to(preserve(a(constant(volume(inside(the(chemostat,(an(inlet(feed(of(500(µl(min<1(was(provided,(containing(only(fresh(medium.((((((
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6.4.2. Residence!time!and!Flow!Parameters!for!the!Chemostat!!Once( the( chemostat( is( designed( and( the( flow( conditions( for( the( desired(operating(concentration(of(bacteria(are(determined((Section(6.4.1),(it(is(interesting(to( analyse( several( parameters( that( are( key( for( the( operating( conditions( of( the(bioreactor.( The( values( of( these( parameters( will( also( help( to( understand( the(suitability(of(the(system(for(the(study(of(bacterial(biofilms(in(wounds.((( The( residence! time( is( the( amount( of( time( a( fluid( element( spends( inside( the(reactor.(It(is(important(to(verify(that(the(residence(time(is(long(enough(to(allow(for(the(desired(concentration(to(be(achieved(inside(the(chemostat,(and(this(determines(the(operating(conditions(as(well,(together(with(the(flow(rates(calculated(in(Section(6.4.1.(The(residence(time(is(equal(to(the(reciprocal(of(the(wash<out(rate,(as(shown(in(Equation(6.11.((
RT = 1D ( Equation!6.11!Where(RT(is(the(residence(time((h),(and(D(is(the(wash<out(rate((h<1).((( Regarding(the(flow(parameters,(it(is(worth(calculating(the(fluid!velocity(in(the(inlet(and(outlet(tubing((which(are(identical)(in(order(to(provide(an(idea(of(the(flow(characteristics(of( the(stream(that( feeds( the(MRD.(The( tubes(have(a(circular(cross(sectional(area,(and(therefore(the(velocity(is(calculated(as(follows:(
v = Flow rateCross section of tube =
F
π d 2 4( )
( Equation!6.12!
Where(v( is(the(velocity(of(the(fluid((cm(h<1),(F( is(the(flow(rate((ml(h<1),(and(d( is(the(diameter(of(the(tubes((cm).((( Related( to( the( fluid(velocity,( the(Reynolds! number( can(be(used( to(determine(the( flow( patterns( in( the( tubing( that( feeds( the( chemostat.( The( Reynolds( number((Re)( is(a(dimensionless(quantity,(defined(as( the(ratio(of( inertial( forces( to(viscous(forces(for(given(flow(conditions.(Depending(on(the(value(of(the(Reynolds(number,(the( flow( can( be( either( laminar( or( turbulent.( The( former( corresponds( to( low(Reynolds(numbers((Re(<(2300),(where(viscous(forces(are(dominant,(and(the(flow(is(constant(and(smooth.(The(latter(refers(to(high(Reynolds(numbers((Re(>(4000),(and(
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in( turbulent( flow( vortices,( eddies( and( wakes( make( the( flow( unpredictable.( The(Reynolds(number(in(a(pipe(can(be(calculated(according(to(Equation(6.13:(
Re = ρTSB  v d
µTSB
( Equation!6.13!
Where(Re(is(the(Reynolds(number((<),(ρTSB,is(the(density(of(TSB((kg(m<3),(which(is(approximated(to(the(density(of(water,(v(is(the(velocity(of(the(fluid((m(s<1),(d(is(the(diameter(of(the(tubes((m),(and(µTSB(is(the(dynamic(viscosity(of(TSB((Pa(s),(which(is(also(approximated( to( that(of(water.(The(units( for( the(calculation(of( the(Reynolds(number(are(standardised(to(the(International(System(of(Units((SI).(( Table(6.2(summarises(the(values(for(residence(time,(fluid(velocity,(and(Reynolds(number,(and(the(values(of(parameters(that(were(needed(for(such(calculations.((
Table!6.2:!Residence!time!and!flow!parameters!for!the!chemostat.!
Parameter! Value!(units)!Wash<out(rate,(D! 0.02((h<1)!
Residence!time,(RT( 50#(h)(Diameter(of(inlet(and(outlet(tubes(=(Hydraulic(diameter,(d( 0.15((cm)(Flow(rate,(F( 30((ml(h<1)(
Velocity!of!inlet!and!outlet!fluid,(v( 1698((cm(h<1)(4.7(×(10<3((m(s<1)(Density(of(TSB(≈(Density(of(water((25(°C),(ρTSB( 997#(kg(m<3)(Dynamic(viscosity(of(TSB(≈(Viscosity(of(water((25(°C),(
µTSB( 8.90(×(10<4((Pa(s)(
Reynolds!number,(Re( (7.9((<)(( The( calculated( residence( time( is( 50( hours.( This(means( that( after( 50( hours( of(continuous(operation,(the(whole(volume(inside(the(chemostat(will(be(replaced(and(the(concentration(will(be(at(steady(state(levels.(This(is(important(in(the(selection(of(operating( conditions,( together(with( the( determination( of( the( time( that( takes( the(initial( inoculum(to(grow(to( the(desired( levels(of( concentration(of(bacteria,(which(will(be(explained(in(Section(6.4.3.(((Table(6.2(also(shows(that(the(values(of(velocity(and(Reynolds(numbers(are(very(small,(as(was(expected( from(the( low(flow(rates(and(small( tube(diameters.(This( is(significant(if(the(appropriateness(of(the(flow(characteristics(within(the(system(is(to(be(verified:(in(order(to(obtain(an(approximation(to(the(real(wound(situation(where(
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the( flow( of( exudate( in( the( wound( is( minimal,( but( existent,( very( slow( and(continuous(flows(are(required,(and(that(is(the(case(for(the(system(designed(in(this(work.(As(a(comparative(example(for(the(orders(of(magnitude(of(flows(in(the(human(body,(blood(flows(at(40(cm(s<1(through(the(aorta((Tortora(&(Derrickson(2012),(and(at(0.03(cm(s<1(through(the(capillaries((Marieb(&(Hoehn(2013),(both(some(orders(of(magnitude(higher( than( the( flow( feeding( the(MRD.(This( agrees(with( the( expected(flow(of(the(exudate(in(the(wound,(which(obviously(has(to(be(much(slower(than(that(of(blood(in(the(blood(vessels((Lanza(et(al.(2011).((
!
6.4.3. Operating!Conditions!of!the!Modified!Robbins!Device!The( necessary( parameters( for( the( chemostat( and( for( the( functioning( of( the(experimental(set<up(have(been(determined( in(Sections(6.4.1(and(6.4.2.(The(MRD<based(experiments(are(one<week(tests,(which(include(preparation(of(the(culture(in(the(chemostat,(biofilm(growth(in(the(MRD,(feeding(of(the(biofilm(in(the(MRD,(and(eventually( infection( of( the( biofilm( using( a( bacteriophage( ‘’cocktail’’/PIT( nano<emulsion( formulation.( The( selected( S.# aureus( strain( for( these( experiments( is( S.#
aureus(15981(given(its(demonstrated(potential(as(a(strong(biofilm<former((Alves(et(al.( 2014).( The( experimental( procedure( is( explained( in( this( section( for( each( day,(identifying(each(day(with(the(‘’age’’(of(biofilms,(and(time(after(treatment.(< Day(1( (0(hours( of( biofilm( formation,( 0(hours( of( treatment):(The( chemostat(was( properly( autoclaved( and( filled(with( 1.5( litres( of( TSB.( The( temperature(probe(and(the(connections(to(the(water(bath(were(fitted(in(order(to(keep(the(temperature( at( 37( °C.( Stirring(was( started,( and( the( system(was( allowed( to(equilibrate( to( the( desired( temperature.( Once( the( steady( state( temperature(was(reached((37.0(±(0.2(°C),(5(ml(of(overnight(culture(of(S.#aureus(15981(with(a(bacterial(density(of(108(CFU(ml<1(were(added.(((Considering( this( initial( inoculum( and( using( the( mass( balance( for( the(chemostat,( the( calculation( of( the( required( time( to( achieve( the( desired(concentration( of( bacteria( is( shown( here.( An( optical( density( of( 2.75(corresponds( to( approximately( 108( CFU(ml<1,( while( the( carrying( capacity( is(nearly(109(CFU(ml<1.(Again,(it(is(assumed(that(the(value(of(the(bacterial(death(rate(is(very(small(in(comparison(with(the(growth(rate,(and(hence(neglected(in(the(calculations.(Firstly,( it( is(necessary(to(consider(the(concentration(inside(
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the(chemostat,(after(introducing(5(ml(of(overnight(culture(of(S.#aureus(15981(with( a( bacterial( density( of( 108( CFU(ml<1.( The( total( volume(of( the( reactor( is(1500(ml,( therefore(the( initial(concentration(of(bacteria( in(the(chemostat,(N0((CFU(ml<1),(is:(
N0 =
108  CFU ml−1 ×  5 ml
1500 ml = 3.3×10
5  CFU ml−1 ( Equation!6.14!(Equation( 6.8( can( be( integrated( between( time( equal( zero( to( time( t,( with(corresponding(concentrations(of(bacteria(N0(and(N(t).(This(integrated(form(is(shown(in(Equation(6.15.((





































(Where(t(is(the(time((h),(a(is(the(bacterial(growth(rate((h<1),(D(is(the(wash<out(rate( (h<1),(C( is( the( carrying( capacity( (CFU(ml<1),(N(t)( is( the( concentration(of(bacteria(at(time(t((CFU(ml<1),(and(N0(is(the(concentration(of(bacteria(at(time(0((CFU(ml<1).((Substituting(the(values(from(Table(6.1(in(Equation(6.15,(and(considering(that(the(desired(concentration(N(t)(is(108(CFU(ml<1,(the(initial(concentration#N0(is(shown(in(Equation(6.14,(and(the(carrying(capacity( is(109(CFU(ml<1,( the( time(required( to( achieve( N(t)( is( 21( hours.( This( means( that,( after( 21( hours( of(operation,( the( desired( concentration( will( be( achieved( with( the( operating(conditions(specified(in(Sections(6.4.1(and(6.4.2.(((After( the( initial( inoculation,( the( chemostat(was(operated(as( a(batch( culture(for(4(hours(with(continuous(stirring(in(order(to(accommodate(the(inoculum(and( re<initiate( its( growth.( After( these( first( four( hours,( the( chemostat( was(connected(to(the(fresh(medium(bottle((containing(autoclaved(TSB(and(kept(at(37( °C).( 500(µl(min<1( of( fresh(TSB(were(pumped( into( the( chemostat( using( a(peristaltic( pump,( and( 500(µl( min<1( were( pumped( from( the( chemostat( to( a(waste(bottle,(constituting(the(outlet(stream.((
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< Day(2( (0(hours( of( biofilm( formation,( 0(hours( of( treatment):(The( chemostat(was( run( for( 24( more( hours( with( continuous( inlet( and( outlet( streams( as(before.(After(48(hours,( it(was( considered( that( the(desired( steady( state(was(reached,( since( it( was( further( ahead( of( the( 21( hours( calculated( above.(However,(the(optical(density(inside(the(chemostat(was(verified(as(well.(( < Day(3( (0(hours( of( biofilm( formation,( 0(hours( of( treatment):(The( chemostat(was( connected( to( both( Robbins( Devices( (control( and( test( devices),( using( a(flow(rate(of(250(µl(min<1(for(each(of(them.(The(peristaltic(pump(provided(500(
µl(min<1(of(fresh(medium(continuously(to(the(chemostat(in(order(to(maintain(a(constant(volume.(During(this(time,(the(biofilm(is(formed(on(the(coupons(of(the(MRD((see(Figure(3.17).(( < Day(4((24(hours(of(biofilm(formation,(0(hours(of(treatment):(The(chemostat(was(disconnected((no(more(bacterial(culture(is(supplied(to(the(MRD),(and(the(biofilms( in( the( MRD( were( fed( using( autoclaved( fresh( medium( with( a(composition(of(50(%((v/v)(TSB(and(50(%((v/v)(PIT(nano<emulsion(in(order(to(prepare( appropriate( controls( of( biofilms( growing( in( the( presence( of(emulsions.(The(biofilms(were(allowed(to(develop(for(24(more(hours.(( < Day( 5( (48( hours( of( biofilm( formation,( 0( hours( of( treatment):( The( feed( of(nutrients( of( the( MRD( was( stopped,( so( the( treatment( of( the( biofilm( using(bacteriophage(formulations(could(take(place.(10(ml(of(treatment(preparation((either( bacteriophage( ‘’cocktail’’( or( bacteriophage( ‘’cocktail’’/PIT( nano<emulsion)( were( pumped( into( each( device:( 10( ml( of( plain( buffer( for( the(control(device,(and(10(ml(of(bacteriophage(‘’cocktail’’/PIT(nano<emulsion(for(the( test( device.( The( flow( is( passed( for( 30(minutes,( clamping( the( inlet( and(outlet( of( both( Robbins( Devices( in( order( to( allow( enough( time( for(bacteriophages(to(adsorb.(Samples(were(taken(from(the(disks(or(coupons(in(order(to(perform(colony(counting(and(confocal(microscopy,(corresponding(to(time( 0( of( treatment.( After( this,( fresh( medium( was( supplied( again( to( both(devices.((
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< Day(6( (72(hours(of(biofilm( formation,(24(hours(after( treatment)( and(Day(7((96( hours( of( biofilm( formation,( 48( hours( after( treatment):( Samples( were(taken(by(clamping(the(inlet(and(outlet(of(the(MRDs(and(stopping(the(feed(and(waste( flows,( and( removing( the( coupons( for( quantification( of( viable( counts(and(confocal(microscopy.((( The( protocol( for( quantification( of( biofilm( biomass( was( described( in( detail( in(Section(3.9.2,(regarding(the(detachment(of(biofilm<forming(cells(from(the(coupons.(Viable( counts(were(determined( according( to( Sections(3.5.1.2( and(3.5.3.(As( far( as(confocal( microscopy( is( concerned,( the( protocol( for( cell( staining( of( the( biofilms(formed( on( the( surface( of( the( disks( was( performed( using( the( commercial( kit(LIVE/DEAD®(BacLightBacterial( Viability( Kit( for(microscopy( (InvitrogenTM,( UK),(and(images(were(obtained(using(a(confocal(microscope((Zeiss(LSM510META).(The(results( for( the( biofilm( growth( and( eradication( are( presented( in( the( following(sections.(
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Figure! 6.8:! Confocal! images! of! S., aureus!
15981!biofilm!formation.(!The(images(presented(are(control(experiments(for( the( biofilm( eradication,( treated( with( PBS(only.( Without( bacteriophages,( the( biofilm( is(allowed( to( grow( normally.( (A)( 0( hours( after(treatment;((B)(24(hours(after(treatment;((C)(48(hours(after(treatment.((Figure(6.8(shows(the(formation(of(S.#aureus(biofilms(in(the(flow(system((MRD).(Figure(6.8(A(shows(that(initially(the(biofilm(is(not(very(dense,(as(evidenced(by(the(uncovered(areas(in(grey(within(the(green(areas.(These(green(areas(correspond(to(living( biofilm<forming( cells.( After( 24( hours,( in( Figure( 6.8( B,( the( biofilm( is(much(more( dense( and( thicker,( with( several( layers( of( cells( covering( the( surface( of( the(coupon.(It(can(also(be(observed(that(in(the(outer(layers(there(are(several(red(areas,(which( correspond( to(dead( cells.( This( is( in( agreement(with( the(biofilm( formation(scheme(proposed( by(Harper( et( al.:( the( different( layers( of( the( biofilm( experience(growth,(since(they(are(continuously(fed(with(fresh(medium,(allowing(the(biofilm(to(grow( vertically,( and(moving( the( ‘’older’’( cells( towards( the( surface( of( the( biofilm(until(they(die(or(detach(from(the(polysaccharide(matrix.(Finally,(Figure(6.8(C(shows(that( after( 48(hours,( the( outer( layers( of( ‘’old’’( cells( are( indeed(detached( from( the(main( body( of( the( biofilm,( and( fresh( younger( cells( almost( completely( cover( the(surface(of(the(disk,(and(are(ready(to(start(the(cycle(again.(The(next(and(final(step(is(the(eradication(of(said(biofilms(using(a(bacteriophage/nano<emulsion(formulation.((









Figure! 6.9:! Confocal! images! of! S., aureus!
15981! biofilm! eradication! using! a!
bacteriophage! ‘’cocktail’’/PIT! nano;
emulsion!formulation.!!(A)(0(hours(after(treatment;((B)(24(hours(after(treatment;((C)(48(hours(after(treatment.((














6.5. Conclusions!The( principal( objective( of( this( chapter( was( the( assessment( of( the( efficacy( of(bacteriophage/nano<emulsion( formulations( for( the( eradication( of( bacterial(biofilms( both( for( S.# aureus( and( P.# aeruginosa,( in( order( to( obtain( a( working(formulation( in( a( realistic( wound( environment.( Different( methods( were( used( in(order(to(achieve(such(objective,(starting(with(a(simplistic(biofilm(model,(the(static(model,( followed(by(a(more( complicated( flow(system,(mimicking( the(burn(wound(environment.(The(main(findings(of(this(chapter(are(listed(as(follows:(1. The( static(model( constitutes( a( valuable( approach( to( assess( the( influence(of(nano<emulsions( on( the( growth( of( bacterial( biofilms.( It( was( found( that( S.#
aureus( biofilms( are( inhibited( by( the( presence( of( nano<emulsions,( in(agreement( with( previous( discoveries( in( the( literature.( However,( P.#
aeruginosa(biofilms(did(not(show(a(significant(reduction(on(their(biomass(due(to( nano<emulsion( droplets,( possibly( because( their( defence( mechanisms(against( external( factors( are( enhanced( as( a( result( of( forming( part( of( the(biofilm(community.(((2. The(static(model(also(allowed(the(quantification(of(the(effect(of(bacteriophage(‘’cocktail’’/PIT( nano<emulsion( formulations,( yielding( different( outcomes( for(the( Gram<positive( and( Gram<negative( bacteria( considered( in( this( thesis.( S.#
aureus( biofilms( were( partially( eradicated( using( the( nano<emulsion(formulations,( but( they( were( not( as( effective( as( antimicrobial( agents( as(bacteriophages( in( suspension.( It( was( hypothesised( that( bacteriophages( do(not( diffuse( as( efficiently( due( to( steric( impediments( because( of( the( external(polysaccharide(matrix,(in(addition(to(the(nano<emulsion(droplets.(It(was(also(proposed( to( increase( the( initial( concentration( of( bacteriophages( in( the(formulation(to(obtain(better(results.(P.#aeruginosa(biofilms,(on(the(other(hand(are( almost( totally( defeated( using( bacteriophage( ‘’cocktail’’/PIT( nano<emulsion( formulations,( suggesting( a( synergistic( effect( between( the(components(of(the(formulation.(( 3. Finally,(the(study(of(biofilms(is(further(approximated(to(the(real(situation(in(a(wound(via(use(of(a(flow(system,(the(modified(Robbins(Device(coupled(with(a(
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7.1. Introduction!Mathematical( models( are( desirable( tools( if( bacteriophage( therapy( is( to( be(applied( in#vivo.( First( of( all,( they(help(understanding(bacteriophage( infectivity(via(simplifications( and( approximation( to(well( known(processes( (i.e.( simple( chemical(reactions(and(their(kinetics).(This( is(an(acceptable(approach,(since(both(bacterial(growth( and( bacteriophage( infectivity( are( density( dependent( processes,( and(because( of( the( complex( nature( of( the( antimicrobial( action( of( bacteriophages.(Moreover,( the( literature( suggests( that( even( simple(models( fit( experimental( data(reasonably( well( (Cairns( et( al.( 2009),( using( few( computational( resources( and(economising( experimental( time.( ( Modelling( strategies( can( also( help( avoiding( or(reducing( the( use( of( in# vitro( experiments,( which( are( normally( tedious( and( time(consuming,( and( animal( testing.( Mathematical( models( provide( quick( results,( are(versatile(and(can(be(adapted(to(as(many(experimental(situations(as(desired(once(the(algorithms(are(perfectly(defined.(When(combined(with(experimental(studies(of(
in# vitro( systems,( theoretical( modelling( aids( in( overcoming( the( difficulties( of( the(transition(of(in#vitro(to(in#vivo(phage(therapy.(((The( advantages( of( modelling( approaches( for( bacteriophage( therapy( are(therefore( quite( clear,( and( this( chapter( focuses( on( the( development( of( a(methodology( to( determine( growth( and( infectivity( parameters( simply( using(turbidity( (optical( density)( data.( This( will( be( used( in( order( to( establish( an(appropriate(model( that( can(be( applied( as( a(predictive( tool( for( complex( infection(scenarios.(((First,(a(description(of(the(customised(set(of(programming(files(in(the(numerical(computing( environment(MATLAB®( ( (The(MathWorks( Inc.,(Natick,(Massachusetts,(2014)( is( detailed( in( Section( 7.2.( It( includes( some( theoretical( considerations(regarding( differential( equation( solving( using( numerical(methods,( and( also( some(information( and( description( of( the( benefits( of( parameter( estimation.( Parameter(estimation( has( not( been( used( traditionally( in( bacteriophage( infectivity( setRups(
! Chapter(7((
( 262(
(Weld(et(al.(2004;(Bull(et(al.(2002),(as(opposed(to(experimental(determination(of(parameters,( which( in( our( own( experience( yields( significant( errors,( since( the(techniques(used(are(subject(to(great(variability((Chan(&(Abedon(2012).((These( concepts( are( then( applied( in( Section( 7.3( to( the( estimation( of( bacterial(growth( parameters( for( the( three( strains( of( S.# aureus( used( in( this( thesis.( Quality(determination( of( bacterial( growth( rate( and( carrying( capacity( depends( on( the(suitability( of( the( growth( model,( but( also( on( the( experimental( data( set( itself;(therefore,( the( different( growth(models( explained( in( the( Literature! Review! are(tested.( The( modified( logistic( model( obtained( in! Chapter! 5! is( also( used( for(parameter(estimation(in(Section(7.3,(and(compared(to(the(existing(models.(((Once( the( growth( parameters( are( calculated,( they( can( be( applied( in( the(bacteriophage( infectivity(models,(either(as( initial(guesses(or(as( fixed(parameters.(This( is( studied( in( Section( 7.4,( after( comprehensively( define( the( chosen( infection(model,( based( on( a( combination( of( suitable( mathematical( models( found( in( the(literature.(The(system(that(is(modelled(includes(only(one(bacteriophage(attacking(one(strain(of(bacteria,(S.#aureus(or(P.#aeruginosa,(but(only(one(strain,(mimicking(the(viable( experimental(measurement( from( a( practical( point( of( view.(Measuring( the(concentration(of(different(strains(together(is(impossible(using(turbidity(techniques(or(viable(counts(alone.(The(outcome(of(this(section(is(a(set(of(infection(parameters:(adsorption( rate,( lysis( rate,( and(burst( size,( to(be(used( for( two(different(purposes.(Firstly,(the(set(of(parameters(in(the(absence(of(nanoRemulsions(can(be(compared(to(the( corresponding( parameters( when( emulsion( droplets( are( present,( in( order( to(determine( if( these( have( a( significant( influence( on( any( particular( step( of( the(infection(process.(Secondly,(these(parameters(can(be(used(as(predictive(tools.(((Finally,(Section(7.5(focuses(on(the(use(of(such(set(of(estimated(parameters(as(a(predictive( tool( for( multiRbacterial( infections( treated( with( bacteriophage(‘’cocktails’’.( This( constitutes( one( step( further( in( the( approximation( to( real(situations( in( wound( infections,( where( there( are( normally( multiple( strains( from(different(bacteria.((((
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7.2. Methodology!Dynamic( processes( such( as( the( growth( of( a( population,( or( bacteriophage(proliferation( due( to( bacterial( lysis,( can( be( described( by( differential( equations( or(systems( of( differential( equations.( Solving( such( differential( equations( gives( a(simulation( of( the( process,( but( it( is( key( to( identify( the( model( output( with(experimental(data((Bock(et(al.(2013).(In(order(to(fit(experimental(data(to(simulated(data,(mathematical(models( incorporate( unknown( parameters( that( are( estimated(via( minimisation( of( the( norm( of( the( residuals( between( experimental( data( and(model(response.(These(parameters(are(also(subject(to(random(errors((similarly(to(the(experimental(data(they(are(derived(from),(and(need(to(be(statistically(analysed(if( the( model( is( to( be( used( to( predict( the( outcome( of( experiments( in( different(conditions(or(environments.(According( to( this,( the(uncertainty(of( the(parameters(depends( dramatically( on( the( ‘’quality’’( of( the( experimental( data.( Parameter(estimation(is(an(empirical(problem(and(it(is(possible(that(some(different(model(can(be( fitted( to( the( same( response.( This( raises( the( issue( of( the( uniqueness( of( the(identified(model(and(casts( some(doubts(on( the(adequacy(of( the(estimated(model(parameters.(((The( common( technique( for( parameter( estimation( consists( of( a( least( squares(approach((Raol(et(al.(2004).(The( least(squares(method(was(first( invented(by(Karl(Gauss(in(1809,(and(independently(by(Legendre(in(1806.(It(is(a(well(established(and(easy( to( understand( method( that( is( applied( to( many( problems( for( the(identification/estimation( of( optimal( estimates( of( unknown( parameters( that( best(describe(the(behaviour(of(a(system(dynamics.(The(least(squares(method(is(a(special(case(of(the(‘’likelihood(estimation(method’’(for(linear(systems(with(Gaussian(noise.(In(general,(least(squares(methods(are(applicable(to(both(linear(as(well(as(nonlinear(problems(and(they(assume(that(the(system(parameters(do(not(rapidly(change(with(time.((( Since(the(system(dynamics(are(to(be(modelled,(appropriate(numerical(methods(are(required( to( solve( the(model’s(differential(equations( (Chapra(2011),( that( is( to(say,( to( evaluate( definite( integrals.( Such( numerical(methods( can( have( a( constant(step( size,( which( are( limited( to( systems( where( the( solution( does( not( change(
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abruptly;(or( they(can(have(adaptive(stepRsize(control,( adjusting( their( step(size( to(the( solution’s( trajectory.( In( applications( such( as( chemical( reaction( kinetics,(epidemiology,( or( population( dynamics,( the( differential( equations( systems( are(usually( highly( nonlinear( and( stiff( (Bock( et( al.( 2013),( and( therefore( adaptive(multistep(methods(are(more(suitable(as(opposed(to(singleRstep(methods.(((The(evaluation(of(parameter(estimation(can(be(implemented(in(MATLAB®(((The(MathWorks( Inc.,( Natick,( Massachusetts,( 2014),( which( is( nowadays( a( standard(programming(environment(for(the(analysis(and(evaluation(of(dynamic(systems.((The( MATLAB®( algorithms( were( customised( for( the( two( scenarios( that( were(modelled:( bacterial( growth,( and( bacteriophage( infectivity.( The( basis( of( the(program( is( identical,( and( it( consists( of( five( ‘subprograms’.( For( bacterial( growth,(these(files(are:(
• growth_fit.m#(Fitting):(This(is(the(main(file(to(be(run,(and(it(‘calls’(the(rest(of(the(mRfiles((growth_fn,(growth_ode,(growth_plt,(and(growth_sim).((











is(generated(via(solving(of(the(growth(differential(equation(for(a(given(set(of(parameters)(and(the(experimental(data.(This(difference(can(be(identified(to(a(‘residual’( function,( and( it( needs( to( be( minimum( for( a( quality( fit( of( the(simulation(to(the(experimental(data.((
• growth_ode.m( (Ordinary( Differential( Equation,( ODE):( ( It( defines( the(differential(equation,(in(this(case,(the(one(corresponding(to(the(logistic(curve(for(growth(of(populations((see(Equation(7.2).((
• growth_plt.m( (Plot):( It( uses( the( MATLAB®( command( plot( to( provide( a(representation( of( the( result( of( the( simulation( after( solving( the( differential(equation(for!the!optimal!set!of!parameters,(together(with(the(experimental(data.((
• growth_sim.m((Simulation):(It(solves(the(differential(equation(for(a(given(set(of(parameters,( using( the(MATLAB®(command(ode45,#ode15s( or#ode23s.( The(solver(ode45(is(appropriate(for(nonRstiff(problems,(and(it(provides(a(medium(degree(of(accuracy.(From(the(numerical(methods(point(of(view,(it(is(based(on(an(explicit(RungeRKutta((order(4,5)(formula.(Its(step(size(is(automatically(set,(and(it(is(a(oneRstep(solver:(in(computing(the(solution(for(a(certain(time(point,(it( only( needs( the( solution( at( the( immediately( preceding( time( point.( The(solvers# ode15s( or# ode23s( are( used( when( for( stiff( problems.( An( ordinary(differential( equation( problem( is( stiff( if( the( intended( solution( varies( slowly,(but( there( are( nearby( solutions( that( vary( rapidly,( so( the( numerical(method(must( take( small( steps( to( obtain( satisfactory( results.( ode15s( or# ode23s# are(used( if( ode45( is( slow( because( the( problem( is( stiff,( but( it( compromises( the(degree(of(accuracy(to(some(extent.(((For( bacteriophage( infectivity,( the( MATLAB®( algorithms( are( similar( to( the(previously(defined(for(bacterial(growth:(
• phage_fit.m:( Similarly( to(growth_fit.m,( this( is( the(main( file( to(be(run,(and( it(refers( to( the(rest(of( the(related(mRfiles((phage_fn,(phage_ode,(phage_plt,(and(
phage_sim).( It( contains( the(optimisation(algorithm((again# lsqnonlin( is(used),(the( experimental( data,( the( initial( conditions( needed( to( solve( the( system( of(
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differential( equations,( the( initial( guesses( for( the( parameters( (which( can( be(fixed( or( left( to( be( estimated),( and( the( timespan( for( the( simulation( and(minimisation.(((
• phage_fn.m:(It(defines(the(function(to(be(minimised:(the(difference(between(the(simulated(data(obtained(from(solving(the(system(of(differential(equations(for(a(given(set(of(parameters((which(varies(in(the(minimisation(process),(and(the(experimental(data.(It(is(important(to(note(that(the(solution(of(the(system(of(ODEs(gives(information(about(the(individual(concentrations((of(susceptible(bacteria,( infected( bacteria,( and( bacteriophages),( whereas( the( experimental(data(refers(to(the(variation(of(the(total!concentration(of(bacteria((susceptible(plus(infected)(with(time(in(the(form(of(optical(density(data.(This(needs(to(be(adjusted(and(implemented(in(the(code.((
• phage_ode.m:(It(defines(the(system(of(differential(equations.((Three(different(species,( and( therefore( equations,( are( considered:( susceptible( bacteria,(infected( bacteria( and( bacteriophage.( These( ODEs( are( specified( in( Section(7.4.1.(((
• phage_plt.m:( It( plots( the( simulation( results( for( the( total( concentration( of(bacteria(using(the(optimal(parameters,(and(the(experimental(data.((
• phage_sim.m:( It(solves( the(system(of(differential(equations(using(ode15s(or#
ode23s,(analogously(to(growth_sim.m.(It(initially(solves(the(system(for(values(of( the(parameters(equal( to( the( initial( guesses.(After( that,( the( function( to(be(optimised(is(calculated,(and(a(new(set(of(parameters((that(makes(the(value(of(said(function(smaller)( is(used(to(reRstart(the(simulation(until(an(optimum(is(found.((( The( inputs( for( these( programs( are:( experimental( data( to( be( compared( to( the(simulated(data;(initial(conditions((required(for(solving(the(differential(equations);(initial(guesses(for(parameters((based(on(experimental(observation(or(found(in(the(literature);( the( timespan( for( the( simulation,( which( corresponds( to( the( same(timespan(in(the(experimental(data(if(these(two(are(to(be(compared;(the(options(for(
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the(optimisation(algorithm,(and(the(options(for(the(solver(command.(The(last(two(are(normally(specified(with(the(default(MATLAB®(values.((Parameter( estimation( problems( are( nothing( but( optimisation( problems.( If( the(optimisation( problem( is( nonlinear( (such( as( our( case,( where( the( differential(equations(are(very(nonlinear,(and(therefore(the(function(that(has(to(be(optimised(is(nonlinear(too),(the(objective(function(to(be(minimised(can(have(a(certain(number(of( local( minima( and( maxima,( which( are( easy( to( find( using( conventional(optimisation(methods.(Finding(the(global(minimum(is(much(more(complicated,(and(analytical( methods( or( numerical( solution( strategies( do( not( normally( yield(acceptable(results.(Global(methods(have(emerged(as(the(alternative(to(search(the(global(optimum((Peifer(&(Timmer(2007;(Pinter(1997;(Pardalos(et(al.(2000).(One(of(the(simplest(global(methods(is(a(Multistart(method((BalsaRCanto(&(Banga(2011).(It(consists( in( testing( a( large( amount( of( initial( guesses( in( a( parameter( estimation(algorithm(based(on(a(local(optimisation(approach((such(as(lsqnonlin).(The(smallest(minimum(is(then(regarded(as(the(global(optimum.(The(drawbacks(of(this(method(are( that( there( is( no( guarantee( of( arriving( to( the( global( solution,( and( that( the(computational(effort(can(be(quite(large.(These(difficulties(are(arising(because(it(is(aRpriori(not(clear(how(many(random(initial(guesses(are(necessary.(However,(it(is(a(good(approximation(using(relatively(simplistic(mathematical(tools.(((
7.3. Test!of!the!Custom!MATLAB®!Program:!Parameter!
Estimation!of!Bacterial!Growth!!Estimation( of( growth( parameters( was( initially( conducted( for( the( simplest(growth( model:( the( logistic( model,( whose( differential( formulation( is( shown( in(Equation(7.2:(
dN(t)









Multistart(was(selected(in(order(to(test(several(initial(guesses(using(the(custom(parameter( estimation( algorithms( (see( Section( 7.2),( since( the( choice( of( an( initial(guess(for(the(unknown(parameters(may(be(significant(regarding(the(quality(of(the(
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fit.(Multistart( tries(a(certain(number((specified(by(the(user)(of( initial(guesses( in(a(defined(range,(and(provides(a(histogram(that(represents(the(number(of(times(that(a(certain(final(value(for(the(parameter(was(‘’hit’’((or(selected(as(the(optimum(that(makes(the(objective(function(minimum,(locally(or(globally),(regardless(of(the(initial(guess.(The(number(of(different(initial(guesses(that(was(selected(for(this(particular(study(was(100.(In(this(manner,(the(number(of(‘’hits’’(that(an(initial(guess(produces(on(one(final(value(of(the(parameter(can(be(regarded(as(the(percentage(of(hits.(((
Multistart(was(also(used( in(order(to(test( the(suitability(of( the(different(growth(models(shown(in(Table(2.7((data(not(shown).(The(conclusion(that(can(be(extracted(from(the(fitting(of(eight(sets(of(triplicates(of(experimental(data(for(the(growth(of(S.#




• Initial(conditions:(There(is(only(one(differential(equation,(and(therefore(one(initial( condition,( which( is( the( initial( concentration( of( bacteria,( or(concentration(of(bacteria(at(time(zero,(N0((CFU(mlR1).(N0( is(the(experimental(value(at(time(zero.(((
• Initial(guesses(for(the(parameters:(Selected(according(to(experimental(data(in(previous(chapters,(and(correspond(to(the(interval(0R1(hR1(for(growth(rate,(and(108R1010(CFU(mlR1(for(carrying(capacity.((
• Timespan(for(the(simulation:(Equal(to(the(experimental(time,(15.5(hours.(





Figure! 7.1:! Bar! plots! obtained! using! the!
program! Multistart# for! the! parameter!
estimation!of!growth!parameters.!!
!(A)( Distribution( of( normal( residuals;( (B)(Distribution(of(a(values((hR1);((C)(Distribution(of(the(logarithm(of(C(values((CFU(mlR1).(The(results(are( referred( to( the( growth( curve( of( S.# aureus(H560.(
!
























S.#aureus(H560/1( 0.4266( 6.21(×(108( 0.443(±(0.002( (6.11(±(0.05)(×(108(S.#aureus(H560/2( 0.4579( 6.16(×(108(
S.#aureus(H560/3( 0.4495( 5.96(×(108(
S.#aureus(H325/1( 0.3638( 9.39(×(108( 0.218(±(0.002( (4.77(±(0.41)(×(109(S.#aureus(H325/2# 0.1143( 8.35(×(109(
S.#aureus(H325/3# 0.2894( 5.03(×(109(

























P.#aeruginosa(PAO1/1( 0.3305( 1.61(×(108( 0.328(±(0.001( (1.73(±(0.06)(×(108(P.#aeruginosa(PAO1/2( 0.3281( 1.78(×(108(
P.#aeruginosa(PAO1/3( 0.3258( 1.80(×(108(
P.#aeruginosa(PAB45291/1( 0.3448( 2.62(×(108( 0.364(±(0.012( (2.35(±(0.09)(×(108(P.#aeruginosa(PAB45291/2# 0.3689( 2.27(×(108(
P.#aeruginosa(PAB45291/3# 0.3813( 2.17(×(108(
P.#aeruginosa(BC00907/1# 0.6236( 9.65(×(107( 0.637(±(0.028( (9.79(±(0.16)(×(107(P.#aeruginosa(BC00907/2# 0.6589( 1.08(×(108(








!(A)( S.# aureus( H560;( (B)( S.# aureus( H325;( (C)( S.#
aureus# Btn766.( The( experimental( data( is( the(average( of( triplicates( and( error( bars( are( not(shown(for(clarity.((
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!(A)( P.# aeruginosa( PAO1;( (B)( P.# aeruginosa(PAB45291;( (C)( P.# aeruginosa( BC00907.( The(experimental( data( is( the( average( of( triplicates(and(error(bars(are(not(shown(for(clarity.((
!
(As(can(be(seen( in(Figure(7.3,( the(Verhulst(model(does(not( fit( the(experimental(data( for( P.# aeruginosa( as( suitably( as( for( S.# aureus.( There( is( a( general( overRprediction(of( the(concentration(of(bacteria(at( the(beginning(of( the(growth(period(for(the(three(strains,(and(therefore(the(growth(rate(is(not(accurately(predicted.(The(model( is(not(able( to( fit( the(slight(decay(by( the(end(of( the(growth(period,(but( the(carrying( capacity( is( reasonably( well( predicted,( especially( for( P.# aeruginosa(BC00907(in(Figure(7.3(C.(The(next(step(to(overcome(the(limitations(of(the(Verhulst(model(is(the(use(of(the(modified(model(that(was(obtained(in(Chapter!5,(shown(in(Equation(7.3:(
dN(t)
dt = amax + n D( )  N(t) 1−
N(t)











Where(amax(is(the(growth(rate(in(TSB((hR1),(n(is(the(parameter(obtained(from(the(linear(or(exponential(fit((R),(D(is(the(dilution(factor(of(emulsion((R),(C(is(the(carrying(capacity((CFU(mlR1),(γ((CFU(mlR1(hR1)(is(a(parameter,(and(N(t)(is(the(concentration(of(bacterial(cells(at(time(t((CFU(mlR1).(((As( an(example(of( the(parameter( estimation(using( the(modified( logistic(model,(the(growth(of(P.#aeruginosa(in(PIT(nanoRemulsions(was(considered.(Since(the(nanoRemulsions(were(not(diluted(at(all,(D(is(equal(to(unity(for(all(the(experimental(data,(and(hence(Equation(7.3(can(be(expressed(as:(
dN(t)
dt = amax + n( )  N(t) 1−
N(t)






' ( Equation!7.4!(The(values(of(growth(rate(and(carrying(capacity(shown(in(Table(7.2(were(used(as( initial( guesses,( and( average( values( of( independent( triplicates( were( used( as(experimental(data.(An(example(of( the( fit( is( shown( in(Figure(7.4( for(P.#aeruginosa(PAO1,(and(a(summary(of(the(estimated(parameters(is(presented(in(Table(7.3.((
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0.33( 0.39( 1.73(×(108( 1.73(×(108( R0.52( R0.22( R3.0(×(105( R1.5(×(105(( The( growth( rate( in( YPD,( amax,( and( the( carrying( capacity,( C,( are( not( fixed(parameters,( but( subject( to( the( optimisation( process.( This( is( because( the( fit( in(Figure(7.3(can(not(be(considered(good(enough.(In(fact,(the(estimated(growth(rate(in(YPD(is(higher(than(the(initial(guess,(as(can(be(seen(in(Table(7.3.(This(is(also(shown(in( Figure( 7.3,( where( the( experimental( data( has( a( steeper( ‘’slope’’( than( the(simulation,(indicating(underRprediction(of(the(growth(rate(by(the(logistic(model.(((Once(the(parameter(estimation(algorithm(has(been(tested(for(a(relatively(simple(system(formed(by(one(differential(equation((such(as(the(growth(of(bacteria(both(in(standard(medium(and(nanoRemulsions),( it( can(be( applied( to( a(more( complicated(system:( the( infection( and( lysis( of( bacteria( by( bacteriophages.( This( is( shown( in(Section(7.4.((
7.4. Bacteriophage!Infectivity!Models!
7.4.1. Introduction!Taking( into( account( the( most( used( infectivity( models( explained( in( the(
Literature! Review,! the( model( chosen( for( the( infectivity( simulations( and(parameter(estimation( is(defined(by(a(combination(of(different(models( (Beretta(&(Kuang( 1998;( Carletti( et( al.( 2004;( Payne( et( al.( 2000).( The( assumptions( and(simplifications(in(the(formulation(of(the(model(are(as(follows:(
• The( logistic( (Verhulst)( growth( model( was( used,( as( it( provides( reasonably(good( fits,( it( is( simple( and( it( only( has( two( parameters( that( can( be( easily(determined( as( explained( in( Section( 7.3.( Once( the( growth( parameters( are(
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known,( different( simulation( options( are( possible( for( the( estimation( of(infectivity(parameters:(fixing(the(growth(parameters(and(estimating(the(rest;(or(using(the(calculated(growth(parameters(as( initial(guesses(and(estimating(all(of(them((growth(and(infectivity(parameters).((
• It(is(considered(that(only(susceptible(bacteria((not(infected(yet)(actually(grow(according(to(the(logistic(law.(However,(infected(bacteria(are(still(involved(in(the(competition(for(resources(and(contribute(towards(the(carrying(capacity,(as(explained(by(Beretta(and(Kuang((Beretta(&(Kuang(1998).((
• The(total(number(of(bacteria,(N(t)(is(the(sum(of(the(susceptible(bacteria((S(t))(plus( the( infected( bacteria( (I(t)).( This( is( the( quantity( that( can( be(experimentally(measured,(since(discerning(between(susceptible(and(infected(bacteria(is(not(feasible(using(turbidity(measurements(or(viable(counts.((
• Adsorption( efficiency( (Storms( et( al.( 2012)( is( not( considered,( since( it( was(demonstrated(that(for(our(particular(experimental(sets(of(data(approximately(100(%(of(the(total(number(of(bacteriophages(is(adsorbed((see(Section(5.3.1).(Adsorption(of(bacteriophages(is(therefore(modelled(as(a(second(order(kinetic(process,(according(to(the(massRaction(law.((
• Lysis( of( infected( bacteria( is( as( a( first( order( kinetic( reaction,( which( only(depends( on( the( concentration( of( infected( bacteria.( The( number( of( free(bacteriophages((progeny)(that(are(produced(is(proportional(to(the(lysis(rate,(and(the(constant(of(proportionality(is(the(burst(size,(L.(((












'− b S(t) P(t) (
dI(t)
dt = b S(t) P(t)− k I(t) (
dP(t)
dt = k L I(t)− b S(t) P(t) (
N(t) = S(t)+ I(t) (
Equation!7.5!
(Where(a(is(the(growth(rate((hR1),(S(t)#is(the(concentration(of(susceptible(bacteria((CFU(mlR1),(N(t)(is(the(total(concentration(of(bacteria((CFU(mlR1),(C(is(the(population(carrying( capacity( (CFU(mlR1),( b( is( the( adsorption( rate( (ml( CFUR1( hR1),( P(t)( is( the(concentration( of( free( bacteriophages( (PFU( mlR1),( I(t)( is( the( concentration( of(infected(bacteria((CFU(mlR1),(k(is(the(bacterial(lysis(rate((hR1),(and(L(is(the(burst(size(of(bacteriophage((PFU).((This(model(was(applied(to(the(infectivity(of(bacteriophages(in(the(presence(and(absence( of( bacteriophages,( and( the( outcomes( are( detailed( and( compared( in( the(following(sections.(
!
7.4.2. Mathematical!Modelling!using!Experimentally!Calculated!
Growth!Parameters!The( infectivity(model( defined( in( Section( 7.4.1(was( used( for( the( estimation( of(infectivity( parameters( both( in( the( presence( and( absence( of( nanoRemulsion(droplets.( As( an( example,( one( experimental( data( set( for( S.# aureus# H325( being(infected(by(Bacteriophage(K(is(shown.((The(inputs(for(the(custom(MATLAB®!programs((phage_fit,(phage_fn,(phage_ode,(
phage_plt,(and(phage_sim)(were:(
• Initial( conditions:( In( this( case( there( are( three( differential( equations,( and(therefore(three(initial(conditions,(which(are(the(initial(concentration(of(both(susceptible( and( infected( bacteria,( and( the( initial( concentration( of(bacteriophage.( It( is( assumed( that( initially( all( bacteria( are( susceptible( of(infection,( and( that( at( the(beginning(of( the( experiment(none(of( the( cells( are(infected( by( bacteriophages.( Therefore( N0( =# S0,# and( I0# =( 0.# N0( is( the(experimental( value( at( time( zero( (CFU( mlR1).( The( initial( concentration( of(phage,(P0,(was(3.5(×(107(PFU(mlR1.((
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• Initial(guesses(for(the(parameters:(Selected(according(to(experimental(data(in(previous( chapters.( The( growth( parameters( calculated( in( Section( 7.3( were(used(either(as(initial(guesses(or(as(fixed(parameters.((
• Timespan(for(the(simulation:(Equal(to(the(experimental(time,(15.5(hours.((













concentration(of(bacteria(reaches(a( lower(peak(concentration((at(about(2.0(×(109(CFU(mlR1).(This(agrees(with(the(fact(that(nanoRemulsions(produce(hindered(growth(of( bacteria,( but( also( with( the( enhanced( infectivity( that( bacteriophage/nanoRemulsion( formulations( have( with( respect( to( simple( phage( suspensions( against(bacterial( infections.( The( fit( generated( by( parameter( estimation( via( optimisation(algorithms( (lsqnonlin)( is( good(as(well,( as( can(be( seen(qualitatively(by( comparing(the(experimental(data((red(crosses)(to(the(simulated(data((continuous(blue(line).(A(quantitative(comparison(of(the(parameters(obtained(in(both(Figures(7.5(and(7.6(is(shown(in(Section(7.4.3.((
7.4.3. Comparison!of!Results!with!and!without!PIT!NanoBemulsions!There( are( certain( estimated( parameters( that( are( dramatically( different( in( the(presence( and( absence( of( nanoRemulsions.( These( differences,( the( reasons( for( the(dissimilarities,(and(their(connexion(with(previous(findings(in(this(thesis(are(shown(in(this(section.(((Firstly,(the(growth(rate(of(bacteria(in(the(presence(of(nanoRemulsion(droplets(is(reduced( by( approximately( one( third( (0.63( hR1( vs.( 0.93( hR1( in( the( absence( of(emulsion).( This( has( been( biologically( explained( and( proved( in( Chapter! 4( and(
Chapter!5(due(to(the(‘’shielding’’(of(the(cell(surface,(which(prevents(nutrients(from(efficiently( penetrate( the( bacterial( cell(wall.(With( respect( to( the(modified( logistic(model(of(growth(that(was(developed(in(Chapter!5,( there(is(also(good(agreement:(the(parameter(n(is(negative(indicating(that(the(growth(rate(is(reduced(with(respect(to(its(value(in(standard(medium.(The(carrying(capacity(shows(a(similar(behaviour(for( identical( reasons( (2.0(×( 109(CFU(mlR1(vs.(4.7(×( 109(CFU(mlR1(in( the(absence(of(emulsion).((The(adsorption(rate,(b,(is(also(reduced(to(almost(half(in(the(presence(of(emulsion(droplets:(this(was(explained(previously(in(this(work(due(to(the(spatial(impediment(that(nanoRemulsions(pose,(since(they(are(very(numerous(in(comparison(to(bacteria(and(bacteriophage,(and(they(are(very(likely(to(cover(their(surfaces.(However,(this(does(not(involve(any(reduction(in(bacteriophage(infectivity.(((
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An(interesting(fact(that(has(not(been(regarded(previously(is(related(to(the(lysis(rate,(k:(it(is(50(%(higher(in(the(presence(of(nanoRemulsions(compared(to(the(lysis(rate( caused( by( simple( bacteriophage( suspensions( in( buffer.( The( lysis( rate( is( not(easily(determined(experimentally,(and(therefore(this(might(mean(that(the(step(that(is(enhanced(the(most((via(nanoRemulsion(droplets)(in(the(infection(process(is(lysis.(((The(determination(of(infection(parameters(via(parameter(estimation(is(a(useful(tool( that( can(be(applied( to(more(complicated(systems,( such(as( the(eradication(of(mixed(bacterial(infections(in(planktonic(culture(using(a(bacteriophage(‘’cocktail’’.(It(can(be(used(to(predict(the(different(bacterial(and(bacteriophage(densities,(since(the(determination( of( such( individual( concentrations( is( experimentally( complicated,(and(can(not(be(discerned(using(turbidity(or(viable(count(assays.((An(example(of(this(is(shown(in(Section(7.5.((
7.5. Mathematical!Modelling!as!a!Predictive!Tool!for!MultiB












'− b1  SS.aureus (t) P1(t)−
−b2  SS.aureus (t) P2 (t) (
dIS.aureus (t)
dt = b1  SS.aureus (t) P1(t)+ b2  SS.aureus (t) P2 (t)− k1 + k2( )  IS.aureus (t) (
dP1(t)
dt = k1  L1  IS.aureus (t)− b1  SS.aureus (t) P1(t) (
dP2 (t)
dt = k2  L2  IS.aureus (t)− b2  SS.aureus (t) P2 (t) (
dSP.aeruginosa (t)








'− b3  SP.aeruginosa (t) P3(t)−
−b4  SP.aeruginosa (t) P4 (t) (
dIP.aeruginosa (t)
dt = b3  SP.aeruginosa (t) P3(t)+ b4  SP.aeruginosa (t) P4 (t)−
− k3 + k4( )  IP.aeruginosa (t) (
dP3(t)
dt = k3  L3  IP.aeruginosa (t)− b3  SP.aeruginosa (t) P3(t) (
dP4 (t)
dt = k4  L4  IP.aeruginosa (t)− b4  SP.aeruginosa (t) P4 (t) (































































aureus( is(extremely(quick.(The(reason( is( logically( the(presence(of(bacteriophages(
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with(relatively(high(adsorption(rates.(S.#aureus(virtually(does(not(grow,(but(decays(immediately( after( adding( bacteriophages( at( time( 0.( On( the( other( hand,( P.#
aeruginosa(grows(until(reaching(a(peak(concentration(of(approximately(1.6(×(106(CFU( mlR1( (not( even( one( log( growth),( before( it( starts( decaying.( In( this( case,( its(growth(rate(is(higher,(combined(with(the(lower(infectivity(of(its(bacteriophages.((Similarly,(in(Figure(7.8,(the(concentration(of(infected(S.#aureus(grows(from(time(0( and,( since( its( bacteriophages( are( very( infective( (despite( the( relatively( low(concentration(of(bacteriophages(that(was(initially(added,(MOI(≈(0.01).(As(their(lysis(rate( is( high( as(well,( the( complete( lysis( of(S.#aureus( occurs( in( the( first( 2(hours( of(treatment.( P.# aeruginosa( infection( is( also( completely( eradicated,( although( at( a(slightly(slower(pace(–(its(concentration(decays(to(0(CFU(mlR1(in(about(3(hours.(((Regarding(bacteriophage(concentrations,( the(higher( lysis(rates(and(burst(sizes(of(Bacteriophage(K(and(DRA88(produce(higher(proliferation(of(such(phages((higher(concentrations( are( achieved( in( the( same( simulation( time),(when( compared(with(DL52( and( DL54.( However,( the( concentration( of( all( bacteriophages( reaches( a(plateau(after(all(bacterial(cells(are(lysed.(If(a(phage(decay(rate(had(been(considered,(this(would(have(meant(a(decrease(in(bacteriophage(concentration(by(the(end(of(the(simulation(time.((This( constitutes( just( an( example( of( the( versatility( of( the( model,( where( the(presence( of( antibiotics,( development( of( resistance,( interactions( amongst( the(species,(etcetera,(could(be(added.(((
7.6. Conclusions!The( aim( of( Chapter! 7( was( essentially( the( development( of( a( successful(parameter( estimation( algorithm( that( would( allow( for( the( determination( of(bacteriophage( infection( parameters,( which( could( be( used( in( simulations( as( a(predictive(tool.(In(this(sense,(the(following(conclusions(can(be(extracted:(1. A( custom( MATLAB®( program( was( developed,( based( on( least( square(minimisation.( It(was( tested( for( the( relatively( simple( estimation(of( bacterial(growth(parameters,(yielding(reasonably(good( fits,( and( therefore( reasonable(values(for(the(parameters,(without(large(computer(resources(needed.(
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2. The( custom( program( was( tested( in( order( to( validate( the( modified( logistic(model(obtained(in(Chapter!5.(The(model(was(proven(to(be(appropriate(when(nanoRemulsions( were( present,( and( the( growth( of( bacteria( was( relatively(hindered( by( the( ‘’protective( layer’’( of( droplets( that( sit( on( the( bacterial( cell(surface.((3. The( custom( program( was( also( used( for( the( estimation( of( infectivity(parameters( both( in( the( presence( and( absence( of( nanoRemulsions.( This( is( a(useful(tool(since(the(experimental(procedures(for(the(determination(of(such(parameters( are( tedious( and( not( very( accurate.( It( also( allowed( for( the(comparison( of( bacteriophage( infection( with( and( without( nanoRemulsions,(confirming( the( observations( in( previous( chapters:( the( adsorption( rate( is(reduced(due(to(spatial( impediments(caused(by(the(droplets;(the(lysis(rate(is(somehow(increased(in(the(presence(of(nanoRemulsions,(and(the(burst(size(is(not( affected( to( the( same( extent.( A( possible( reason( for( the( latter( is( the(difference(in(the(order(of(magnitude(of(the(parameter,(when(compared(to(the(lysis(and(adsorption(rates((the(burst(size(is(one(or(two(orders(of(magnitude(larger).(( 4. Finally,( the( estimated( parameters( were( implemented( in( a( novel( model(formulation,(including(a(mixed(infection((S.#aureus(and(P.#aeruginosa),(treated(with(a(bacteriophage(cocktail.(The(observations( from(the(simulation(can(be(interesting( in(situations(when(experimental(determination(of( the( individual(concentrations(of(the(species(is(complicated.(The(model(is(also(versatile,(and(can(include(several(other(phenomena,(such(as(the(development(of(resistance(of( bacteria( towards( phages( or( antibiotics,( the( combined( treatment( of(bacterial(infections(using(bacteriophages(and(antibiotics,(etcetera.((
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8.1. Conclusions!The( final( conclusions( for( this( work( can( be( summarised( in( relation( to( the(specified(objectives(in(the(Literature(Review.((
1. Stabilisation!of!bacteriophages!using!nanoGemulsions:!Two(reliable(and(reproducible(emulsification(methods(were(successfully(used(to(obtain(nano@emulsions(as(a(biocompatible(vehicle(for(stabilisation,(storage(and(delivery(of(bacteriophages( to( treat(S.#aureus( and(P.#aeruginosa( infections( in(planktonic(culture.(The(differences(between( the( formulations(using(PIT(emulsions(and(Homogenisation(emulsions(were(determined(in(terms(of(bacteriophage(shelf(life,( and( the( influence( that( particle( size( distribution( of( oil@in@water( nano@emulsions(has(on(such(shelf( life(was(found(to(be(significant.(In(particular,(S.#
aureus# and( P.# aeruginosa( bacteriophages( stored( in( PIT( nano@emulsions(showed( enhanced( anti@bacterial( performance( against( different( strains( of(bacteria.( The( enhancement( of( bacteriophage( activity( when( delivered( via(nano@emulsions( constitutes( a( novel( finding( and( it( has( been( published((Esteban(et(al.,(2014).(It(can(be(concluded(that(PIT(formulations(are(suitable(for( storage( and( delivery( of( bacteriophages( to( the( point( of( infection,( rather(than( the( simple( suspension( of( bacteriophages( in( SM( buffer,( whilst(Homogenisation( formulations( yield( inactivation( of( bacteriophages( in( the(storage( period.( Additionally,( it( was( demonstrated( that( both( PIT( and(Homogenisation(nano@emulsions(slow(down(bacterial(growth(for(both(Gram@positive(and(Gram@negative(bacteria(to(a(different(extent(depending(on(how(diluted( they( are.( These( findings( prompted( further( investigation( into( the(mechanisms( that( cause( both( enhanced( bacteriophage( infectivity( and(hindered(bacterial(growth.(!
2. Study! of! the! mechanisms! and! interactions! in! the! bacteriaGemulsionG
bacteriophage! system! from!an! experimental! point! of! view:!A(thorough(investigation(of(how(nano@emulsions(affect(both(infectivity(of(bacteriophages(and(bacterial(growth(was(performed,(since(it(plays(an(important(part(in(the(design(of(the(formulation.(Starting(from(a(simplistic(point(of(view,(the(spatial(distribution( of( the( components( of( the( system( (bacteria,( emulsion( droplets(
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and(bacteriophages)(was(elucidated(via( simple( calculations(of( size,( volume,(surface( area( and( concentration( of( bacteria,( droplets( and( bacteriophages.( It(was(found(that(encapsulation(of(bacteriophages(was(impossible(due(to(steric(impediments,(in(conjunction(with(hydrophobicity(of(bacteriophages(in(some(cases,( and( that( nano@emulsion( droplets( cover( the( surface( of( bacterial( cells(and( are( surrounding( bacteriophages( in( a( much( higher( number.( As( far( as(bacterial(growth(is(concerned,(relationships(between(the(growth(parameters(of( S.# aureus# (growth( rate( and( carrying( capacity)( and( the( concentration( of(nano@emulsion(droplets(were(obtained.(This(allowed(for(the(modification(of(the( conventional( logistic( model( of( growth,( including( new( parameters( that(account(for(the(influence(of(nano@emulsions,(or(more(generally(any(external(factor( that( influences( bacterial( growth.( The( new( model( was( successfully(simulated( and( compared( to( experimental( data( with( modified( bacterial(growth(patterns( in(nano@emulsion(preparations,( and( it( is(useful( to(quantify(delayed( or( partially( inhibited( growth,( but( also( enhanced( growth( in(hypothetical( situations(where( the( carrying( capacity( is( increased.(Regarding(bacteriophage( infectivity,( their( adsorption( rate( and( adsorption( efficiency,(their( eclipse( and( latent( period,( and( their( burst( size( were( experimentally(determined.(The(experimental(determination(of(the(infection(parameters(was(performed( for( both( systems( including( and( not( including( nano@emulsion(droplets(in(order(to(observe(any(differences(that(would(allow(for(explanation(of(the(infection(mechanisms.(The(adsorption(rate(was(found(to(be(slower(in(PIT( nano@emulsions( than( in( SM( buffer,( because( of( the( potential( spatial(impediment( that( a( bacteriophage(may( encounter( when( trying( to( approach(the(bacterial(surface(if(nano@emulsion(droplets(are(covering(the(host(cell.(The(results( for( the( rest( of( the( infection( parameters( were( not( significantly(different( in( the( presence( or( absence( of( nano@emulsions,( and( they(were(not(useful(to(clarify(the(fact(that(bacteriophage(infectivity( is(enhanced(by(nano@emulsions.( Most( importantly,( the( enhanced( infectivity( of(bacteriophage/nano@emulsion( formulations(was(gained(via(measurement(of(Zeta(potential.(It(can(be(concluded(that(electrostatic(interactions(play(a(vital(role(in(this(particular(system,(which(is(supported(by(the(literature.(Values(of(Zeta( potential( of( Bacteriophage( K/PIT( nano@emulsion( compared( with( the(
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values(of(Bacteriophage(K(alone(suggest(that(the(presence(of(nano@emulsions(discards( the( possible( electrostatic( repulsion( between( bacteria( and(bacteriophages( (both( very( negatively( ‘’charged’’),( causing( a( more( effective(contact( that( results( in( the( enhanced( killing( effect( of( our( bacteriophage(formulations.(
3. Assessment! of! the! efficacy! of! bacteriophage/nanoGemulsion!
formulations! for! the! eradication! of! bacterial! biofilms:! This( constitutes(one( step( further( into( a( working( formulation( in( a( realistic( wound(environment.( A( static( model( was( initially( used,( and( it( was( found( that( S.#
aureus( biofilms( are( inhibited( by( the( presence( of( nano@emulsions,( in(agreement( with( previous( discoveries( in( the( literature.( However,( P.#
aeruginosa(biofilms(did(not(show(a(significant(reduction(on(their(biomass(due(to( nano@emulsion( droplets,( possibly( because( their( defence( mechanisms(against( external( factors( are( enhanced( as( a( result( of( forming( part( of( the(biofilm( community.( The( static(model( also( allowed( the( quantification( of( the(effect(of(bacteriophage( ‘’cocktail’’/PIT(nano@emulsion( formulations,(yielding(different(outcomes(for(Gram@positive(and(Gram@negative(bacteria.(The(study(of(biofilms(is(further(approximated(to(the(real(situation(in(a(wound(via(use(of(a( flow(system,( the(modified(Robbins(Device( coupled(with(a( chemostat.(The(chemostat( provides( a( continuous( culture( of( S.# aureus( cells( growing( in( the(exponential( phase,( with( the( potential( of( forming( biofilms( under( flow(conditions.( The( system( was( successfully( designed( and( tested( for( biofilm(growth(and(attack(using(our(formulations.(Confocal(images(and(viable(counts(confirmed( the(effectiveness(and(suitability(of(bacteriophage/nano@emulsion(preparations( against( bacterial( biofilms( in( only( 24( hours( of( treatment.( To(conclude,( the( formulations(prepared(during( this( thesis(have(been(validated(and( proved( extremely( effective( against( bacterial( infections,( both( in(planktonic(culture(and(in(various(biofilm(set@ups.((
4. Theoretical! calculation! of! growth! and! infection! parameters,! and!
prediction!of!different! infection!scenarios!via!mathematical!modelling!
approaches:( Via( development( of( a( successful( parameter( estimation(algorithm( that( allowed( for( the( determination( of( bacteriophage( infection(parameters,(which(can(be(used(in(simulations(as(a(predictive(tool.(A(custom(
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MATLAB®( program(was( developed,( based( on( least( square(minimisation.( It(was( tested( for( the( relatively( simple( estimation( of( bacterial( growth(parameters,( yielding( reasonably( good( fits,( and( therefore( reasonable( values(for( the( parameters,( without( large( computer( resources( needed.( It( was( also(tested(in(order(to(validate(the(modified(logistic(model(when(nano@emulsions(were( present,( and( the( growth( of( bacteria( was( relatively( hindered( by( the(‘’protective(layer’’(of(droplets(that(sit(on(the(bacterial(cell(surface.(The(custom(program(was( also(used( for( the( estimation(of( infectivity(parameters(both( in(the(presence(and(absence(of(nano@emulsions.(This( is(a(useful( tool( since( the(experimental( procedures( for( the( determination( of( such( parameters( are(tedious( and( not( very( accurate.( It( also( allowed( for( the( comparison( of(bacteriophage( infection( with( and( without( nano@emulsions.( Finally,( the(estimated( parameters( were( implemented( in( a( novel( model( formulation,(including( a( mixed( infection( (S.# aureus( and( P.# aeruginosa),( treated( with( a(bacteriophage( cocktail.( The( observations( from( the( simulation( can( be(interesting( in(situations(when(experimental(determination(of( the( individual(concentrations(of(the(species(is(complicated.(The(model(is(also(versatile,(and(can(include(several(other(phenomena,(such(as(the(development(of(resistance(of( bacteria( towards( phages( or( antibiotics,( the( combined( treatment( of(bacterial(infections(using(bacteriophages(and(antibiotics,(etcetera.(((The(outcomes(of( this( thesis( constitute( a( strong(basis( for( the( formulation(of( a(commercial( emulsion( cream( or( impregnated( dressing( containing( stabilised(bacteriophages( that(would(be(able( to( attack(pathogenic(bacteria(present( in(burn(infection( sites.( They( include( the( experimental( and( theoretical( study( of( the(infectivity( of( such( formulations,( and( they( set( the( foundation( for( further(developments,(some(of(which(are(suggested(in(the(next(section.(
!
8.2. Future!Work!Following( the(conclusions(presented(above,( some(suggestions(are( shown(here(for( future( work( on( this( topic.( They( are( mainly( classified( in( two( categories:(experimental(and(theoretical.(
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% First Column is time in hours, 
% Second Column is absorbance in a.u. 
  
t_exp = PaeruginosaGrowthDay0(:,1); 
  
abs_exp = 9951978.09074782 * exp(1.0709234294 * 
PaeruginosaGrowthDay0(:,19));    % Now absorbance is converted  
                                                                            
% into bacterial density (CFU/ml) 
    
% Fixed initial conditions 
  
x0 = abs_exp(1); 
  
% Fixed model parameters (Initial guesses?) 
  
a = pars(1);%0.2; 
K = pars(2);%3e9; 
  
p = [a, K]; 
  
% Simulation time vector: 
  
tspan = t_exp; 
  
% 2 unknown model parameters: 
    p_init = [a 
              K];  
           
%0 known parameters: 
  
    p_fix = []; 
     
lb = 0*ones(size(p_init)); 
ub = []; 
options = optimset('Display','iter','TolFun', 1e-20,'TolX',1e-20); 
plt = 0; 
  












varp = resnorm*inv(Jacobian'*Jacobian)/length(tspan); 
  
stdp = sqrt(diag(varp)); %The standard deviation is the square root 
                         %of the variance 
                          
%p = [a,       K]; 
  
p = [p_est(1), p_est(2)]; 
  
x0 = abs_exp(1); 
disp(' Parameters:') 
disp([' a = ', num2str(p_est(1)), ' +/- ', num2str(stdp(1))]) 
disp([' C = ', num2str(p_est(2)), ' +/- ', num2str(stdp(2))]) 
  
plt = 1; 
  
abs = growth_sim(tspan,x0, p,plt); 
end (
growth_fn.m!




abs_exp = 9951978.09074782 * exp(1.0709234294 * 
PaeruginosaGrowthDay0(:,19)); 
  
p = [p_var(1), p_var(2), p_fix]; 
  
x0 = abs_exp(1); 
  
abs = growth_sim(tspan,x0, p, 0); 
  
%LSQNONLIN: objective function should return the model error 
  





function dxout = growth_ode(t,x,p) 
  
a = p(1); 




db = a*x(1)*(1-((1/K)*x(1)));  
  
dxout = db'; (
growth_plt.m!


















function abs = growth_sim(tspan,x0,p,plt) 
  
ode_options = []; 
[t,x] = ode15s(@growth_ode,tspan,x0,ode_options, p); 
  
%Output 
    abs = x(:,1); 
if plt==1 
























title('Multistart: Distribution of Normal residual values') 
figure 
hist(pmultistart(2,:),n_starts) 
title('Multistart: Distribution of parameter a values') 
figure 
hist(pmultistart(3,:),n_starts) 
title('Multistart: Distribution of log of parameter C values') 
!(
